<!DOCTYPE html>
<html lang="en" class="no-js">
    <head>
        <meta charset="UTF-8">
        <meta http-equiv="X-UA-Compatible" content="IE=edge">
        <meta name="applicable-device" content="pc,mobile">
        <meta name="viewport" content="width=device-width, initial-scale=1">

        <title>A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFÎ²-mediated breast cancer cell migration and invasion | Breast Cancer Research | Full Text</title>

        

    <meta name="citation_abstract" content="Tumor cell migration and invasion are critical initiation steps in the process of breast cancer metastasis, the primary cause of breast cancer morbidity and death. Here we investigated the role of p21Cip1 (p21), a member of the core cell cycle machinery, in transforming growth factor-beta (TGF&#946;)-mediated breast cancer cell migration and invasion. A mammary fat pad xenograft mouse model was used to assess the mammary tumor growth and local invasion. The triple negative human breast cancer cell lines MDA-MB231 and its sub-progenies SCP2 and SCP25, SUM159PT, SUM149PT, SUM229PE and SUM1315MO2 were treated with 5 ng/ml TGF&#946; and the protein expression levels were measured by Western blot. Cell migration and invasion were examined using the scratch/wound healing and Transwell assay. TGF&#946; transcriptional activity was measured by a TGF&#946;/Smad reporter construct (CAGA12-luc) using luciferase assay. q-PCR was used for assessing TGF&#946; downstream target genes. The interactions among p21, p/CAF and Smad3 were performed by co-immunoprecipitation. In addition, Smad3 on DNA binding ability was measured by DNA immunoprecipitation using biotinylated Smad binding element DNA probes. Finally, the association among active TGF&#946;/Smad signaling, p21 and p/CAF with lymph node metastasis was examined by immunohistochemistry in tissue microarray containing 50 invasive ductal breast tumors, 25 of which are lymph node positive. We found p21 expression to correlate with poor overall and distant metastasis free survival in breast cancer patients. Furthermore, using xenograft animal models and in vitro studies, we found p21 to be essential for tumor cell invasion. The invasive effects of p21 were found to correlate with Smad3, and p/CAF interaction downstream of TGF&#946;. p21 and p/CAF regulates TGF&#946;-mediated transcription of pro-metastatic genes by controlling Smad3 acetylation, DNA binding and transcriptional activity. In addition, we found that active TGF&#946;/Smad signaling correlates with high p21 and p/CAF expression levels and lymph node involvement using tissue microarrays from breast cancer patients. Together these results highlight an important role for p21 and p/CAF in promoting breast cancer cell migration and invasion at the transcriptional level and may open new avenues for breast cancer therapy.">

    <meta name="journal_id" content="13058">

    <meta name="dc.title" content="A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGF&#946;-mediated breast cancer cell migration and invasion">

    <meta name="dc.source" content="Breast Cancer Research 2012 14:5">

    <meta name="dc.format" content="text/html">

    <meta name="dc.publisher" content="BioMed Central">

    <meta name="dc.date" content="2012-09-20">

    <meta name="dc.type" content="OriginalPaper">

    <meta name="dc.language" content="En">

    <meta name="dc.copyright" content="2012 Dai et al.; licensee BioMed Central Ltd.">

    <meta name="dc.rights" content="http://creativecommons.org/licenses/by/2.0">

    <meta name="dc.rightsAgent" content="reprints@biomedcentral.com">

    <meta name="dc.description" content="Tumor cell migration and invasion are critical initiation steps in the process of breast cancer metastasis, the primary cause of breast cancer morbidity and death. Here we investigated the role of p21Cip1 (p21), a member of the core cell cycle machinery, in transforming growth factor-beta (TGF&#946;)-mediated breast cancer cell migration and invasion. A mammary fat pad xenograft mouse model was used to assess the mammary tumor growth and local invasion. The triple negative human breast cancer cell lines MDA-MB231 and its sub-progenies SCP2 and SCP25, SUM159PT, SUM149PT, SUM229PE and SUM1315MO2 were treated with 5 ng/ml TGF&#946; and the protein expression levels were measured by Western blot. Cell migration and invasion were examined using the scratch/wound healing and Transwell assay. TGF&#946; transcriptional activity was measured by a TGF&#946;/Smad reporter construct (CAGA12-luc) using luciferase assay. q-PCR was used for assessing TGF&#946; downstream target genes. The interactions among p21, p/CAF and Smad3 were performed by co-immunoprecipitation. In addition, Smad3 on DNA binding ability was measured by DNA immunoprecipitation using biotinylated Smad binding element DNA probes. Finally, the association among active TGF&#946;/Smad signaling, p21 and p/CAF with lymph node metastasis was examined by immunohistochemistry in tissue microarray containing 50 invasive ductal breast tumors, 25 of which are lymph node positive. We found p21 expression to correlate with poor overall and distant metastasis free survival in breast cancer patients. Furthermore, using xenograft animal models and in vitro studies, we found p21 to be essential for tumor cell invasion. The invasive effects of p21 were found to correlate with Smad3, and p/CAF interaction downstream of TGF&#946;. p21 and p/CAF regulates TGF&#946;-mediated transcription of pro-metastatic genes by controlling Smad3 acetylation, DNA binding and transcriptional activity. In addition, we found that active TGF&#946;/Smad signaling correlates with high p21 and p/CAF expression levels and lymph node involvement using tissue microarrays from breast cancer patients. Together these results highlight an important role for p21 and p/CAF in promoting breast cancer cell migration and invasion at the transcriptional level and may open new avenues for breast cancer therapy.">

    <meta name="prism.issn" content="1465-542X">

    <meta name="prism.publicationName" content="Breast Cancer Research">

    <meta name="prism.publicationDate" content="2012-09-20">

    <meta name="prism.volume" content="14">

    <meta name="prism.number" content="5">

    <meta name="prism.section" content="OriginalPaper">

    <meta name="prism.startingPage" content="1">

    <meta name="prism.endingPage" content="22">

    <meta name="prism.copyright" content="2012 Dai et al.; licensee BioMed Central Ltd.">

    <meta name="prism.rightsAgent" content="reprints@biomedcentral.com">

    <meta name="prism.url" content="https://breast-cancer-research.biomedcentral.com/articles/10.1186/bcr3322">

    <meta name="prism.doi" content="doi:10.1186/bcr3322">

    <meta name="citation_pdf_url" content="https://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3322">

    <meta name="citation_fulltext_html_url" content="https://breast-cancer-research.biomedcentral.com/articles/10.1186/bcr3322">

    <meta name="citation_journal_title" content="Breast Cancer Research">

    <meta name="citation_journal_abbrev" content="Breast Cancer Res">

    <meta name="citation_publisher" content="BioMed Central">

    <meta name="citation_issn" content="1465-542X">

    <meta name="citation_title" content="A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGF&#946;-mediated breast cancer cell migration and invasion">

    <meta name="citation_volume" content="14">

    <meta name="citation_issue" content="5">

    <meta name="citation_publication_date" content="2012/10">

    <meta name="citation_online_date" content="2012/09/20">

    <meta name="citation_firstpage" content="1">

    <meta name="citation_lastpage" content="22">

    <meta name="citation_article_type" content="Research article">

    <meta name="citation_fulltext_world_readable" content="">

    <meta name="citation_language" content="en">

    <meta name="dc.identifier" content="doi:10.1186/bcr3322">

    <meta name="DOI" content="10.1186/bcr3322">

    <meta name="citation_doi" content="10.1186/bcr3322">

    <meta name="description" content="Tumor cell migration and invasion are critical initiation steps in the process of breast cancer metastasis, the primary cause of breast cancer morbidity and death. Here we investigated the role of p21Cip1 (p21), a member of the core cell cycle machinery, in transforming growth factor-beta (TGF&#946;)-mediated breast cancer cell migration and invasion. A mammary fat pad xenograft mouse model was used to assess the mammary tumor growth and local invasion. The triple negative human breast cancer cell lines MDA-MB231 and its sub-progenies SCP2 and SCP25, SUM159PT, SUM149PT, SUM229PE and SUM1315MO2 were treated with 5 ng/ml TGF&#946; and the protein expression levels were measured by Western blot. Cell migration and invasion were examined using the scratch/wound healing and Transwell assay. TGF&#946; transcriptional activity was measured by a TGF&#946;/Smad reporter construct (CAGA12-luc) using luciferase assay. q-PCR was used for assessing TGF&#946; downstream target genes. The interactions among p21, p/CAF and Smad3 were performed by co-immunoprecipitation. In addition, Smad3 on DNA binding ability was measured by DNA immunoprecipitation using biotinylated Smad binding element DNA probes. Finally, the association among active TGF&#946;/Smad signaling, p21 and p/CAF with lymph node metastasis was examined by immunohistochemistry in tissue microarray containing 50 invasive ductal breast tumors, 25 of which are lymph node positive. We found p21 expression to correlate with poor overall and distant metastasis free survival in breast cancer patients. Furthermore, using xenograft animal models and in vitro studies, we found p21 to be essential for tumor cell invasion. The invasive effects of p21 were found to correlate with Smad3, and p/CAF interaction downstream of TGF&#946;. p21 and p/CAF regulates TGF&#946;-mediated transcription of pro-metastatic genes by controlling Smad3 acetylation, DNA binding and transcriptional activity. In addition, we found that active TGF&#946;/Smad signaling correlates with high p21 and p/CAF expression levels and lymph node involvement using tissue microarrays from breast cancer patients. Together these results highlight an important role for p21 and p/CAF in promoting breast cancer cell migration and invasion at the transcriptional level and may open new avenues for breast cancer therapy.">

    <meta name="dc.creator" content="Dai, Meiou">

    <meta name="dc.creator" content="Al-Odaini, Amal A">

    <meta name="dc.creator" content="Arakelian, Ani">

    <meta name="dc.creator" content="Rabbani, Shafaat A">

    <meta name="dc.creator" content="Ali, Suhad">

    <meta name="dc.creator" content="Lebrun, Jean-Jacques">

    <meta name="dc.subject" content="Cancer Research">

    <meta name="dc.subject" content="Oncology">

    <meta name="dc.subject" content="Surgical Oncology">

    <meta name="citation_reference" content="citation_journal_title=Cell; citation_title=The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases; citation_author=JW Harper, GR Adami, N Wei, K Keyomarsi, SJ Elledge; citation_volume=75; citation_publication_date=1993; citation_pages=805-816; citation_doi=10.1016/0092-8674(93)90499-G; citation_id=CR1_3055">

    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=p21 is a universal inhibitor of cyclin kinases; citation_author=Y Xiong, GJ Hannon, H Zhang, D Casso, R Kobayashi, D Beach; citation_volume=366; citation_publication_date=1993; citation_pages=701-704; citation_doi=10.1038/366701a0; citation_id=CR2_3055">

    <meta name="citation_reference" content="citation_journal_title=Cell; citation_title=p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21; citation_author=H Toyoshima, T Hunter; citation_volume=78; citation_publication_date=1994; citation_pages=67-74; citation_doi=10.1016/0092-8674(94)90573-8; citation_id=CR3_3055">

    <meta name="citation_reference" content="citation_journal_title=Genes Dev; citation_title=p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene; citation_author=S Matsuoka, MC Edwards, C Bai, S Parker, P Zhang, A Baldini, JW Harper, SJ Elledge; citation_volume=9; citation_publication_date=1995; citation_pages=650-662; citation_doi=10.1101/gad.9.6.650; citation_id=CR4_3055">

    <meta name="citation_reference" content="citation_journal_title=Nat Rev Cancer; citation_title=Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors?; citation_author=A Besson, RK Assoian, JM Roberts; citation_volume=4; citation_publication_date=2004; citation_pages=948-955; citation_doi=10.1038/nrc1501; citation_id=CR5_3055">

    <meta name="citation_reference" content="citation_journal_title=Dev Cell; citation_title=CDK inhibitors: cell cycle regulators and beyond; citation_author=A Besson, SF Dowdy, JM Roberts; citation_volume=14; citation_publication_date=2008; citation_pages=159-169; citation_doi=10.1016/j.devcel.2008.01.013; citation_id=CR6_3055">

    <meta name="citation_reference" content="citation_journal_title=Nat Rev Cancer; citation_title=p21 in cancer: intricate networks and multiple activities; citation_author=T Abbas, A Dutta; citation_volume=9; citation_publication_date=2009; citation_pages=400-414; citation_doi=10.1038/nrc2657; citation_id=CR7_3055">

    <meta name="citation_reference" content="citation_journal_title=Blood; citation_title=Absence of WAF1 mutations in a variety of human malignancies; citation_author=M Shiohara, WS el-Deiry, M Wada, T Nakamaki, S Takeuchi, R Yang, DL Chen, B Vogelstein, HP Koeffler; citation_volume=84; citation_publication_date=1994; citation_pages=3781-3784; citation_id=CR8_3055">

    <meta name="citation_reference" content="citation_journal_title=Cell; citation_title=Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control; citation_author=C Deng, P Zhang, JW Harper, SJ Elledge, P Leder; citation_volume=82; citation_publication_date=1995; citation_pages=675-684; citation_doi=10.1016/0092-8674(95)90039-X; citation_id=CR9_3055">

    <meta name="citation_reference" content="citation_journal_title=Cancer Res; citation_title=Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia; citation_author=AV Biankin, JG Kench, AL Morey, CS Lee, SA Biankin, DR Head, TB Hugh, SM Henshall, RL Sutherland; citation_volume=61; citation_publication_date=2001; citation_pages=8830-8837; citation_id=CR10_3055">

    <meta name="citation_reference" content="citation_journal_title=Cancer Lett; citation_title=Aberrant expression of p21(WAF1/CIP1) and p27(KIP1) in cervical carcinoma; citation_author=TH Cheung, KW Lo, MM Yu, SF Yim, CS Poon, TK Chung, YF Wong; citation_volume=172; citation_publication_date=2001; citation_pages=93-98; citation_doi=10.1016/S0304-3835(01)00624-3; citation_id=CR11_3055">

    <meta name="citation_reference" content="citation_journal_title=Int J Oncol; citation_title=p21WAF1/CIP1 protein expression in primary ovarian cancer; citation_author=G Ferrandina, A Stoler, A Fagotti, F Fanfani, R Sacco, A De Pasqua, S Mancuso, G Scambia; citation_volume=17; citation_publication_date=2000; citation_pages=1231-1235; citation_id=CR12_3055">

    <meta name="citation_reference" content="citation_journal_title=Prostate; citation_title=Prognostic value and expression of p21(waf1/cip1) protein in prostate cancer; citation_author=S Aaltomaa, P Lipponen, M Eskelinen, M Ala-Opas, VM Kosma; citation_volume=39; citation_publication_date=1999; citation_pages=8-15; citation_doi=10.1002/(SICI)1097-0045(19990401)39:1&lt;8::AID-PROS2&gt;3.0.CO;2-N; citation_id=CR13_3055">

    <meta name="citation_reference" content="citation_journal_title=Genes Dev; citation_title=Migratory neighbors and distant invaders: tumor-associated niche cells; citation_author=J Wels, RN Kaplan, S Rafii, D Lyden; citation_volume=22; citation_publication_date=2008; citation_pages=559-574; citation_doi=10.1101/gad.1636908; citation_id=CR14_3055">

    <meta name="citation_reference" content="citation_journal_title=Nat Rev Cancer; citation_title=TGFbeta signalling: a complex web in cancer progression; citation_author=H Ikushima, K Miyazono; citation_volume=10; citation_publication_date=2010; citation_pages=415-424; citation_doi=10.1038/nrc2853; citation_id=CR15_3055">

    <meta name="citation_reference" content="citation_journal_title=Annu Rev Cell Biol; citation_title=The transforming growth factor-beta family; citation_author=J Massague; citation_volume=6; citation_publication_date=1990; citation_pages=597-641; citation_doi=10.1146/annurev.cb.06.110190.003121; citation_id=CR16_3055">

    <meta name="citation_reference" content="citation_journal_title=Cell Res; citation_title=Roles of TGFbeta in metastasis; citation_author=D Padua, J Massague; citation_volume=19; citation_publication_date=2009; citation_pages=89-102; citation_doi=10.1038/cr.2008.316; citation_id=CR17_3055">

    <meta name="citation_reference" content="citation_journal_title=Proc Natl Acad Sci USA; citation_title=Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program; citation_author=CR Chen, Y Kang, J Massague; citation_volume=98; citation_publication_date=2001; citation_pages=992-999; citation_doi=10.1073/pnas.98.3.992; citation_id=CR18_3055">

    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest; citation_author=GJ Hannon, D Beach; citation_volume=371; citation_publication_date=1994; citation_pages=257-261; citation_doi=10.1038/371257a0; citation_id=CR19_3055">

    <meta name="citation_reference" content="citation_journal_title=J Biol Chem; citation_title=Potential role of WAF1/Cip1/p21 as a mediator of TGF-beta cytoinhibitory effect; citation_author=CY Li, L Suardet, JB Little; citation_volume=270; citation_publication_date=1995; citation_pages=4971-4974; citation_doi=10.1074/jbc.270.10.4971; citation_id=CR20_3055">

    <meta name="citation_reference" content="citation_journal_title=Nat Genet; citation_title=TGF-beta signaling in tumor suppression and cancer progression; citation_author=R Derynck, RJ Akhurst, A Balmain; citation_volume=29; citation_publication_date=2001; citation_pages=117-129; citation_doi=10.1038/ng1001-117; citation_id=CR21_3055">

    <meta name="citation_reference" content="citation_journal_title=Trends Cell Biol; citation_title=TGF-beta signaling in cancer -- a double-edged sword; citation_author=RJ Akhurst, R Derynck; citation_volume=11; citation_publication_date=2001; citation_pages=S44-51; citation_id=CR22_3055">

    <meta name="citation_reference" content="citation_journal_title=Curr Opin Genet Dev; citation_title=TGF-beta signaling: positive and negative effects on tumorigenesis; citation_author=LM Wakefield, AB Roberts; citation_volume=12; citation_publication_date=2002; citation_pages=22-29; citation_doi=10.1016/S0959-437X(01)00259-3; citation_id=CR23_3055">

    <meta name="citation_reference" content="citation_journal_title=J Clin Invest; citation_title=TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression; citation_author=B Tang, M Vu, T Booker, SJ Santner, FR Miller, MR Anver, LM Wakefield; citation_volume=112; citation_publication_date=2003; citation_pages=1116-1124; citation_doi=10.1172/JCI200318899; citation_id=CR24_3055">

    <meta name="citation_reference" content="citation_journal_title=Trends Cell Mol Biol; citation_title=Targeting TGF-beta signaling in human cancer therapy; citation_author=L Humbert, JC Neel, JJ Lebrun; citation_volume=5; citation_publication_date=2010; citation_pages=69-107; citation_id=CR25_3055">

    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A; citation_author=XJ Yang, VV Ogryzko, J Nishikawa, BH Howard, Y Nakatani; citation_volume=382; citation_publication_date=1996; citation_pages=319-324; citation_doi=10.1038/382319a0; citation_id=CR26_3055">

    <meta name="citation_reference" content="citation_journal_title=Nat Cell Biol; citation_title=Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells; citation_author=BP Zhou, Y Liao, W Xia, B Spohn, MH Lee, MC Hung; citation_volume=3; citation_publication_date=2001; citation_pages=245-252; citation_doi=10.1038/35060032; citation_id=CR27_3055">

    <meta name="citation_reference" content="citation_journal_title=Nat Protoc; citation_title=Extraction, purification and analysis of histones; citation_author=D Shechter, HL Dormann, CD Allis, SB Hake; citation_volume=2; citation_publication_date=2007; citation_pages=1445-1457; citation_doi=10.1038/nprot.2007.202; citation_id=CR28_3055">

    <meta name="citation_reference" content="citation_journal_title=Mol Cell; citation_title=PARP-1 attenuates Smad-mediated transcription; citation_author=P Lonn, LP van der Heide, M Dahl, U Hellman, CH Heldin, A Moustakas; citation_volume=40; citation_publication_date=2010; citation_pages=521-532; citation_doi=10.1016/j.molcel.2010.10.029; citation_id=CR29_3055">

    <meta name="citation_reference" content="citation_journal_title=Clin Cancer Res; citation_title=The bisphosphonate olpadronate inhibits skeletal prostate cancer progression in a green fluorescent protein nude mouse model; citation_author=M Yang, DW Burton, J Geller, DJ Hillegonds, RH Hastings, LJ Deftos, RM Hoffman; citation_volume=12; citation_publication_date=2006; citation_pages=2602-2606; citation_doi=10.1158/1078-0432.CCR-05-2050; citation_id=CR30_3055">

    <meta name="citation_reference" content="citation_journal_title=Eur J Cancer; citation_title=Subcellular localisation of cyclin B, Cdc2 and p21(WAF1/CIP1) in breast cancer. association with prognosis; citation_author=ZE Winters, NC Hunt, MJ Bradburn, JA Royds, H Turley, AL Harris, CJ Norbury; citation_volume=37; citation_publication_date=2001; citation_pages=2405-2412; citation_doi=10.1016/S0959-8049(01)00327-6; citation_id=CR31_3055">

    <meta name="citation_reference" content="citation_journal_title=Clin Cancer Res; citation_title=Phosphorylation/cytoplasmic localization of p21Cip1/WAF1 is associated with HER2/neu overexpression and provides a novel combination predictor for poor prognosis in breast cancer patients; citation_author=W Xia, JS Chen, X Zhou, PR Sun, DF Lee, Y Liao, BP Zhou, MC Hung; citation_volume=10; citation_publication_date=2004; citation_pages=3815-3824; citation_doi=10.1158/1078-0432.CCR-03-0527; citation_id=CR32_3055">

    <meta name="citation_reference" content="citation_journal_title=Breast Cancer Res; citation_title=Cytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/neu in breast cancer and is an independent predictor of prognosis; citation_author=ZE Winters, RD Leek, MJ Bradburn, CJ Norbury, AL Harris; citation_volume=5; citation_publication_date=2003; citation_pages=R242-249; citation_doi=10.1186/bcr654; citation_id=CR33_3055">

    <meta name="citation_reference" content="citation_journal_title=Breast Cancer Res Treat; citation_title=An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients; citation_author=B Gyorffy, A Lanczky, AC Eklund, C Denkert, J Budczies, Q Li, Z Szallasi; citation_volume=123; citation_publication_date=2010; citation_pages=725-731; citation_doi=10.1007/s10549-009-0674-9; citation_id=CR34_3055">

    <meta name="citation_reference" content="citation_journal_title=Proc Natl Acad Sci USA; citation_title=Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway; citation_author=Y Kang, W He, S Tulley, GP Gupta, I Serganova, CR Chen, K Manova-Todorova, R Blasberg, WL Gerald, J Massague; citation_volume=102; citation_publication_date=2005; citation_pages=13909-13914; citation_doi=10.1073/pnas.0506517102; citation_id=CR35_3055">

    <meta name="citation_reference" content="citation_journal_title=Cell; citation_title=A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis; citation_author=S Valastyan, F Reinhardt, N Benaich, D Calogrias, AM Szasz, ZC Wang, JE Brock, AL Richardson, RA Weinberg; citation_volume=137; citation_publication_date=2009; citation_pages=1032-1046; citation_doi=10.1016/j.cell.2009.03.047; citation_id=CR36_3055">

    <meta name="citation_reference" content="citation_journal_title=Nat Rev Cancer; citation_title=The pathogenesis of cancer metastasis: the &#39;seed and soil&#39; hypothesis revisited; citation_author=IJ Fidler; citation_volume=3; citation_publication_date=2003; citation_pages=453-458; citation_doi=10.1038/nrc1098; citation_id=CR37_3055">

    <meta name="citation_reference" content="citation_journal_title=Cancer Cell; citation_title=Latent bone metastasis in breast cancer tied to Src-dependent survival signals; citation_author=XH Zhang, Q Wang, W Gerald, CA Hudis, L Norton, M Smid, JA Foekens, J Massague; citation_volume=16; citation_publication_date=2009; citation_pages=67-78; citation_doi=10.1016/j.ccr.2009.05.017; citation_id=CR38_3055">

    <meta name="citation_reference" content="citation_journal_title=Proc Natl Acad Sci USA; citation_title=Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism; citation_author=MB Datto, Y Li, JF Panus, DJ Howe, Y Xiong, XF Wang; citation_volume=92; citation_publication_date=1995; citation_pages=5545-5549; citation_doi=10.1073/pnas.92.12.5545; citation_id=CR39_3055">

    <meta name="citation_reference" content="citation_journal_title=J Clin Invest; citation_title=Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors; citation_author=AJ Minn, Y Kang, I Serganova, GP Gupta, DD Giri, M Doubrovin, V Ponomarev, WL Gerald, R Blasberg, J Massague; citation_volume=115; citation_publication_date=2005; citation_pages=44-55; citation_doi=10.1172/JCI22320; citation_id=CR40_3055">

    <meta name="citation_reference" content="citation_journal_title=Cancer Cell; citation_title=A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes; citation_author=RM Neve, K Chin, J Fridlyand, J Yeh, FL Baehner, T Fevr, L Clark, N Bayani, JP Coppe, F Tong, T Speed, PT Spellman, S DeVries, A Lapuk, NJ Wang, WL Kuo, JL Stilwell, D Pinkel, DG Albertson, FM Waldman, F McCormick, RB Dickson, MD Johnson, M Lippman, S Ethier, A Gazdar, JW Gray; citation_volume=10; citation_publication_date=2006; citation_pages=515-527; citation_doi=10.1016/j.ccr.2006.10.008; citation_id=CR41_3055">

    <meta name="citation_reference" content="citation_journal_title=Mol Biol Cell; citation_title=The RhoA activator GEF-H1/Lfc is a transforming growth factor-beta target gene and effector that regulates alpha-smooth muscle actin expression and cell migration; citation_author=A Tsapara, P Luthert, J Greenwood, CS Hill, K Matter, MS Balda; citation_volume=21; citation_publication_date=2010; citation_pages=860-870; citation_doi=10.1091/mbc.E09-07-0567; citation_id=CR42_3055">

    <meta name="citation_reference" content="citation_journal_title=Dev Cell; citation_title=CRL2(LRR-1) targets a CDK inhibitor for cell cycle control in C. elegans and actin-based motility regulation in human cells; citation_author=NG Starostina, JM Simpliciano, MA McGuirk, ET Kipreos; citation_volume=19; citation_publication_date=2010; citation_pages=753-764; citation_doi=10.1016/j.devcel.2010.10.013; citation_id=CR43_3055">

    <meta name="citation_reference" content="citation_journal_title=J Biol Chem; citation_title=Cytoplasmic p21Cip1 is involved in Ras-induced inhibition of the ROCK/LIMK/cofilin pathway; citation_author=S Lee, DM Helfman; citation_volume=279; citation_publication_date=2004; citation_pages=1885-1891; citation_doi=10.1074/jbc.M306968200; citation_id=CR44_3055">

    <meta name="citation_reference" content="citation_journal_title=Proc Natl Acad Sci USA; citation_title=Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases; citation_author=BD Chang, K Watanabe, EV Broude, J Fang, JC Poole, TV Kalinichenko, IB Roninson; citation_volume=97; citation_publication_date=2000; citation_pages=4291-4296; citation_doi=10.1073/pnas.97.8.4291; citation_id=CR45_3055">

    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=Cancer-related inflammation; citation_author=A Mantovani, P Allavena, A Sica, F Balkwill; citation_volume=454; citation_publication_date=2008; citation_pages=436-444; citation_doi=10.1038/nature07205; citation_id=CR46_3055">

    <meta name="citation_reference" content="citation_journal_title=Mol Cell Biol; citation_title=A novel transcriptional repression domain mediates p21(WAF1/CIP1) induction of p300 transactivation; citation_author=AW Snowden, LA Anderson, GA Webster, ND Perkins; citation_volume=20; citation_publication_date=2000; citation_pages=2676-2686; citation_doi=10.1128/MCB.20.8.2676-2686.2000; citation_id=CR47_3055">

    <meta name="citation_reference" content="citation_journal_title=Mol Cell Biol; citation_title=p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha; citation_author=A Fritah, C Saucier, J Mester, G Redeuilh, M Sabbah; citation_volume=25; citation_publication_date=2005; citation_pages=2419-2430; citation_doi=10.1128/MCB.25.6.2419-2430.2005; citation_id=CR48_3055">

    <meta name="citation_reference" content="citation_journal_title=Oncogene; citation_title=Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation; citation_author=Z Nagy, L Tora; citation_volume=26; citation_publication_date=2007; citation_pages=5341-5357; citation_doi=10.1038/sj.onc.1210604; citation_id=CR49_3055">

    <meta name="citation_reference" content="citation_journal_title=Nucleic Acids Res; citation_title=The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling; citation_author=S Itoh, J Ericsson, J Nishikawa, CH Heldin, P Ten Dijke; citation_volume=28; citation_publication_date=2000; citation_pages=4291-4298; citation_doi=10.1093/nar/28.21.4291; citation_id=CR50_3055">

    <meta name="citation_reference" content="citation_journal_title=J Biol Chem; citation_title=The DNA binding activities of Smad2 and Smad3 are regulated by coactivator-mediated acetylation; citation_author=M Simonsson, M Kanduri, E Gronroos, CH Heldin, J Ericsson; citation_volume=281; citation_publication_date=2006; citation_pages=39870-39880; citation_doi=10.1074/jbc.M607868200; citation_id=CR51_3055">

    <meta name="citation_reference" content="citation_journal_title=J Biol Chem; citation_title=Smad signaling antagonizes STAT5-mediated gene transcription and mammary epithelial cell differentiation; citation_author=E Cocolakis, M Dai, L Drevet, J Ho, E Haines, S Ali, JJ Lebrun; citation_volume=283; citation_publication_date=2008; citation_pages=1293-1307; citation_doi=10.1074/jbc.M707492200; citation_id=CR52_3055">

    <meta name="citation_reference" content="citation_journal_title=N Engl J Med; citation_title=Micrometastases or isolated tumor cells and the outcome of breast cancer; citation_author=M de Boer, CH van Deurzen, JA van Dijck, GF Borm, PJ van Diest, EM Adang, JW Nortier, EJ Rutgers, C Seynaeve, MB Menke-Pluymers, P Bult, VC Tjan-Heijnen; citation_volume=361; citation_publication_date=2009; citation_pages=653-663; citation_doi=10.1056/NEJMoa0904832; citation_id=CR53_3055">

    <meta name="citation_reference" content="citation_journal_title=Am J Pathol; citation_title=Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma; citation_author=BI Dalal, PA Keown, AH Greenberg; citation_volume=143; citation_publication_date=1993; citation_pages=381-389; citation_id=CR54_3055">

    <meta name="citation_reference" content="citation_journal_title=J Cell Biol; citation_title=Cytoplasmic p21(Cip1/WAF1) regulates neurite remodeling by inhibiting Rho-kinase activity; citation_author=H Tanaka, T Yamashita, M Asada, S Mizutani, H Yoshikawa, M Tohyama; citation_volume=158; citation_publication_date=2002; citation_pages=321-329; citation_doi=10.1083/jcb.200202071; citation_id=CR55_3055">

    <meta name="citation_reference" content="citation_journal_title=Cell; citation_title=Mechanisms of TGF-beta signaling from cell membrane to the nucleus; citation_author=Y Shi, J Massague; citation_volume=113; citation_publication_date=2003; citation_pages=685-700; citation_doi=10.1016/S0092-8674(03)00432-X; citation_id=CR56_3055">

    <meta name="citation_reference" content="citation_journal_title=Cancer Res; citation_title=Reduction in Smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines; citation_author=F Tian, S DaCosta Byfield, WT Parks, S Yoo, A Felici, B Tang, E Piek, LM Wakefield, AB Roberts; citation_volume=63; citation_publication_date=2003; citation_pages=8284-8292; citation_id=CR57_3055">

    <meta name="citation_reference" content="Petersen M, Pardali E, van der Horst G, Cheung H, van den Hoogen C, van der Pluijm G, Ten Dijke P: Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis. 
Oncogene 
29:1351&#8211;1361.">

    <meta name="citation_author" content="Dai, Meiou">

    <meta name="citation_author_institution" content="Division of Medical Oncology, Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada">

    <meta name="citation_author" content="Al-Odaini, Amal A">

    <meta name="citation_author_institution" content="Division of Medical Oncology, Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada">

    <meta name="citation_author" content="Arakelian, Ani">

    <meta name="citation_author_institution" content="Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada">

    <meta name="citation_author" content="Rabbani, Shafaat A">

    <meta name="citation_author_institution" content="Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada">

    <meta name="citation_author" content="Ali, Suhad">

    <meta name="citation_author_institution" content="Division of Medical Oncology, Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada">

    <meta name="citation_author" content="Lebrun, Jean-Jacques">

    <meta name="citation_author_institution" content="Division of Medical Oncology, Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada">



        <meta name="format-detection" content="telephone=no">

        
<link rel="apple-touch-icon" sizes="180x180" href=/static/img/favicons/bmc/apple-touch-icon-582ef1d0f5.png>
<link rel="icon" type="image/png" sizes="32x32" href=/static/img/favicons/bmc/favicon-32x32-5d7879efe1.png>
<link rel="icon" type="image/png" sizes="16x16" href=/static/img/favicons/bmc/favicon-16x16-c241ac1a2f.png>
<link rel="manifest" href=/static/app-bmc/manifest-3bb9ad383b.json>
<link rel="mask-icon" href=/static/img/favicons/bmc/safari-pinned-tab-427338756f.svg color="#e6e6e6">
<link rel="shortcut icon" data-test="shortcut-icon" href=/static/img/favicons/bmc/favicon-1886637b78.ico>
<meta name="msapplication-config" content=/static/app-bmc/browserconfig-ecd9aa8205.xml>
<meta name="msapplication-TileColor"
      content="#1b3051">
<meta name="msapplication-TileImage"
      content=/static/img/favicons/bmc/app-icon-144x144.png>
<meta name="theme-color"
      content="#1b3051">


        
        <script>(function(H){H.className=H.className.replace(/\bno-js\b/,'js')})(document.documentElement)</script>

        


    
        <link rel="stylesheet" media="screen" href=/static/app-bmc/css/core-article-cd4a428820.css>
    

    <link rel="stylesheet" media="screen" href=/static/app-bmc/css/core-b076aec3c2.css>
    <link rel="stylesheet" media="print" href=/static/app-bmc/css/print-b8af42253b.css>
    

    

    
        <style>@media only screen and (-webkit-min-device-pixel-ratio: 0) and (min-color-index: 0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio: 0) and (min-resolution: 3 e1dpcm) { button{line-height:inherit}html,label{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}html{-webkit-font-smoothing:subpixel-antialiased;box-sizing:border-box;color:#333;font-size:100%;height:100%;line-height:1.61803;overflow-y:scroll}*{box-sizing:inherit}body{background:#fff;font-size:1.8em;margin:0;max-width:100%;min-height:100%}button,div,form,input{margin:0;padding:0}body,p{padding:0}a{color:#004b83;text-decoration:underline;text-decoration-skip-ink:auto}a>img{vertical-align:middle}h1,h2,h3{margin-top:0}h1{font-size:28px;font-weight:700}html.webfonts-loaded h1,html.webfonts-loaded h2,html.webfonts-loaded h3{font-family:Europa,Trebuchet MS}h1,h2,h3{color:#1b3051;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-style:normal;line-height:1.4}h2{font-size:26px;font-weight:700;margin-bottom:.5em}h3{font-size:18px;margin-bottom:.7em}p{margin:0}ul{margin-top:0}p{margin-bottom:1.5em}p:last-child{margin-bottom:0}p:empty{display:none}.c-ad{text-align:center}@media only screen and (min-width:320px){.c-ad{padding:8px}}.c-ad--728x90{background-color:#ccc;display:none}.c-ad--728x90 .c-ad__inner{min-height:calc(1.5em + 94px)}.c-ad--728x90 iframe{height:90px;max-width:970px}@media only screen and (min-width:768px){.js .c-ad--728x90{display:none}.js .u-show-following-ad+.c-ad--728x90{display:block}}.c-ad iframe{border:0;overflow:auto;vertical-align:top}.c-ad__label{color:#333;font-weight:400;line-height:1.5;margin-bottom:4px}.c-ad__label,.c-skip-link{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem}.c-skip-link{background:#dceaf6;bottom:auto;color:#004b83;padding:8px;position:absolute;text-align:center;transform:translateY(-100%);z-index:9999}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out 0s}}@media print{.c-skip-link{display:none}}.c-skip-link:link{color:#004b83}.c-dropdown__button:after{border-color:transparent transparent transparent #fff;border-style:solid;border-width:4px 0 4px 14px;content:"";display:block;height:0;margin-left:3px;width:0}.c-dropdown{display:inline-block;position:relative}.c-dropdown__button{background-color:transparent;border:0;display:inline-block;padding:0;white-space:nowrap}.c-dropdown__button:after{border-color:currentcolor transparent transparent;border-width:5px 4px 0 5px;display:inline-block;margin-left:8px;vertical-align:middle}.c-dropdown__menu{background-color:#fff;border:1px solid #d9d9d9;border-radius:3px;box-shadow:0 2px 6px rgba(0,0,0,.1);font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:14px;line-height:1.4;list-style:none;margin:0;padding:8px 0;position:absolute;top:100%;transform:translateY(8px);width:180px;z-index:100}.c-dropdown__menu:after,.c-dropdown__menu:before{border-style:solid;bottom:100%;content:"";display:block;height:0;left:16px;position:absolute;width:0}.c-dropdown__menu:before{border-color:transparent transparent #d9d9d9;border-width:0 9px 9px;transform:translateX(-1px)}.c-dropdown__menu:after{border-color:transparent transparent #fff;border-width:0 8px 8px}.c-dropdown__menu--right{left:auto;right:0}.c-dropdown__menu--right:after,.c-dropdown__menu--right:before{left:auto;right:16px}.c-dropdown__menu--right:before{transform:translateX(1px)}.c-dropdown__link{background-color:transparent;color:#004b83;display:block;padding:4px 16px;text-decoration:none}.c-header{background-color:#1b3051;border-bottom:4px solid #1b3051;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:14px;padding:16px 0}.c-header__container{-webkit-box-align:center;-webkit-box-pack:justify;align-items:center;display:flex;justify-content:space-between;margin:0 auto;max-width:1280px;padding:0 16px}.c-header__brand{margin-right:48px}.c-header__brand a,.c-journal-title a{text-decoration:none}.c-header__menu,.c-header__navigation{display:flex}.c-header__navigation{-webkit-box-align:center;align-items:center}.c-header__menu{list-style:none;margin:0;padding:0}.c-header__item{color:#fff;margin-right:24px}.c-header__item:last-child{margin-right:0}.c-header__link{color:#fff;text-decoration:none}html.webfonts-loaded .c-journal-title{font-family:Europa,Trebuchet MS}.c-form-field{margin-bottom:1em}.c-form-field__label{color:#666;display:block;font-size:14px;margin-bottom:.4em}.c-form-field__input{border:1px solid #a6a6a6;border-radius:3px;box-shadow:inset 0 1px 3px 0 rgba(0,0,0,.21);font-size:14px;line-height:1.28571;padding:.75em 1em;vertical-align:middle;width:100%}.c-popup-search{background-color:#25426f;box-shadow:0 3px 3px -3px rgba(0,0,0,.21);padding:16px 0;position:relative;z-index:10}@media only screen and (min-width:1024px){.js .c-popup-search{position:absolute;top:100%;width:100%}.c-popup-search__container{margin:auto;max-width:70%}}.c-logo img{display:block}.ctx-search .c-form-field{margin-bottom:0}.ctx-search .c-form-field__label{color:#fff}.ctx-search .c-form-field__input{border-bottom-right-radius:0;border-top-right-radius:0;margin-right:0}.c-journal-header{overflow:hidden}.c-journal-header__inner{padding-bottom:8px;padding-top:8px}@media only screen and (min-width:540px){.c-journal-header__inner{-webkit-box-pack:justify;display:flex;justify-content:space-between}}.c-journal-header__identity{background-size:auto 80px;min-height:16px;padding:6px 0}@media only screen and (min-width:540px){.c-journal-header__identity{background-position:0}}.c-journal-header__identity--default{background:url(/static/images/bmc/identities/patterns/default-7e3a6b1388.svg) 0 0 no-repeat #04caa8}.c-journal-title{color:#1b3051;display:flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:26px;font-style:normal;font-weight:700;line-height:1.4;margin-bottom:0}.c-journal-title>a{color:#0097ef;color:#1b3051;display:flex;text-decoration:none}.c-journal-title__text{-webkit-box-flex:0;align-self:center;display:block;flex:0 1 auto}.c-logo,.c-logo>a{-webkit-box-align:baseline;align-items:baseline;display:flex}.c-logo__strapline{display:none}@media only screen and (min-width:540px){.c-logo__strapline{display:block;margin:0 0 0 16px;transform:translateY(1px)}}.c-navbar{background:#f2f2f2;border-bottom:1px solid #d9d9d9;border-top:1px solid #d9d9d9;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:14px;line-height:1.42857;padding:16px 0}.c-navbar__container{-webkit-box-pack:justify;flex-wrap:wrap;justify-content:space-between;margin:0 auto;max-width:1280px;padding:0 16px}.c-navbar__container,.c-navbar__content{-webkit-box-align:center;align-items:center;display:flex}.c-navbar__content{-webkit-box-flex:0;flex:0 1 auto}@media only screen and (min-width:1024px){.c-navbar__content{display:flex!important}}.c-navbar__nav{display:flex;list-style:none;margin:0;padding:0}@media only screen and (min-width:1024px){.c-navbar__nav{transform:translateY(1px)}}.c-navbar__item:not(:first-child){margin-left:16px}.c-navbar__link{background:0 0;border:0;color:currentcolor;display:block;text-decoration:none;text-transform:capitalize}.c-navbar__link--is-shown{text-decoration:underline}.c-logo{display:block}html.webfonts-loaded .u-h3,html.webfonts-loaded .u-h4{font-family:Europa,Trebuchet MS}.u-button{-webkit-box-align:center;-webkit-box-pack:center;align-items:center;background-color:#f2f2f2;background-image:linear-gradient(#fff,#f2f2f2);border:1px solid #ccc;border-radius:2px;cursor:pointer;display:inline-flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;justify-content:center;line-height:1.3;margin:0;padding:8px;position:relative;text-decoration:none;transition:all .25s ease 0s,color .25s ease 0s,border-color .25s ease 0s;width:auto}.u-button svg{fill:currentcolor}.u-button{color:#004b83}.u-clearfix:after,.u-clearfix:before{content:"";display:table}.u-clearfix:after{clear:both}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-display-flex{display:flex;width:100%}.u-align-items-center{-webkit-box-align:center;align-items:center}.u-flex-static{-webkit-box-flex:0;flex:0 1 auto;flex:0 0 auto}.u-display-none{display:none}.js .u-js-hide{display:none;visibility:hidden}@media print{.u-hide-print{display:none}}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-list-reset{list-style:none;margin:0;padding:0}.u-position-relative{position:relative}.u-mt-32{margin-top:32px}.u-mr-24{margin-right:24px}.u-mr-48{margin-right:48px}.u-mb-32{margin-bottom:32px}.u-ml-8{margin-left:8px}.u-button-reset{background-color:transparent;border:0;padding:0}.u-text-sm{font-size:14px}.u-h3,.u-h4{color:#1b3051;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:18px;font-style:normal;line-height:1.4;margin-bottom:.7em}.u-h4{font-style:italic;font-weight:700}.u-vh-full{min-height:100vh}.u-hide{display:none;visibility:hidden}@media only screen and (min-width:1024px){.u-hide-at-lg{display:none;visibility:hidden}}@media only screen and (max-width:1023px){.u-hide-at-lt-lg{display:none;visibility:hidden}}.u-visually-hidden{clip:rect(0,0,0,0);border:0;height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}body{font-size:1.125rem} }</style>

        <link rel="stylesheet" data-inline-css-source="critical-css" href="/static/app-bmc/css/enhanced-2b5751e1cf.css"
              media="print" onload="this.media='only screen and (-webkit-min-device-pixel-ratio:0) and (min-color-index:0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio:0) and (min-resolution: 3e1dpcm)';this.onload=null">

        <style>@media only screen and (-webkit-min-device-pixel-ratio: 0) and (min-color-index: 0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio: 0) and (min-resolution: 3 e1dpcm) { .c-reading-companion__figure-title,.u-h3,.u-h4{font-family:Georgia,Palatino,serif;font-style:normal;line-height:1.4}.u-h3{margin-bottom:1em}.u-h4{margin-bottom:1em}button{line-height:inherit}html,label{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}html{-webkit-font-smoothing:subpixel-antialiased;box-sizing:border-box;color:#333;font-size:100%;height:100%;line-height:1.61803;overflow-y:scroll}*{box-sizing:inherit}body{background:#fff;font-size:1.8em;margin:0;max-width:100%;min-height:100%}button,div,form,input{margin:0;padding:0}body,p{padding:0}a{color:#004b83;overflow-wrap:break-word;text-decoration:underline;text-decoration-skip-ink:auto;word-break:break-word}a>img{vertical-align:middle}h1,h2,h3{margin-top:0}h1{font-size:28px;font-weight:700}html.webfonts-loaded h1,html.webfonts-loaded h2,html.webfonts-loaded h3{font-family:Europa,Trebuchet MS}h1,h2,h3{color:#1b3051;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-style:normal;line-height:1.4}h2{font-size:26px;font-weight:700;margin-bottom:.5em}h3{font-size:18px;margin-bottom:.7em}p{margin:0}ul{margin-top:0}p{margin-bottom:1.5em;overflow-wrap:break-word;word-break:break-word}p:last-child{margin-bottom:0}p:empty{display:none}.u-h3{font-size:1.75rem;font-size:1.5rem;font-weight:700}.c-reading-companion__figure-title{font-size:1.25rem;font-weight:700}.u-h4{font-size:1.25rem;font-weight:700}body{font-size:1.125rem}.c-article-header{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;margin-bottom:40px}.c-article-identifiers{color:#6f6f6f;display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3;list-style:none;margin:0 0 8px;padding:0}.c-article-identifiers__item{border-right:1px solid #6f6f6f;list-style:none;margin-right:8px;padding-right:8px}.c-article-identifiers__item:last-child{border-right:0;margin-right:0;padding-right:0}.c-article-identifiers__open{color:#cc4b14}.c-article-title{font-size:1.5rem;line-height:1.25;margin-bottom:16px}@media only screen and (min-width:768px){.c-article-title{font-size:1.875rem;line-height:1.2}}.c-article-author-list{display:inline;font-size:1rem;list-style:none;margin:0 8px 0 0;padding:0;width:100%}.c-article-author-list__item{margin-left:0}.c-article-author-list li,.c-article-author-list__item{display:inline;padding-right:0}.c-article-author-list__item svg{margin-left:4px}.c-article-author-list__show-more{margin-right:4px}@media only screen and (max-width:539px){html.js .js-small-screen-show-inline{display:inline!important;visibility:visible!important}.js .js-smaller-author-etal{display:none;visibility:hidden}}.c-article-info-details{font-size:1rem;margin-bottom:8px;margin-top:16px}.c-article-info-details__cite-as{border-left:1px solid #6f6f6f;margin-left:8px;padding-left:8px}.c-button-author-list{background:#ebf1f5;border:4px solid #ebf1f5;border-radius:20px;color:#666;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;line-height:1.4;padding:2px 11px 2px 8px;text-decoration:none}.c-button-author-list svg{margin:1px 4px 0 0}.c-article-metrics-bar{display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3}.c-article-metrics-bar__wrapper{margin:0 0 16px}.c-article-metrics-bar__item{-webkit-box-align:baseline;align-items:baseline;border-right:1px solid #6f6f6f;margin-right:8px}.c-article-metrics-bar__item:last-child{border-right:0}.c-article-metrics-bar__count{font-weight:700;margin:0}.c-article-metrics-bar__label{color:#626262;font-style:normal;font-weight:400;margin:0 10px 0 5px}.c-article-metrics-bar__details{margin:0}.c-article-main-column{font-family:Georgia,Palatino,serif;margin-right:8.6%;width:60.2%}@media only screen and (max-width:1023px){.c-article-main-column{margin-right:0;width:100%}}.c-article-associated-content__container .c-article-associated-content__title,.c-article-section__title{border-bottom:2px solid #d5d5d5;font-size:1.25rem;line-height:1.3;padding-bottom:8px}@media only screen and (min-width:768px){.c-article-associated-content__container .c-article-associated-content__title,.c-article-section__title{font-size:1.5rem;line-height:1.24}}.c-article-section{clear:both}.c-article-section__content{margin-bottom:40px;padding-top:8px}@media only screen and (max-width:1023px){.c-article-section__content{padding-left:0}}.c-article__sub-heading{color:#222;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.125rem;font-style:normal;font-weight:400;line-height:1.3;margin:0 0 8px}@media only screen and (min-width:768px){.c-article__sub-heading{font-size:1.5rem;line-height:1.24}}.c-reading-companion__figure-full-link svg{margin-left:4px}.c-article-authors-search{margin-bottom:24px;margin-top:0}.c-article-authors-search__item,.c-article-authors-search__title{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.c-article-authors-search__title{color:#626262;font-size:1.05rem;font-weight:700;margin:0;padding:0}.c-article-authors-search__item{font-size:1rem}.c-article-authors-search__text{margin:0}.c-article-share-box__no-sharelink-info{font-size:.813rem;font-weight:700;margin-bottom:24px;padding-top:4px}.c-article-share-box__only-read-input{border:1px solid #d5d5d5;display:inline-block;font-size:.875rem;font-weight:700;margin-bottom:8px;padding:8px 10px}.c-article-share-box__button--link-like{background-color:transparent;border:0;color:#0067c5;cursor:pointer;font-size:.875rem;margin-bottom:8px;margin-left:10px}.c-article-associated-content__container .c-article-associated-content__collection-label{font-size:.875rem;line-height:1.4}.c-article-associated-content__container .c-article-associated-content__collection-title,.c-nature-box{line-height:1.3}.c-article-extras{float:left;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;width:31.2%}@media only screen and (max-width:1023px){.c-article-extras{display:none}}.c-reading-companion{clear:both}.c-reading-companion__sticky{max-width:389px}.c-reading-companion__scroll-pane{margin:0;min-height:200px;overflow:hidden auto}.c-reading-companion__tabs{-webkit-box-orient:horizontal;-webkit-box-direction:normal;display:flex;flex-flow:row nowrap;font-size:1rem;list-style:none;margin:0 0 8px;padding:0}.c-reading-companion__tabs>li{-webkit-box-flex:1;flex-grow:1}.c-reading-companion__tab{background-color:#eee;border:1px solid #d5d5d5;border-image:initial;border-left-width:0;color:#0067c5;font-size:1rem;padding:8px 8px 8px 15px;text-align:left;width:100%}.c-reading-companion__tabs li:first-child .c-reading-companion__tab{border-left-width:1px}.c-reading-companion__tab--active{background-color:#fff;border-bottom:1px solid #fff;color:#222;font-weight:700}.c-reading-companion__figures-list,.c-reading-companion__references-list,.c-reading-companion__sections-list{list-style:none;padding:0}.c-reading-companion__references-list--numeric{list-style:decimal inside}.c-reading-companion__sections-list{margin:0 0 8px;min-height:50px}.c-reading-companion__section-item{font-size:1rem;padding:0}.c-reading-companion__section-item a{display:block;line-height:1em;overflow:hidden;padding:8px 0 8px 16px;text-overflow:ellipsis;white-space:nowrap}.c-reading-companion__figure-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:16px 8px 16px 0}.c-reading-companion__figure-item:first-child{border-top:none;padding-top:8px}.c-reading-companion__reference-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:8px 8px 8px 16px}.c-reading-companion__reference-item:first-child{border-top:none}.c-reading-companion__reference-item a{word-break:break-word}.c-reading-companion__reference-citation{display:inline}.c-reading-companion__reference-links{font-size:.813rem;font-weight:700;list-style:none;margin:8px 0 0;padding:0;text-align:right}.c-reading-companion__reference-links>a{display:inline-block;padding-left:8px}.c-reading-companion__reference-links>a:first-child{display:inline-block;padding-left:0}.c-reading-companion__figure-title{display:block;margin:0 0 8px}.c-reading-companion__figure-links{-webkit-box-pack:justify;display:flex;justify-content:space-between;margin:8px 0 0}.c-reading-companion__figure-links>a{display:inline-block}.c-reading-companion__panel{border-top:none;display:none;margin-top:0;padding-top:0}.c-article-associated-content__container .c-article-associated-content__collection.collection .c-article-associated-content__collection-label,.c-article-associated-content__container .c-article-associated-content__collection.section .c-article-associated-content__collection-label,.c-reading-companion__panel--active{display:block}.c-pdf-download{display:flex;margin-bottom:24px;max-height:48px}@media only screen and (min-width:540px){.c-pdf-download{max-height:none}}@media only screen and (min-width:1024px){.c-pdf-download{max-height:48px}}.c-pdf-download__link{-webkit-box-pack:justify;-webkit-box-flex:1;background:#173962;border:1px solid transparent;border-radius:2px;color:#fff;display:flex;flex:1 1 0%;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;justify-content:space-between;line-height:1.3;padding:13px 24px;text-decoration:none}.u-display-none{display:none}.js .u-js-hide,.u-hide{display:none;visibility:hidden}.u-visually-hidden{clip:rect(0,0,0,0);border:0;height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}@media print{.u-hide-print{display:none}}@media only screen and (min-width:1024px){.u-hide-at-lg{display:none;visibility:hidden}}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-list-reset{list-style:none;margin:0;padding:0}.hide{display:none;visibility:hidden}@media only screen and (max-width:30em){.js .js-smaller-author-etal{display:none;visibility:hidden}}.c-article-associated-content__container a{text-decoration:underline}.c-article-associated-content__container .c-article-associated-content__collection.collection~.c-article-associated-content__collection.collection .c-article-associated-content__collection-label,.c-article-associated-content__container .c-article-associated-content__collection.section~.c-article-associated-content__collection.section .c-article-associated-content__collection-label,.c-article-associated-content__container .c-article-associated-content__title{display:none}.c-article-associated-content__container .c-article-associated-content__collection.collection,.c-article-associated-content__container .c-article-associated-content__collection.section{margin-bottom:5px}.c-article-associated-content__container .c-article-associated-content__collection.section~.c-article-associated-content__collection.collection{margin-top:28px}.c-article-associated-content__container .c-article-associated-content__collection:first-child{margin-top:0}.c-article-associated-content__container .c-article-associated-content__collection:last-child{margin-bottom:2.4rem}.c-article-associated-content__container .c-article-associated-content__collection-label{color:#1b3051}.c-article-associated-content__container .c-article-associated-content__collection-title{font-size:1.063rem;font-weight:400}.c-article-main-column .c-pdf-download{display:none}@media only screen and (max-width:1023px){.c-article-main-column .c-pdf-download{display:block}}.webfonts-loaded .c-article__sub-heading{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif} }</style>
        <link rel="stylesheet" data-inline-css-source="critical-css" href="/static/app-bmc/css/enhanced-article-415bd1e493.css"
              media="print" onload="this.media='only screen and (-webkit-min-device-pixel-ratio:0) and (min-color-index:0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio:0) and (min-resolution: 3e1dpcm)';this.onload=null">
    



        

        
    <script type="text/javascript">
        config = {
            env: 'live',
            site: 'breast-cancer-research.biomedcentral.com',
            siteWithPath: 'breast-cancer-research.biomedcentral.com' + window.location.pathname,
            twitterHashtag: '',
            cmsPrefix: 'https://studio-cms.springernature.com/studio/',
            
            doi: '10.1186/bcr3322',
            figshareScriptUrl: 'https://widgets.figshare.com/static/figshare.js',
            hasFigshareInvoked: false,
            publisherBrand: 'BioMed Central',
            mustardcut: false
        };
    </script>

        
    <script type="text/javascript" data-test="dataLayer">
        window.dataLayer = [{"content":{"article":{"doi":"10.1186/bcr3322","articleType":"Research article","peerReviewType":"Closed","supplement":null,"keywords":"SUM159 Cell;Breast Cancer Cell Migration;Thiazolyl Blue Tetrazolium Bromide;SCP2 Cell;Triple Negative Human Breast Cancer"},"contentInfo":{"imprint":"BioMed Central","title":"A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFÎ²-mediated breast cancer cell migration and invasion","publishedAt":1348099200000,"publishedAtDate":"2012-09-20","author":["Meiou Dai","Amal A Al-Odaini","Ani Arakelian","Shafaat A Rabbani","Suhad Ali","Jean-Jacques Lebrun"],"collection":[]},"attributes":{"deliveryPlatform":"oscar","template":"rebrand","cms":null,"copyright":{"creativeCommonsType":null,"openAccess":false},"environment":"live"},"journal":{"siteKey":"breast-cancer-research.biomedcentral.com","volume":"14","issue":"5","title":"Breast Cancer Research","type":"BioMed","journalID":13058,"section":[]},"category":{"pmc":{"primarySubject":"Biomedicine"},"contentType":"Research article","publishingSegment":"BioMed2"}},"session":{"authentication":{"authenticationID":[]}},"version":"1.0.0","page":{"category":{"pageType":"article"},"attributes":{"featureFlags":[],"environment":"live"}},"event":"dataLayerCreated"}];
    </script>

        

        
            <script>
                window.dataLayer.push({
                    cmpAndNewGtmFeatureFlag: true
                });
            </script>
        

        
        
            <script>
                window.dataLayer.push({
                    ga4MeasurementId: 'G-PJCTJWPV25',
                    ga360TrackingId: 'UA-54492316-9',
                    twitterId: 'o47a2',
                    ga4ServerUrl: 'https://collect.biomedcentral.com',
                    imprint: 'biomedcentral'
                });
            </script>
        
        

        
    <script>
        (function(w, d) {
            w.config = w.config || {};
            w.config.mustardcut = false;

            
            if (w.matchMedia && w.matchMedia('only screen and (-webkit-min-device-pixel-ratio:0) and (min-color-index:0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio:0) and (min-resolution: 3e1dpcm)').matches) {
                w.config.mustardcut = true;
                d.classList.add('js');
                d.classList.remove('grade-c');
            }
        })(window, document.documentElement);
    </script>



        
<script>
    (function () {
        if ( typeof window.CustomEvent === "function" ) return false;
        function CustomEvent ( event, params ) {
            params = params || { bubbles: false, cancelable: false, detail: null };
            var evt = document.createEvent( 'CustomEvent' );
            evt.initCustomEvent( event, params.bubbles, params.cancelable, params.detail );
            return evt;
        }

        CustomEvent.prototype = window.Event.prototype;

        window.CustomEvent = CustomEvent;
    })();
</script>

        
    <script class="js-entry">
        if (window.config.mustardcut) {
            (function(w, d) {
                
                
                
                    window.Component = {};
                    window.suppressShareButton = true;
                

                var currentScript = d.currentScript || d.head.querySelector('script.js-entry');

                
                function catchNoModuleSupport() {
                    var scriptEl = d.createElement('script');
                    return (!('noModule' in scriptEl) && 'onbeforeload' in scriptEl)
                }

                var headScripts = [
                    {'src': '/static/js/polyfill-es5-bundle-95f6277fcf.js', 'async': false},
                    {'src': '/static/js/airbrake-es5-bundle-80569d2d62.js', 'async': false},
                ];

                var bodyScripts = [
                    {'src': '/static/js/app-es5-bundle-5306b345a4.js', 'async': false, 'module': false},
                    {'src': '/static/js/app-es6-bundle-8425be8e90.js', 'async': false, 'module': true}
                    
                    
                        , {'src': '/static/js/global-article-es5-bundle-d18afc649a.js', 'async': false, 'module': false},
                        {'src': '/static/js/global-article-es6-bundle-cef3b249aa.js', 'async': false, 'module': true}
                    
                ];

                function createScript(script) {
                    var scriptEl = d.createElement('script');
                    scriptEl.src = script.src;
                    scriptEl.async = script.async;
                    if (script.module === true) {
                        scriptEl.type = "module";
                        if (catchNoModuleSupport()) {
                            scriptEl.src = '';
                        }
                    } else if (script.module === false) {
                        scriptEl.setAttribute('nomodule', true)
                    }
                    if (script.charset) {
                        scriptEl.setAttribute('charset', script.charset);
                    }

                    return scriptEl;
                }

                for (var i = 0; i < headScripts.length; ++i) {
                    var scriptEl = createScript(headScripts[i]);
                    currentScript.parentNode.insertBefore(scriptEl, currentScript.nextSibling);
                }

                d.addEventListener('DOMContentLoaded', function() {
                    for (var i = 0; i < bodyScripts.length; ++i) {
                        var scriptEl = createScript(bodyScripts[i]);
                        d.body.appendChild(scriptEl);
                    }
                });

                // Webfont repeat view
                var config = w.config;
                if (config && config.publisherBrand && sessionStorage.fontsLoaded === 'true') {
                    d.documentElement.className += ' webfonts-loaded';
                }
            })(window, document);
        }
    </script>




        
            
            
                <script data-test="gtm-head">
    window.initGTM = function() {
        if (window.config.mustardcut) {
            (function (w, d, s, l, i) {
                w[l] = w[l] || [];
                w[l].push({'gtm.start': new Date().getTime(), event: 'gtm.js'});
                var f = d.getElementsByTagName(s)[0],
                        j = d.createElement(s),
                        dl = l != 'dataLayer' ? '&l=' + l : '';
                j.async = true;
                
                    j.src = 'https://collect.biomedcentral.com/gtm.js?id=' + i + dl;
                
                f.parentNode.insertBefore(j, f);
            })(window, document, 'script', 'dataLayer', 'GTM-MRVXSHQ');
        }
    }
</script>

            
            
        

        <script>
    (function (w, d, t) {
        function cc() {
            var h = w.location.hostname;
            var e = d.createElement(t),
            s = d.getElementsByTagName(t)[0];

            if (h.indexOf('springer.com') > -1) {
                e.src = 'https://push-content.springernature.io/pcf_sb_5_1617714720898560639/production_live/consent-bundle-17-9.js';
                e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");
            } else if (h.indexOf('biomedcentral.com') > -1) {
                e.src = 'https://push-content.springernature.io/pcf_sb_5_1617714720898560639/production_live/consent-bundle-15-9.js';
                e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");
            } else if (h.indexOf('springeropen.com') > -1) {
                e.src = 'https://push-content.springernature.io/pcf_sb_5_1617714720898560639/production_live/consent-bundle-16-9.js';
                e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");
            } else {
                e.src = '/static/js/cookie-consent-es5-bundle-444fb65518.js';
                e.setAttribute('data-consent', h);
            }
            s.insertAdjacentElement('afterend', e);
        }

        cc();
    })(window, document, 'script');
</script>


        
    
        
    


        
    
    <link rel="canonical" href="//breast-cancer-research.biomedcentral.com/articles/10.1186/bcr3322"/>
    

        
        
        
        <meta property="og:url" content="https://breast-cancer-research.biomedcentral.com/articles/10.1186/bcr3322">
        <meta property="og:type" content="article">
        <meta property="og:site_name" content="BioMed Central">
        <meta property="og:title" content="A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFÎ²-mediated breast cancer cell migration and invasion - Breast Cancer Research">
        <meta property="og:description" content="Introduction Tumor cell migration and invasion are critical initiation steps in the process of breast cancer metastasis, the primary cause of breast cancer morbidity and death. Here we investigated the role of p21Cip1 (p21), a member of the core cell cycle machinery, in transforming growth factor-beta (TGFÎ²)-mediated breast cancer cell migration and invasion. Methods A mammary fat pad xenograft mouse model was used to assess the mammary tumor growth and local invasion. The triple negative human breast cancer cell lines MDA-MB231 and its sub-progenies SCP2 and SCP25, SUM159PT, SUM149PT, SUM229PE and SUM1315MO2 were treated with 5 ng/ml TGFÎ² and the protein expression levels were measured by Western blot. Cell migration and invasion were examined using the scratch/wound healing and Transwell assay. TGFÎ² transcriptional activity was measured by a TGFÎ²/Smad reporter construct (CAGA12-luc) using luciferase assay. q-PCR was used for assessing TGFÎ² downstream target genes. The interactions among p21, p/CAF and Smad3 were performed by co-immunoprecipitation. In addition, Smad3 on DNA binding ability was measured by DNA immunoprecipitation using biotinylated Smad binding element DNA probes. Finally, the association among active TGFÎ²/Smad signaling, p21 and p/CAF with lymph node metastasis was examined by immunohistochemistry in tissue microarray containing 50 invasive ductal breast tumors, 25 of which are lymph node positive. Results We found p21 expression to correlate with poor overall and distant metastasis free survival in breast cancer patients. Furthermore, using xenograft animal models and in vitro studies, we found p21 to be essential for tumor cell invasion. The invasive effects of p21 were found to correlate with Smad3, and p/CAF interaction downstream of TGFÎ². p21 and p/CAF regulates TGFÎ²-mediated transcription of pro-metastatic genes by controlling Smad3 acetylation, DNA binding and transcriptional activity. In addition, we found that active TGFÎ²/Smad signaling correlates with high p21 and p/CAF expression levels and lymph node involvement using tissue microarrays from breast cancer patients. Conclusions Together these results highlight an important role for p21 and p/CAF in promoting breast cancer cell migration and invasion at the transcriptional level and may open new avenues for breast cancer therapy.">
        <meta property="og:image" content="https://media.springernature.com/w200/springer-static/cover/journal/13058.jpg">
    
        

        
    <script type="application/ld+json">{"mainEntity":{"headline":"A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFÎ²-mediated breast cancer cell migration and invasion","description":"Tumor cell migration and invasion are critical initiation steps in the process of breast cancer metastasis, the primary cause of breast cancer morbidity and death. Here we investigated the role of p21Cip1 (p21), a member of the core cell cycle machinery, in transforming growth factor-beta (TGFÎ²)-mediated breast cancer cell migration and invasion. A mammary fat pad xenograft mouse model was used to assess the mammary tumor growth and local invasion. The triple negative human breast cancer cell lines MDA-MB231 and its sub-progenies SCP2 and SCP25, SUM159PT, SUM149PT, SUM229PE and SUM1315MO2 were treated with 5 ng/ml TGFÎ² and the protein expression levels were measured by Western blot. Cell migration and invasion were examined using the scratch/wound healing and Transwell assay. TGFÎ² transcriptional activity was measured by a TGFÎ²/Smad reporter construct (CAGA12-luc) using luciferase assay. q-PCR was used for assessing TGFÎ² downstream target genes. The interactions among p21, p/CAF and Smad3 were performed by co-immunoprecipitation. In addition, Smad3 on DNA binding ability was measured by DNA immunoprecipitation using biotinylated Smad binding element DNA probes. Finally, the association among active TGFÎ²/Smad signaling, p21 and p/CAF with lymph node metastasis was examined by immunohistochemistry in tissue microarray containing 50 invasive ductal breast tumors, 25 of which are lymph node positive. We found p21 expression to correlate with poor overall and distant metastasis free survival in breast cancer patients. Furthermore, using xenograft animal models and in vitro studies, we found p21 to be essential for tumor cell invasion. The invasive effects of p21 were found to correlate with Smad3, and p/CAF interaction downstream of TGFÎ². p21 and p/CAF regulates TGFÎ²-mediated transcription of pro-metastatic genes by controlling Smad3 acetylation, DNA binding and transcriptional activity. In addition, we found that active TGFÎ²/Smad signaling correlates with high p21 and p/CAF expression levels and lymph node involvement using tissue microarrays from breast cancer patients. Together these results highlight an important role for p21 and p/CAF in promoting breast cancer cell migration and invasion at the transcriptional level and may open new avenues for breast cancer therapy.","datePublished":"2012-09-20","dateModified":"2012-09-20","pageStart":"1","pageEnd":"22","sameAs":"https://doi.org/10.1186/bcr3322","keywords":"Cancer Research,Oncology,Surgical Oncology","image":"https://static-content.springer.com/image/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_Fig1_HTML.jpg","isPartOf":{"name":"Breast Cancer Research","issn":["1465-542X"],"volumeNumber":"14","@type":["Periodical","PublicationVolume"]},"publisher":{"name":"BioMed Central","logo":{"url":"https://www.springernature.com/app-sn/public/images/logo-springernature.png","@type":"ImageObject"},"@type":"Organization"},"author":[{"name":"Dai, Meiou","affiliation":[{"name":"McGill University Health Center, Royal Victoria Hospital","address":{"name":"Division of Medical Oncology, Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Al-Odaini, Amal A","affiliation":[{"name":"McGill University Health Center, Royal Victoria Hospital","address":{"name":"Division of Medical Oncology, Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Arakelian, Ani","affiliation":[{"name":"McGill University Health Center, Royal Victoria Hospital","address":{"name":"Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Rabbani, Shafaat A","affiliation":[{"name":"McGill University Health Center, Royal Victoria Hospital","address":{"name":"Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Ali, Suhad","affiliation":[{"name":"McGill University Health Center, Royal Victoria Hospital","address":{"name":"Division of Medical Oncology, Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Lebrun, Jean-Jacques","affiliation":[{"name":"McGill University Health Center, Royal Victoria Hospital","address":{"name":"Division of Medical Oncology, Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada","@type":"PostalAddress"},"@type":"Organization"}],"email":"jj.lebrun@mcgill.ca","@type":"Person"}],"@type":"ScholarlyArticle"},"@context":"https://schema.org","@type":"WebPage"}</script>

        
    </head>

    <body class="journal journal-fulltext"
    
          >
        
    
        
            <!-- Google Tag Manager (noscript) -->
            <noscript>
                <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-MRVXSHQ"
                        height="0" width="0" style="display:none;visibility:hidden"></iframe>
            </noscript>
            <!-- End Google Tag Manager (noscript) -->
        
    

        <div class="u-visually-hidden" aria-hidden="true">
    
    <?xml version="1.0" encoding="UTF-8"?><!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><symbol id="icon-access" viewBox="0 0 18 18"><path d="m14 8c.5522847 0 1 .44771525 1 1v7h2.5c.2761424 0 .5.2238576.5.5v1.5h-18v-1.5c0-.2761424.22385763-.5.5-.5h2.5v-7c0-.55228475.44771525-1 1-1s1 .44771525 1 1v6.9996556h8v-6.9996556c0-.55228475.4477153-1 1-1zm-8 0 2 1v5l-2 1zm6 0v7l-2-1v-5zm-2.42653766-7.59857636 7.03554716 4.92488299c.4162533.29137735.5174853.86502537.226108 1.28127873-.1721584.24594054-.4534847.39241464-.7536934.39241464h-14.16284822c-.50810197 0-.92-.41189803-.92-.92 0-.30020869.1464741-.58153499.39241464-.75369337l7.03554714-4.92488299c.34432015-.2410241.80260453-.2410241 1.14692468 0zm-.57346234 2.03988748-3.65526982 2.55868888h7.31053962z" fill-rule="evenodd"/></symbol><symbol id="icon-account" viewBox="0 0 18 18"><path d="m10.2379028 16.9048051c1.3083556-.2032362 2.5118471-.7235183 3.5294683-1.4798399-.8731327-2.5141501-2.0638925-3.935978-3.7673711-4.3188248v-1.27684611c1.1651924-.41183641 2-1.52307546 2-2.82929429 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.30621883.83480763 2.41745788 2 2.82929429v1.27684611c-1.70347856.3828468-2.89423845 1.8046747-3.76737114 4.3188248 1.01762123.7563216 2.22111275 1.2766037 3.52946833 1.4798399.40563808.0629726.81921174.0951949 1.23790281.0951949s.83226473-.0322223 1.2379028-.0951949zm4.3421782-2.1721994c1.4927655-1.4532925 2.419919-3.484675 2.419919-5.7326057 0-4.418278-3.581722-8-8-8s-8 3.581722-8 8c0 2.2479307.92715352 4.2793132 2.41991895 5.7326057.75688473-2.0164459 1.83949951-3.6071894 3.48926591-4.3218837-1.14534283-.70360829-1.90918486-1.96796271-1.90918486-3.410722 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.44275929-.763842 2.70711371-1.9091849 3.410722 1.6497664.7146943 2.7323812 2.3054378 3.4892659 4.3218837zm-5.580081 3.2673943c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"/></symbol><symbol id="icon-alert" viewBox="0 0 18 18"><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill-rule="evenodd"/></symbol><symbol id="icon-arrow-broad" viewBox="0 0 16 16"><path d="m6.10307866 2.97190702v7.69043288l2.44965196-2.44676915c.38776071-.38730439 1.0088052-.39493524 1.38498697-.01919617.38609051.38563612.38643641 1.01053024-.00013864 1.39665039l-4.12239817 4.11754683c-.38616704.3857126-1.01187344.3861062-1.39846576-.0000311l-4.12258206-4.11773056c-.38618426-.38572979-.39254614-1.00476697-.01636437-1.38050605.38609047-.38563611 1.01018509-.38751562 1.4012233.00306241l2.44985644 2.4469734v-8.67638639c0-.54139983.43698413-.98042709.98493125-.98159081l7.89910522-.0043627c.5451687 0 .9871152.44142642.9871152.98595351s-.4419465.98595351-.9871152.98595351z" fill-rule="evenodd" transform="matrix(-1 0 0 -1 14 15)"/></symbol><symbol id="icon-arrow-down" viewBox="0 0 16 16"><path d="m3.28337502 11.5302405 4.03074001 4.176208c.37758093.3912076.98937525.3916069 1.367372-.0000316l4.03091977-4.1763942c.3775978-.3912252.3838182-1.0190815.0160006-1.4001736-.3775061-.39113013-.9877245-.39303641-1.3700683.003106l-2.39538585 2.4818345v-11.6147896l-.00649339-.11662112c-.055753-.49733869-.46370161-.88337888-.95867408-.88337888-.49497246 0-.90292107.38604019-.95867408.88337888l-.00649338.11662112v11.6147896l-2.39518594-2.4816273c-.37913917-.39282218-.98637524-.40056175-1.35419292-.0194697-.37750607.3911302-.37784433 1.0249269.00013556 1.4165479z" fill-rule="evenodd"/></symbol><symbol id="icon-arrow-left" viewBox="0 0 16 16"><path d="m4.46975946 3.28337502-4.17620792 4.03074001c-.39120768.37758093-.39160691.98937525.0000316 1.367372l4.1763942 4.03091977c.39122514.3775978 1.01908149.3838182 1.40017357.0160006.39113012-.3775061.3930364-.9877245-.00310603-1.3700683l-2.48183446-2.39538585h11.61478958l.1166211-.00649339c.4973387-.055753.8833789-.46370161.8833789-.95867408 0-.49497246-.3860402-.90292107-.8833789-.95867408l-.1166211-.00649338h-11.61478958l2.4816273-2.39518594c.39282216-.37913917.40056173-.98637524.01946965-1.35419292-.39113012-.37750607-1.02492687-.37784433-1.41654791.00013556z" fill-rule="evenodd"/></symbol><symbol id="icon-arrow-right" viewBox="0 0 16 16"><path d="m11.5302405 12.716625 4.176208-4.03074003c.3912076-.37758093.3916069-.98937525-.0000316-1.367372l-4.1763942-4.03091981c-.3912252-.37759778-1.0190815-.38381821-1.4001736-.01600053-.39113013.37750607-.39303641.98772445.003106 1.37006824l2.4818345 2.39538588h-11.6147896l-.11662112.00649339c-.49733869.055753-.88337888.46370161-.88337888.95867408 0 .49497246.38604019.90292107.88337888.95867408l.11662112.00649338h11.6147896l-2.4816273 2.39518592c-.39282218.3791392-.40056175.9863753-.0194697 1.3541929.3911302.3775061 1.0249269.3778444 1.4165479-.0001355z" fill-rule="evenodd"/></symbol><symbol id="icon-arrow-sub" viewBox="0 0 16 16"><path d="m7.89692134 4.97190702v7.69043288l-2.44965196-2.4467692c-.38776071-.38730434-1.0088052-.39493519-1.38498697-.0191961-.38609047.3856361-.38643643 1.0105302.00013864 1.3966504l4.12239817 4.1175468c.38616704.3857126 1.01187344.3861062 1.39846576-.0000311l4.12258202-4.1177306c.3861843-.3857298.3925462-1.0047669.0163644-1.380506-.3860905-.38563612-1.0101851-.38751563-1.4012233.0030624l-2.44985643 2.4469734v-8.67638639c0-.54139983-.43698413-.98042709-.98493125-.98159081l-7.89910525-.0043627c-.54516866 0-.98711517.44142642-.98711517.98595351s.44194651.98595351.98711517.98595351z" fill-rule="evenodd"/></symbol><symbol id="icon-arrow-up" viewBox="0 0 16 16"><path d="m12.716625 4.46975946-4.03074003-4.17620792c-.37758093-.39120768-.98937525-.39160691-1.367372.0000316l-4.03091981 4.1763942c-.37759778.39122514-.38381821 1.01908149-.01600053 1.40017357.37750607.39113012.98772445.3930364 1.37006824-.00310603l2.39538588-2.48183446v11.61478958l.00649339.1166211c.055753.4973387.46370161.8833789.95867408.8833789.49497246 0 .90292107-.3860402.95867408-.8833789l.00649338-.1166211v-11.61478958l2.39518592 2.4816273c.3791392.39282216.9863753.40056173 1.3541929.01946965.3775061-.39113012.3778444-1.02492687-.0001355-1.41654791z" fill-rule="evenodd"/></symbol><symbol id="icon-article" viewBox="0 0 18 18"><path d="m13 15v-12.9906311c0-.0073595-.0019884-.0093689.0014977-.0093689l-11.00158888.00087166v13.00506804c0 .5482678.44615281.9940603.99415146.9940603h10.27350412c-.1701701-.2941734-.2675644-.6357129-.2675644-1zm-12 .0059397v-13.00506804c0-.5562408.44704472-1.00087166.99850233-1.00087166h11.00299537c.5510129 0 .9985023.45190985.9985023 1.0093689v2.9906311h3v9.9914698c0 1.1065798-.8927712 2.0085302-1.9940603 2.0085302h-12.01187942c-1.09954652 0-1.99406028-.8927712-1.99406028-1.9940603zm13-9.0059397v9c0 .5522847.4477153 1 1 1s1-.4477153 1-1v-9zm-10-2h7v4h-7zm1 1v2h5v-2zm-1 4h7v1h-7zm0 2h7v1h-7zm0 2h7v1h-7z" fill-rule="evenodd"/></symbol><symbol id="icon-audio" viewBox="0 0 18 18"><path d="m13.0957477 13.5588459c-.195279.1937043-.5119137.193729-.7072234.0000551-.1953098-.193674-.1953346-.5077061-.0000556-.7014104 1.0251004-1.0168342 1.6108711-2.3905226 1.6108711-3.85745208 0-1.46604976-.5850634-2.83898246-1.6090736-3.85566829-.1951894-.19379323-.1950192-.50782531.0003802-.70141028.1953993-.19358497.512034-.19341614.7072234.00037709 1.2094886 1.20083761 1.901635 2.8250555 1.901635 4.55670148 0 1.73268608-.6929822 3.35779608-1.9037571 4.55880738zm2.1233994 2.1025159c-.195234.193749-.5118687.1938462-.7072235.0002171-.1953548-.1936292-.1954528-.5076613-.0002189-.7014104 1.5832215-1.5711805 2.4881302-3.6939808 2.4881302-5.96012998 0-2.26581266-.9046382-4.3883241-2.487443-5.95944795-.1952117-.19377107-.1950777-.50780316.0002993-.70141031s.5120117-.19347426.7072234.00029682c1.7683321 1.75528196 2.7800854 4.12911258 2.7800854 6.66056144 0 2.53182498-1.0120556 4.90597838-2.7808529 6.66132328zm-14.21898205-3.6854911c-.5523759 0-1.00016505-.4441085-1.00016505-.991944v-3.96777631c0-.54783558.44778915-.99194407 1.00016505-.99194407h2.0003301l5.41965617-3.8393633c.44948677-.31842296 1.07413994-.21516983 1.39520191.23062232.12116339.16823446.18629727.36981184.18629727.57655577v12.01603479c0 .5478356-.44778914.9919441-1.00016505.9919441-.20845738 0-.41170538-.0645985-.58133413-.184766l-5.41965617-3.8393633zm0-.991944h2.32084805l5.68047235 4.0241292v-12.01603479l-5.68047235 4.02412928h-2.32084805z" fill-rule="evenodd"/></symbol><symbol id="icon-block" viewBox="0 0 24 24"><path d="m0 0h24v24h-24z" fill-rule="evenodd"/></symbol><symbol id="icon-book" viewBox="0 0 18 18"><path d="m4 13v-11h1v11h11v-11h-13c-.55228475 0-1 .44771525-1 1v10.2675644c.29417337-.1701701.63571286-.2675644 1-.2675644zm12 1h-13c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1h13zm0 3h-13c-1.1045695 0-2-.8954305-2-2v-12c0-1.1045695.8954305-2 2-2h13c.5522847 0 1 .44771525 1 1v14c0 .5522847-.4477153 1-1 1zm-8.5-13h6c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1 2h4c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-4c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"/></symbol><symbol id="icon-broad" viewBox="0 0 24 24"><path d="m9.18274226 7.81v7.7999954l2.48162734-2.4816273c.3928221-.3928221 1.0219731-.4005617 1.4030652-.0194696.3911301.3911301.3914806 1.0249268-.0001404 1.4165479l-4.17620796 4.1762079c-.39120769.3912077-1.02508144.3916069-1.41671995-.0000316l-4.1763942-4.1763942c-.39122514-.3912251-.39767006-1.0190815-.01657798-1.4001736.39113012-.3911301 1.02337106-.3930364 1.41951349.0031061l2.48183446 2.4818344v-8.7999954c0-.54911294.4426881-.99439484.99778758-.99557515l8.00221246-.00442485c.5522847 0 1 .44771525 1 1s-.4477153 1-1 1z" fill-rule="evenodd" transform="matrix(-1 0 0 -1 20.182742 24.805206)"/></symbol><symbol id="icon-calendar" viewBox="0 0 18 18"><path d="m12.5 0c.2761424 0 .5.21505737.5.49047852v.50952148h2c1.1072288 0 2 .89451376 2 2v12c0 1.1072288-.8945138 2-2 2h-12c-1.1072288 0-2-.8945138-2-2v-12c0-1.1072288.89451376-2 2-2h1v1h-1c-.55393837 0-1 .44579254-1 1v3h14v-3c0-.55393837-.4457925-1-1-1h-2v1.50952148c0 .27088381-.2319336.49047852-.5.49047852-.2761424 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.2319336-.49047852.5-.49047852zm3.5 7h-14v8c0 .5539384.44579254 1 1 1h12c.5539384 0 1-.4457925 1-1zm-11 6v1h-1v-1zm3 0v1h-1v-1zm3 0v1h-1v-1zm-6-2v1h-1v-1zm3 0v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-3-2v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-5.5-9c.27614237 0 .5.21505737.5.49047852v.50952148h5v1h-5v1.50952148c0 .27088381-.23193359.49047852-.5.49047852-.27614237 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.23193359-.49047852.5-.49047852z" fill-rule="evenodd"/></symbol><symbol id="icon-chevron-less" viewBox="0 0 10 10"><path d="m5.58578644 4-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 -1 -1 0 9 9)"/></symbol><symbol id="icon-chevron-more" viewBox="0 0 10 10"><path d="m5.58578644 6-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4.00000002c-.39052429.3905243-1.02368927.3905243-1.41421356 0s-.39052429-1.02368929 0-1.41421358z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 1)"/></symbol><symbol id="icon-chevron-right" viewBox="0 0 10 10"><path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"/></symbol><symbol id="icon-circle-fill" viewBox="0 0 16 16"><path d="m8 14c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule="evenodd"/></symbol><symbol id="icon-circle" viewBox="0 0 16 16"><path d="m8 12c2.209139 0 4-1.790861 4-4s-1.790861-4-4-4-4 1.790861-4 4 1.790861 4 4 4zm0 2c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule="evenodd"/></symbol><symbol id="icon-citation" viewBox="0 0 18 18"><path d="m8.63593473 5.99995183c2.20913897 0 3.99999997 1.79084375 3.99999997 3.99996146 0 1.40730761-.7267788 2.64486871-1.8254829 3.35783281 1.6240224.6764218 2.8754442 2.0093871 3.4610603 3.6412466l-1.0763845.000006c-.5310008-1.2078237-1.5108121-2.1940153-2.7691712-2.7181346l-.79002167-.329052v-1.023992l.63016577-.4089232c.8482885-.5504661 1.3698342-1.4895187 1.3698342-2.51898361 0-1.65683828-1.3431457-2.99996146-2.99999997-2.99996146-1.65685425 0-3 1.34312318-3 2.99996146 0 1.02946491.52154569 1.96851751 1.36983419 2.51898361l.63016581.4089232v1.023992l-.79002171.329052c-1.25835905.5241193-2.23817037 1.5103109-2.76917113 2.7181346l-1.07638453-.000006c.58561612-1.6318595 1.8370379-2.9648248 3.46106024-3.6412466-1.09870405-.7129641-1.82548287-1.9505252-1.82548287-3.35783281 0-2.20911771 1.790861-3.99996146 4-3.99996146zm7.36897597-4.99995183c1.1018574 0 1.9950893.89353404 1.9950893 2.00274083v5.994422c0 1.10608317-.8926228 2.00274087-1.9950893 2.00274087l-3.0049107-.0009037v-1l3.0049107.00091329c.5490631 0 .9950893-.44783123.9950893-1.00275046v-5.994422c0-.55646537-.4450595-1.00275046-.9950893-1.00275046h-14.00982141c-.54906309 0-.99508929.44783123-.99508929 1.00275046v5.9971821c0 .66666024.33333333.99999036 1 .99999036l2-.00091329v1l-2 .0009037c-1 0-2-.99999041-2-1.99998077v-5.9971821c0-1.10608322.8926228-2.00274083 1.99508929-2.00274083zm-8.5049107 2.9999711c.27614237 0 .5.22385547.5.5 0 .2761349-.22385763.5-.5.5h-4c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm3 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-1c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm4 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238651-.5-.5 0-.27614453.2238576-.5.5-.5z" fill-rule="evenodd"/></symbol><symbol id="icon-close" viewBox="0 0 16 16"><path d="m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z" fill-rule="evenodd"/></symbol><symbol id="icon-collections" viewBox="0 0 18 18"><path d="m15 4c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2h1c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-1v-1zm-4-3c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2v-9c0-1.1045695.8954305-2 2-2zm0 1h-8c-.51283584 0-.93550716.38604019-.99327227.88337887l-.00672773.11662113v9c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227zm-1.5 7c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"/></symbol><symbol id="icon-compare" viewBox="0 0 18 18"><path d="m12 3c3.3137085 0 6 2.6862915 6 6s-2.6862915 6-6 6c-1.0928452 0-2.11744941-.2921742-2.99996061-.8026704-.88181407.5102749-1.90678042.8026704-3.00003939.8026704-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6c1.09325897 0 2.11822532.29239547 3.00096303.80325037.88158756-.51107621 1.90619177-.80325037 2.99903697-.80325037zm-6 1c-2.76142375 0-5 2.23857625-5 5 0 2.7614237 2.23857625 5 5 5 .74397391 0 1.44999672-.162488 2.08451611-.4539116-1.27652344-1.1000812-2.08451611-2.7287264-2.08451611-4.5460884s.80799267-3.44600721 2.08434391-4.5463015c-.63434719-.29121054-1.34037-.4536985-2.08434391-.4536985zm6 0c-.7439739 0-1.4499967.16248796-2.08451611.45391156 1.27652341 1.10008123 2.08451611 2.72872644 2.08451611 4.54608844s-.8079927 3.4460072-2.08434391 4.5463015c.63434721.2912105 1.34037001.4536985 2.08434391.4536985 2.7614237 0 5-2.2385763 5-5 0-2.76142375-2.2385763-5-5-5zm-1.4162763 7.0005324h-3.16744736c.15614659.3572676.35283837.6927622.58425872 1.0006671h1.99892988c.23142036-.3079049.42811216-.6433995.58425876-1.0006671zm.4162763-2.0005324h-4c0 .34288501.0345146.67770871.10025909 1.0011864h3.79948181c.0657445-.32347769.1002591-.65830139.1002591-1.0011864zm-.4158423-1.99953894h-3.16831543c-.13859957.31730812-.24521946.651783-.31578599.99935097h3.79988742c-.0705665-.34756797-.1771864-.68204285-.315786-.99935097zm-1.58295822-1.999926-.08316107.06199199c-.34550042.27081213-.65446126.58611297-.91825862.93727862h2.00044041c-.28418626-.37830727-.6207872-.71499149-.99902072-.99927061z" fill-rule="evenodd"/></symbol><symbol id="icon-download-file" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.5046024 4c.27614237 0 .5.21637201.5.49209595v6.14827645l1.7462789-1.77990922c.1933927-.1971171.5125222-.19455839.7001689-.0069117.1932998.19329992.1910058.50899492-.0027774.70277812l-2.59089271 2.5908927c-.19483374.1948337-.51177825.1937771-.70556873-.0000133l-2.59099079-2.5909908c-.19484111-.1948411-.19043735-.5151448-.00279066-.70279146.19329987-.19329987.50465175-.19237083.70018565.00692852l1.74638684 1.78001764v-6.14827695c0-.27177709.23193359-.49209595.5-.49209595z" fill-rule="evenodd"/></symbol><symbol id="icon-download" viewBox="0 0 16 16"><path d="m12.9975267 12.999368c.5467123 0 1.0024733.4478567 1.0024733 1.000316 0 .5563109-.4488226 1.000316-1.0024733 1.000316h-9.99505341c-.54671233 0-1.00247329-.4478567-1.00247329-1.000316 0-.5563109.44882258-1.000316 1.00247329-1.000316zm-4.9975267-11.999368c.55228475 0 1 .44497754 1 .99589209v6.80214418l2.4816273-2.48241149c.3928222-.39294628 1.0219732-.4006883 1.4030652-.01947579.3911302.39125371.3914806 1.02525073-.0001404 1.41699553l-4.17620792 4.17752758c-.39120769.3913313-1.02508144.3917306-1.41671995-.0000316l-4.17639421-4.17771394c-.39122513-.39134876-.39767006-1.01940351-.01657797-1.40061601.39113012-.39125372 1.02337105-.3931606 1.41951349.00310701l2.48183446 2.48261871v-6.80214418c0-.55001601.44386482-.99589209 1-.99589209z" fill-rule="evenodd"/></symbol><symbol id="icon-editors" viewBox="0 0 18 18"><path d="m8.72592184 2.54588137c-.48811714-.34391207-1.08343326-.54588137-1.72592184-.54588137-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400182l-.79002171.32905522c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274v.9009805h-1v-.9009805c0-2.5479714 1.54557359-4.79153984 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4 1.09079823 0 2.07961816.43662103 2.80122451 1.1446278-.37707584.09278571-.7373238.22835063-1.07530267.40125357zm-2.72592184 14.45411863h-1v-.9009805c0-2.5479714 1.54557359-4.7915398 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.40732121-.7267788 2.64489414-1.8254829 3.3578652 2.2799093.9496145 3.8254829 3.1931829 3.8254829 5.7411543v.9009805h-1v-.9009805c0-2.1155483-1.2760206-4.0125067-3.2099783-4.8180274l-.7900217-.3290552v-1.02400184l.6301658-.40892721c.8482885-.55047139 1.3698342-1.489533 1.3698342-2.51900785 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400184l-.79002171.3290552c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274z" fill-rule="evenodd"/></symbol><symbol id="icon-email" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-.0049107 2.55749512v1.44250488l-7 4-7-4v-1.44250488l7 4z" fill-rule="evenodd"/></symbol><symbol id="icon-error" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm2.8630343 4.71100931-2.8630343 2.86303426-2.86303426-2.86303426c-.39658757-.39658757-1.03281091-.39438847-1.4265779-.00062147-.39651227.39651226-.39348876 1.03246767.00062147 1.4265779l2.86303426 2.86303426-2.86303426 2.8630343c-.39658757.3965875-.39438847 1.0328109-.00062147 1.4265779.39651226.3965122 1.03246767.3934887 1.4265779-.0006215l2.86303426-2.8630343 2.8630343 2.8630343c.3965875.3965876 1.0328109.3943885 1.4265779.0006215.3965122-.3965123.3934887-1.0324677-.0006215-1.4265779l-2.8630343-2.8630343 2.8630343-2.86303426c.3965876-.39658757.3943885-1.03281091.0006215-1.4265779-.3965123-.39651227-1.0324677-.39348876-1.4265779.00062147z" fill-rule="evenodd"/></symbol><symbol id="icon-ethics" viewBox="0 0 18 18"><path d="m6.76384967 1.41421356.83301651-.8330165c.77492941-.77492941 2.03133823-.77492941 2.80626762 0l.8330165.8330165c.3750728.37507276.8837806.58578644 1.4142136.58578644h1.3496361c1.1045695 0 2 .8954305 2 2v1.34963611c0 .53043298.2107137 1.03914081.5857864 1.41421356l.8330165.83301651c.7749295.77492941.7749295 2.03133823 0 2.80626762l-.8330165.8330165c-.3750727.3750728-.5857864.8837806-.5857864 1.4142136v1.3496361c0 1.1045695-.8954305 2-2 2h-1.3496361c-.530433 0-1.0391408.2107137-1.4142136.5857864l-.8330165.8330165c-.77492939.7749295-2.03133821.7749295-2.80626762 0l-.83301651-.8330165c-.37507275-.3750727-.88378058-.5857864-1.41421356-.5857864h-1.34963611c-1.1045695 0-2-.8954305-2-2v-1.3496361c0-.530433-.21071368-1.0391408-.58578644-1.4142136l-.8330165-.8330165c-.77492941-.77492939-.77492941-2.03133821 0-2.80626762l.8330165-.83301651c.37507276-.37507275.58578644-.88378058.58578644-1.41421356v-1.34963611c0-1.1045695.8954305-2 2-2h1.34963611c.53043298 0 1.03914081-.21071368 1.41421356-.58578644zm-1.41421356 1.58578644h-1.34963611c-.55228475 0-1 .44771525-1 1v1.34963611c0 .79564947-.31607052 1.55871121-.87867966 2.12132034l-.8330165.83301651c-.38440512.38440512-.38440512 1.00764896 0 1.39205408l.8330165.83301646c.56260914.5626092.87867966 1.3256709.87867966 2.1213204v1.3496361c0 .5522847.44771525 1 1 1h1.34963611c.79564947 0 1.55871121.3160705 2.12132034.8786797l.83301651.8330165c.38440512.3844051 1.00764896.3844051 1.39205408 0l.83301646-.8330165c.5626092-.5626092 1.3256709-.8786797 2.1213204-.8786797h1.3496361c.5522847 0 1-.4477153 1-1v-1.3496361c0-.7956495.3160705-1.5587112.8786797-2.1213204l.8330165-.83301646c.3844051-.38440512.3844051-1.00764896 0-1.39205408l-.8330165-.83301651c-.5626092-.56260913-.8786797-1.32567087-.8786797-2.12132034v-1.34963611c0-.55228475-.4477153-1-1-1h-1.3496361c-.7956495 0-1.5587112-.31607052-2.1213204-.87867966l-.83301646-.8330165c-.38440512-.38440512-1.00764896-.38440512-1.39205408 0l-.83301651.8330165c-.56260913.56260914-1.32567087.87867966-2.12132034.87867966zm3.58698944 11.4960218c-.02081224.002155-.04199226.0030286-.06345763.002542-.98766446-.0223875-1.93408568-.3063547-2.75885125-.8155622-.23496767-.1450683-.30784554-.4531483-.16277726-.688116.14506827-.2349677.45314827-.3078455.68811595-.1627773.67447084.4164161 1.44758575.6483839 2.25617384.6667123.01759529.0003988.03495764.0017019.05204365.0038639.01713363-.0017748.03452416-.0026845.05212715-.0026845 2.4852814 0 4.5-2.0147186 4.5-4.5 0-1.04888973-.3593547-2.04134635-1.0074477-2.83787157-.1742817-.21419731-.1419238-.5291218.0722736-.70340353.2141973-.17428173.5291218-.14192375.7034035.07227357.7919032.97327203 1.2317706 2.18808682 1.2317706 3.46900153 0 3.0375661-2.4624339 5.5-5.5 5.5-.02146768 0-.04261937-.0013529-.06337445-.0039782zm1.57975095-10.78419583c.2654788.07599731.419084.35281842.3430867.61829728-.0759973.26547885-.3528185.419084-.6182973.3430867-.37560116-.10752146-.76586237-.16587951-1.15568824-.17249193-2.5587807-.00064534-4.58547766 2.00216524-4.58547766 4.49928198 0 .62691557.12797645 1.23496.37274865 1.7964426.11035133.2531347-.0053975.5477984-.25853224.6581497-.25313473.1103514-.54779841-.0053975-.65814974-.2585322-.29947131-.6869568-.45606667-1.43097603-.45606667-2.1960601 0-3.05211432 2.47714695-5.50006595 5.59399617-5.49921198.48576182.00815502.96289603.0795037 1.42238033.21103795zm-1.9766658 6.41091303 2.69835-2.94655317c.1788432-.21040373.4943901-.23598862.7047939-.05714545.2104037.17884318.2359886.49439014.0571454.70479387l-3.01637681 3.34277395c-.18039088.1999106-.48669547.2210637-.69285412.0478478l-1.93095347-1.62240047c-.21213845-.17678204-.24080048-.49206439-.06401844-.70420284.17678204-.21213844.49206439-.24080048.70420284-.06401844z" fill-rule="evenodd"/></symbol><symbol id="icon-explore" viewBox="0 0 18 18"><path d="m9 17c4.418278 0 8-3.581722 8-8s-3.581722-8-8-8-8 3.581722-8 8 3.581722 8 8 8zm0 1c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9zm0-2.5c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5c2.969509 0 5.400504-2.3575119 5.497023-5.31714844.0090007-.27599565.2400359-.49243782.5160315-.48343711.2759957.0090007.4924378.2400359.4834371.51603155-.114093 3.4985237-2.9869632 6.284554-6.4964916 6.284554zm-.29090657-12.99359748c.27587424-.01216621.50937715.20161139.52154336.47748563.01216621.27587423-.20161139.50937715-.47748563.52154336-2.93195733.12930094-5.25315116 2.54886451-5.25315116 5.49456849 0 .27614237-.22385763.5-.5.5s-.5-.22385763-.5-.5c0-3.48142406 2.74307146-6.34074398 6.20909343-6.49359748zm1.13784138 8.04763908-1.2004882-1.20048821c-.19526215-.19526215-.19526215-.51184463 0-.70710678s.51184463-.19526215.70710678 0l1.20048821 1.2004882 1.6006509-4.00162734-4.50670359 1.80268144-1.80268144 4.50670359zm4.10281269-6.50378907-2.6692597 6.67314927c-.1016411.2541026-.3029834.4554449-.557086.557086l-6.67314927 2.6692597 2.66925969-6.67314926c.10164107-.25410266.30298336-.45544495.55708602-.55708602z" fill-rule="evenodd"/></symbol><symbol id="icon-filter" viewBox="0 0 16 16"><path d="m14.9738641 0c.5667192 0 1.0261359.4477136 1.0261359 1 0 .24221858-.0902161.47620768-.2538899.65849851l-5.6938314 6.34147206v5.49997973c0 .3147562-.1520673.6111434-.4104543.7999971l-2.05227171 1.4999945c-.45337535.3313696-1.09655869.2418269-1.4365902-.1999993-.13321514-.1730955-.20522717-.3836284-.20522717-.5999978v-6.99997423l-5.69383133-6.34147206c-.3731872-.41563511-.32996891-1.0473954.09653074-1.41107611.18705584-.15950448.42716133-.2474224.67571519-.2474224zm-5.9218641 8.5h-2.105v6.491l.01238459.0070843.02053271.0015705.01955278-.0070558 2.0532976-1.4990996zm-8.02585008-7.5-.01564945.00240169 5.83249953 6.49759831h2.313l5.836-6.499z"/></symbol><symbol id="icon-home" viewBox="0 0 18 18"><path d="m9 5-6 6v5h4v-4h4v4h4v-5zm7 6.5857864v4.4142136c0 .5522847-.4477153 1-1 1h-5v-4h-2v4h-5c-.55228475 0-1-.4477153-1-1v-4.4142136c-.25592232 0-.51184464-.097631-.70710678-.2928932l-.58578644-.5857864c-.39052429-.3905243-.39052429-1.02368929 0-1.41421358l8.29289322-8.29289322 8.2928932 8.29289322c.3905243.39052429.3905243 1.02368928 0 1.41421358l-.5857864.5857864c-.1952622.1952622-.4511845.2928932-.7071068.2928932zm-7-9.17157284-7.58578644 7.58578644.58578644.5857864 7-6.99999996 7 6.99999996.5857864-.5857864z" fill-rule="evenodd"/></symbol><symbol id="icon-image" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm-3.49645283 10.1752453-3.89407257 6.7495552c.11705545.048464.24538859.0751995.37998328.0751995h10.60290092l-2.4329715-4.2154691-1.57494129 2.7288098zm8.49779013 6.8247547c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v13.98991071l4.50814957-7.81026689 3.08089884 5.33809539 1.57494129-2.7288097 3.5875735 6.2159812zm-3.0059397-11c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm0 1c-.5522847 0-1 .44771525-1 1s.4477153 1 1 1 1-.44771525 1-1-.4477153-1-1-1z" fill-rule="evenodd"/></symbol><symbol id="icon-info" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule="evenodd"/></symbol><symbol id="icon-institution" viewBox="0 0 18 18"><path d="m7 16.9998189v-2.0003623h4v2.0003623h2v-3.0005434h-8v3.0005434zm-3-10.00181122h-1.52632364c-.27614237 0-.5-.22389817-.5-.50009056 0-.13995446.05863589-.27350497.16166338-.36820841l1.23156713-1.13206327h-2.36690687v12.00217346h3v-2.0003623h-3v-1.0001811h3v-1.0001811h1v-4.00072448h-1zm10 0v2.00036224h-1v4.00072448h1v1.0001811h3v1.0001811h-3v2.0003623h3v-12.00217346h-2.3695309l1.2315671 1.13206327c.2033191.186892.2166633.50325042.0298051.70660631-.0946863.10304615-.2282126.16169266-.3681417.16169266zm3-3.00054336c.5522847 0 1 .44779634 1 1.00018112v13.00235456h-18v-13.00235456c0-.55238478.44771525-1.00018112 1-1.00018112h3.45499992l4.20535144-3.86558216c.19129876-.17584288.48537447-.17584288.67667324 0l4.2053514 3.86558216zm-4 3.00054336h-8v1.00018112h8zm-2 6.00108672h1v-4.00072448h-1zm-1 0v-4.00072448h-2v4.00072448zm-3 0v-4.00072448h-1v4.00072448zm8-4.00072448c.5522847 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.4477153-1.00018112 1-1.00018112zm-12 0c.55228475 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.44771525-1.00018112 1-1.00018112zm5.99868798-7.81907007-5.24205601 4.81852671h10.48411203zm.00131202 3.81834559c-.55228475 0-1-.44779634-1-1.00018112s.44771525-1.00018112 1-1.00018112 1 .44779634 1 1.00018112-.44771525 1.00018112-1 1.00018112zm-1 11.00199236v1.0001811h2v-1.0001811z" fill-rule="evenodd"/></symbol><symbol id="icon-location" viewBox="0 0 18 18"><path d="m9.39521328 16.2688008c.79596342-.7770119 1.59208152-1.6299956 2.33285652-2.5295081 1.4020032-1.7024324 2.4323601-3.3624519 2.9354918-4.871847.2228715-.66861448.3364384-1.29323246.3364384-1.8674457 0-3.3137085-2.6862915-6-6-6-3.36356866 0-6 2.60156856-6 6 0 .57421324.11356691 1.19883122.3364384 1.8674457.50313169 1.5093951 1.53348863 3.1694146 2.93549184 4.871847.74077492.8995125 1.53689309 1.7524962 2.33285648 2.5295081.13694479.1336842.26895677.2602648.39521328.3793207.12625651-.1190559.25826849-.2456365.39521328-.3793207zm-.39521328 1.7311992s-7-6-7-11c0-4 3.13400675-7 7-7 3.8659932 0 7 3.13400675 7 7 0 5-7 11-7 11zm0-8c-1.65685425 0-3-1.34314575-3-3s1.34314575-3 3-3c1.6568542 0 3 1.34314575 3 3s-1.3431458 3-3 3zm0-1c1.1045695 0 2-.8954305 2-2s-.8954305-2-2-2-2 .8954305-2 2 .8954305 2 2 2z" fill-rule="evenodd"/></symbol><symbol id="icon-newsletter" viewBox="0 0 18 18"><path d="m9 11.8482489 2-1.1428571v-1.7053918h-4v1.7053918zm-3-1.7142857v-2.1339632h6v2.1339632l3-1.71428574v-6.41967746h-12v6.41967746zm10-5.3839632 1.5299989.95624934c.2923814.18273835.4700011.50320827.4700011.8479983v8.44575236c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-8.44575236c0-.34479003.1776197-.66525995.47000106-.8479983l1.52999894-.95624934v-2.75c0-.55228475.44771525-1 1-1h12c.5522847 0 1 .44771525 1 1zm0 1.17924764v3.07075236l-7 4-7-4v-3.07075236l-1 .625v8.44575236c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-8.44575236zm-10-1.92924764h6v1h-6zm-1 2h8v1h-8z" fill-rule="evenodd"/></symbol><symbol id="icon-orcid" viewBox="0 0 18 18"><path d="m9 1c4.418278 0 8 3.581722 8 8s-3.581722 8-8 8-8-3.581722-8-8 3.581722-8 8-8zm-2.90107518 5.2732337h-1.41865256v7.1712107h1.41865256zm4.55867178.02508949h-2.99247027v7.14612121h2.91062487c.7673039 0 1.4476365-.1483432 2.0410182-.445034s1.0511995-.7152915 1.3734671-1.2558144c.3222677-.540523.4833991-1.1603247.4833991-1.85942385 0-.68545815-.1602789-1.30270225-.4808414-1.85175082-.3205625-.54904856-.7707074-.97532211-1.3504481-1.27883343-.5797408-.30351132-1.2413173-.45526471-1.9847495-.45526471zm-.1892674 1.07933542c.7877654 0 1.4143875.22336734 1.8798852.67010873.4654977.44674138.698243 1.05546001.698243 1.82617415 0 .74343221-.2310402 1.34447791-.6931277 1.80315511-.4620874.4586773-1.0750688.6880124-1.8389625.6880124h-1.46810075v-4.98745039zm-5.08652545-3.71099194c-.21825533 0-.410525.08444276-.57681478.25333081-.16628977.16888806-.24943341.36245684-.24943341.58071218 0 .22345188.08314364.41961891.24943341.58850696.16628978.16888806.35855945.25333082.57681478.25333082.233845 0 .43390938-.08314364.60019916-.24943342.16628978-.16628977.24943342-.36375592.24943342-.59240436 0-.233845-.08314364-.43131115-.24943342-.59240437s-.36635416-.24163862-.60019916-.24163862z" fill-rule="evenodd"/></symbol><symbol id="icon-plus" viewBox="0 0 16 16"><path d="m1.00087166 7h5.99912834v-5.99912834c0-.55276615.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v5.99912834h5.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-5.9991283v5.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-5.9991283h-5.99912834c-.55276615 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"/></symbol><symbol id="icon-print" viewBox="0 0 18 18"><path d="m16.0049107 5h-14.00982141c-.54941618 0-.99508929.4467783-.99508929.99961498v6.00077002c0 .5570958.44271433.999615.99508929.999615h1.00491071v-3h12v3h1.0049107c.5494162 0 .9950893-.4467783.9950893-.999615v-6.00077002c0-.55709576-.4427143-.99961498-.9950893-.99961498zm-2.0049107-1v-2.00208688c0-.54777062-.4519464-.99791312-1.0085302-.99791312h-7.9829396c-.55661731 0-1.0085302.44910695-1.0085302.99791312v2.00208688zm1 10v2.0018986c0 1.103521-.9019504 1.9981014-2.0085302 1.9981014h-7.9829396c-1.1092806 0-2.0085302-.8867064-2.0085302-1.9981014v-2.0018986h-1.00491071c-1.10185739 0-1.99508929-.8874333-1.99508929-1.999615v-6.00077002c0-1.10435686.8926228-1.99961498 1.99508929-1.99961498h1.00491071v-2.00208688c0-1.10341695.90195036-1.99791312 2.0085302-1.99791312h7.9829396c1.1092806 0 2.0085302.89826062 2.0085302 1.99791312v2.00208688h1.0049107c1.1018574 0 1.9950893.88743329 1.9950893 1.99961498v6.00077002c0 1.1043569-.8926228 1.999615-1.9950893 1.999615zm-1-3h-10v5.0018986c0 .5546075.44702548.9981014 1.0085302.9981014h7.9829396c.5565964 0 1.0085302-.4491701 1.0085302-.9981014zm-9 1h8v1h-8zm0 2h5v1h-5zm9-5c-.5522847 0-1-.44771525-1-1s.4477153-1 1-1 1 .44771525 1 1-.4477153 1-1 1z" fill-rule="evenodd"/></symbol><symbol id="icon-search"><path d="M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z" fill-rule="evenodd"/></symbol><symbol id="icon-social-facebook" viewBox="0 0 24 24"><path d="m6.00368507 20c-1.10660471 0-2.00368507-.8945138-2.00368507-1.9940603v-12.01187942c0-1.10128908.89451376-1.99406028 1.99406028-1.99406028h12.01187942c1.1012891 0 1.9940603.89451376 1.9940603 1.99406028v12.01187942c0 1.1012891-.88679 1.9940603-2.0032184 1.9940603h-2.9570132v-6.1960818h2.0797387l.3114113-2.414723h-2.39115v-1.54164807c0-.69911803.1941355-1.1755439 1.1966615-1.1755439l1.2786739-.00055875v-2.15974763l-.2339477-.02492088c-.3441234-.03134957-.9500153-.07025255-1.6293054-.07025255-1.8435726 0-3.1057323 1.12531866-3.1057323 3.19187953v1.78079225h-2.0850778v2.414723h2.0850778v6.1960818z" fill-rule="evenodd"/></symbol><symbol id="icon-social-twitter" viewBox="0 0 24 24"><path d="m18.8767135 6.87445248c.7638174-.46908424 1.351611-1.21167363 1.6250764-2.09636345-.7135248.43394112-1.50406.74870123-2.3464594.91677702-.6695189-.73342162-1.6297913-1.19486605-2.6922204-1.19486605-2.0399895 0-3.6933555 1.69603749-3.6933555 3.78628909 0 .29642457.0314329.58673729.0942985.8617704-3.06469922-.15890802-5.78835241-1.66547825-7.60988389-3.9574208-.3174714.56076194-.49978171 1.21167363-.49978171 1.90536824 0 1.31404706.65223085 2.47224203 1.64236444 3.15218497-.60350999-.0198635-1.17401554-.1925232-1.67222562-.47366811v.04583885c0 1.83355406 1.27302891 3.36609966 2.96411421 3.71294696-.31118484.0886217-.63651445.1329326-.97441718.1329326-.2357461 0-.47149219-.0229194-.69466516-.0672303.47149219 1.5065703 1.83253297 2.6036468 3.44975116 2.632678-1.2651707 1.0160946-2.85724264 1.6196394-4.5891906 1.6196394-.29861172 0-.59093688-.0152796-.88011875-.0504227 1.63450624 1.0726291 3.57548241 1.6990934 5.66104951 1.6990934 6.79263079 0 10.50641749-5.7711113 10.50641749-10.7751859l-.0094298-.48894775c.7229547-.53478659 1.3516109-1.20250585 1.8419628-1.96190282-.6632323.30100846-1.3751855.50422736-2.1217148.59590507z" fill-rule="evenodd"/></symbol><symbol id="icon-social-youtube" viewBox="0 0 24 24"><path d="m10.1415 14.3973208-.0005625-5.19318431 4.863375 2.60554491zm9.963-7.92753362c-.6845625-.73643756-1.4518125-.73990314-1.803375-.7826454-2.518875-.18714178-6.2971875-.18714178-6.2971875-.18714178-.007875 0-3.7861875 0-6.3050625.18714178-.352125.04274226-1.1188125.04620784-1.8039375.7826454-.5394375.56084773-.7149375 1.8344515-.7149375 1.8344515s-.18 1.49597903-.18 2.99138042v1.4024082c0 1.495979.18 2.9913804.18 2.9913804s.1755 1.2736038.7149375 1.8344515c.685125.7364376 1.5845625.7133337 1.9850625.7901542 1.44.1420891 6.12.1859866 6.12.1859866s3.78225-.005776 6.301125-.1929178c.3515625-.0433198 1.1188125-.0467854 1.803375-.783223.5394375-.5608477.7155-1.8344515.7155-1.8344515s.18-1.4954014.18-2.9913804v-1.4024082c0-1.49540139-.18-2.99138042-.18-2.99138042s-.1760625-1.27360377-.7155-1.8344515z" fill-rule="evenodd"/></symbol><symbol id="icon-subject-medicine" viewBox="0 0 18 18"><path d="m12.5 8h-6.5c-1.65685425 0-3 1.34314575-3 3v1c0 1.6568542 1.34314575 3 3 3h1v-2h-.5c-.82842712 0-1.5-.6715729-1.5-1.5s.67157288-1.5 1.5-1.5h1.5 2 1 2c1.6568542 0 3-1.34314575 3-3v-1c0-1.65685425-1.3431458-3-3-3h-2v2h1.5c.8284271 0 1.5.67157288 1.5 1.5s-.6715729 1.5-1.5 1.5zm-5.5-1v-1h-3.5c-1.38071187 0-2.5-1.11928813-2.5-2.5s1.11928813-2.5 2.5-2.5h1.02786405c.46573528 0 .92507448.10843528 1.34164078.31671843l1.13382424.56691212c.06026365-1.05041141.93116291-1.88363055 1.99667093-1.88363055 1.1045695 0 2 .8954305 2 2h2c2.209139 0 4 1.790861 4 4v1c0 2.209139-1.790861 4-4 4h-2v1h2c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2h-2c0 1.1045695-.8954305 2-2 2s-2-.8954305-2-2h-1c-2.209139 0-4-1.790861-4-4v-1c0-2.209139 1.790861-4 4-4zm0-2v-2.05652691c-.14564246-.03538148-.28733393-.08714006-.42229124-.15461871l-1.15541752-.57770876c-.27771087-.13885544-.583937-.21114562-.89442719-.21114562h-1.02786405c-.82842712 0-1.5.67157288-1.5 1.5s.67157288 1.5 1.5 1.5zm4 1v1h1.5c.2761424 0 .5-.22385763.5-.5s-.2238576-.5-.5-.5zm-1 1v-5c0-.55228475-.44771525-1-1-1s-1 .44771525-1 1v5zm-2 4v5c0 .5522847.44771525 1 1 1s1-.4477153 1-1v-5zm3 2v2h2c.5522847 0 1-.4477153 1-1s-.4477153-1-1-1zm-4-1v-1h-.5c-.27614237 0-.5.2238576-.5.5s.22385763.5.5.5zm-3.5-9h1c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"/></symbol><symbol id="icon-success" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm3.4860198 4.98163161-4.71802968 5.50657859-2.62834168-2.02300024c-.42862421-.36730544-1.06564993-.30775346-1.42283677.13301307-.35718685.44076653-.29927542 1.0958383.12934879 1.46314377l3.40735508 2.7323063c.42215801.3385221 1.03700951.2798252 1.38749189-.1324571l5.38450527-6.33394549c.3613513-.43716226.3096573-1.09278382-.115462-1.46437175-.4251192-.37158792-1.0626796-.31842941-1.4240309.11873285z" fill-rule="evenodd"/></symbol><symbol id="icon-table" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587l-4.0059107-.001.001.001h-1l-.001-.001h-5l.001.001h-1l-.001-.001-3.00391071.001c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm-11.0059107 5h-3.999v6.9941413c0 .5572961.44630695 1.0058587.99508929 1.0058587h3.00391071zm6 0h-5v8h5zm5.0059107-4h-4.0059107v3h5.001v1h-5.001v7.999l4.0059107.001c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-12.5049107 9c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.22385763-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1.499-5h-5v3h5zm-6 0h-3.00391071c-.54871518 0-.99508929.44887827-.99508929 1.00585866v1.99414134h3.999z" fill-rule="evenodd"/></symbol><symbol id="icon-tick-circle" viewBox="0 0 24 24"><path d="m12 2c5.5228475 0 10 4.4771525 10 10s-4.4771525 10-10 10-10-4.4771525-10-10 4.4771525-10 10-10zm0 1c-4.97056275 0-9 4.02943725-9 9 0 4.9705627 4.02943725 9 9 9 4.9705627 0 9-4.0294373 9-9 0-4.97056275-4.0294373-9-9-9zm4.2199868 5.36606669c.3613514-.43716226.9989118-.49032077 1.424031-.11873285s.4768133 1.02720949.115462 1.46437175l-6.093335 6.94397871c-.3622945.4128716-.9897871.4562317-1.4054264.0971157l-3.89719065-3.3672071c-.42862421-.3673054-.48653564-1.0223772-.1293488-1.4631437s.99421256-.5003185 1.42283677-.1330131l3.11097438 2.6987741z" fill-rule="evenodd"/></symbol><symbol id="icon-tick" viewBox="0 0 16 16"><path d="m6.76799012 9.21106946-3.1109744-2.58349728c-.42862421-.35161617-1.06564993-.29460792-1.42283677.12733148s-.29927541 1.04903009.1293488 1.40064626l3.91576307 3.23873978c.41034319.3393961 1.01467563.2976897 1.37450571-.0948578l6.10568327-6.660841c.3613513-.41848908.3096572-1.04610608-.115462-1.4018218-.4251192-.35571573-1.0626796-.30482786-1.424031.11366122z" fill-rule="evenodd"/></symbol><symbol id="icon-update" viewBox="0 0 18 18"><path d="m1 13v1c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-1h-1v-10h-14v10zm16-1h1v2c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-2h1v-9c0-.55228475.44771525-1 1-1h14c.5522847 0 1 .44771525 1 1zm-1 0v1h-4.5857864l-1 1h-2.82842716l-1-1h-4.58578644v-1h5l1 1h2l1-1zm-13-8h12v7h-12zm1 1v5h10v-5zm1 1h4v1h-4zm0 2h4v1h-4z" fill-rule="evenodd"/></symbol><symbol id="icon-upload" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.85576936 4.14572769c.19483374-.19483375.51177826-.19377714.70556874.00001334l2.59099082 2.59099079c.1948411.19484112.1904373.51514474.0027906.70279143-.1932998.19329987-.5046517.19237083-.7001856-.00692852l-1.74638687-1.7800176v6.14827687c0 .2717771-.23193359.492096-.5.492096-.27614237 0-.5-.216372-.5-.492096v-6.14827641l-1.74627892 1.77990922c-.1933927.1971171-.51252214.19455839-.70016883.0069117-.19329987-.19329988-.19100584-.50899493.00277731-.70277808z" fill-rule="evenodd"/></symbol><symbol id="icon-video" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-8.30912922 2.24944486 4.60460462 2.73982242c.9365543.55726659.9290753 1.46522435 0 2.01804082l-4.60460462 2.7398224c-.93655425.5572666-1.69578148.1645632-1.69578148-.8937585v-5.71016863c0-1.05087579.76670616-1.446575 1.69578148-.89375851zm-.67492769.96085624v5.5750128c0 .2995102-.10753745.2442517.16578928.0847713l4.58452283-2.67497259c.3050619-.17799716.3051624-.21655446 0-.39461026l-4.58452283-2.67497264c-.26630747-.15538481-.16578928-.20699944-.16578928.08477139z" fill-rule="evenodd"/></symbol><symbol id="icon-warning" viewBox="0 0 18 18"><path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"/></symbol><symbol id="icon-facebook-bordered" viewBox="463.812 263.868 32 32"><path d="M479.812,263.868c-8.837,0-16,7.163-16,16s7.163,16,16,16s16-7.163,16-16S488.649,263.868,479.812,263.868z
	 M479.812,293.868c-7.732,0-14-6.269-14-14s6.268-14,14-14s14,6.269,14,14S487.545,293.868,479.812,293.868z"/><path d="M483.025,280.48l0.32-2.477h-2.453v-1.582c0-0.715,0.199-1.207,1.227-1.207h1.311v-2.213
	c-0.227-0.029-1.003-0.098-1.907-0.098c-1.894,0-3.186,1.154-3.186,3.271v1.826h-2.142v2.477h2.142v6.354h2.557v-6.354
	L483.025,280.48L483.025,280.48z"/></symbol><symbol id="icon-twitter-bordered" viewBox="463.812 263.868 32 32"><g><path d="M486.416,276.191c-0.483,0.215-1.007,0.357-1.554,0.429c0.558-0.338,0.991-0.868,1.19-1.502
		c-0.521,0.308-1.104,0.536-1.72,0.657c-0.494-0.526-1.2-0.854-1.979-0.854c-1.496,0-2.711,1.213-2.711,2.71
		c0,0.212,0.023,0.419,0.069,0.616c-2.252-0.111-4.25-1.19-5.586-2.831c-0.231,0.398-0.365,0.866-0.365,1.361
		c0,0.94,0.479,1.772,1.204,2.257c-0.441-0.015-0.861-0.138-1.227-0.339v0.031c0,1.314,0.937,2.41,2.174,2.656
		c-0.227,0.062-0.47,0.098-0.718,0.098c-0.171,0-0.343-0.018-0.511-0.049c0.35,1.074,1.347,1.859,2.531,1.883
		c-0.928,0.726-2.095,1.16-3.366,1.16c-0.22,0-0.433-0.014-0.644-0.037c1.2,0.768,2.621,1.215,4.155,1.215
		c4.983,0,7.71-4.129,7.71-7.711c0-0.115-0.004-0.232-0.006-0.351C485.592,277.212,486.054,276.734,486.416,276.191z"/></g><path d="M479.812,263.868c-8.837,0-16,7.163-16,16s7.163,16,16,16s16-7.163,16-16S488.649,263.868,479.812,263.868z
	 M479.812,293.868c-7.732,0-14-6.269-14-14s6.268-14,14-14s14,6.269,14,14S487.545,293.868,479.812,293.868z"/></symbol><symbol id="icon-weibo-bordered" viewBox="463.812 263.868 32 32"><path d="M479.812,263.868c-8.838,0-16,7.163-16,16s7.162,16,16,16c8.837,0,16-7.163,16-16S488.649,263.868,479.812,263.868z
	 M479.812,293.868c-7.732,0-14-6.269-14-14s6.268-14,14-14c7.731,0,14,6.269,14,14S487.545,293.868,479.812,293.868z"/><g><path d="M478.552,285.348c-2.616,0.261-4.876-0.926-5.044-2.649c-0.167-1.722,1.814-3.33,4.433-3.588
		c2.609-0.263,4.871,0.926,5.041,2.647C483.147,283.479,481.164,285.089,478.552,285.348 M483.782,279.63
		c-0.226-0.065-0.374-0.109-0.259-0.403c0.25-0.639,0.276-1.188,0.005-1.581c-0.515-0.734-1.915-0.693-3.521-0.021
		c0,0-0.508,0.224-0.378-0.181c0.247-0.798,0.209-1.468-0.178-1.852c-0.87-0.878-3.194,0.032-5.183,2.027
		c-1.489,1.494-2.357,3.082-2.357,4.453c0,2.619,3.354,4.213,6.631,4.213c4.297,0,7.154-2.504,7.154-4.493
		C485.697,280.594,484.689,279.911,483.782,279.63"/><path d="M486.637,274.833c-1.039-1.154-2.57-1.592-3.982-1.291l0,0c-0.325,0.068-0.532,0.391-0.465,0.72
		c0.068,0.328,0.391,0.537,0.72,0.466c1.005-0.215,2.092,0.104,2.827,0.92c0.736,0.818,0.938,1.939,0.625,2.918l0,0
		c-0.102,0.318,0.068,0.661,0.39,0.762c0.32,0.104,0.658-0.069,0.763-0.391v-0.001C487.953,277.558,487.674,275.985,486.637,274.833
		"/><path d="M485.041,276.276c-0.504-0.562-1.25-0.774-1.938-0.63c-0.279,0.06-0.461,0.339-0.396,0.621
		c0.062,0.281,0.335,0.461,0.617,0.398l0,0c0.336-0.071,0.702,0.03,0.947,0.307s0.312,0.649,0.207,0.979l0,0
		c-0.089,0.271,0.062,0.565,0.336,0.654c0.274,0.09,0.564-0.062,0.657-0.336C485.686,277.604,485.549,276.837,485.041,276.276"/><path d="M478.694,282.227c-0.09,0.156-0.293,0.233-0.451,0.166c-0.151-0.062-0.204-0.235-0.115-0.389
		c0.093-0.155,0.284-0.229,0.44-0.168C478.725,281.892,478.782,282.071,478.694,282.227 M477.862,283.301
		c-0.253,0.405-0.795,0.58-1.202,0.396c-0.403-0.186-0.521-0.655-0.27-1.051c0.248-0.39,0.771-0.566,1.176-0.393
		C477.979,282.423,478.109,282.889,477.862,283.301 M478.812,280.437c-1.244-0.326-2.65,0.294-3.19,1.396
		c-0.553,1.119-0.021,2.369,1.236,2.775c1.303,0.42,2.84-0.225,3.374-1.436C480.758,281.989,480.1,280.77,478.812,280.437"/></g></symbol><symbol id="icon-arrow-left-bullet" viewBox="0 0 8 16"><path d="M3 8l5 5v3L0 8l8-8v3L3 8z"/></symbol><symbol id="icon-chevron-down" viewBox="0 0 16 16"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 3)"/></symbol><symbol id="icon-download-rounded"><path d="M0 13c0-.556.449-1 1.002-1h9.996a.999.999 0 110 2H1.002A1.006 1.006 0 010 13zM7 1v6.8l2.482-2.482c.392-.392 1.022-.4 1.403-.02a1.001 1.001 0 010 1.417l-4.177 4.177a1.001 1.001 0 01-1.416 0L1.115 6.715a.991.991 0 01-.016-1.4 1 1 0 011.42.003L5 7.8V1c0-.55.444-.996 1-.996.552 0 1 .445 1 .996z"/></symbol><symbol id="icon-ext-link" viewBox="0 0 16 16"><path d="M12.9 16H3.1C1.4 16 0 14.6 0 12.9V3.2C0 1.4 1.4 0 3.1 0h3.7v1H3.1C2 1 1 2 1 3.2v9.7C1 14 2 15 3.1 15h9.7c1.2 0 2.1-1 2.1-2.1V8.7h1v4.2c.1 1.7-1.3 3.1-3 3.1z"/><path d="M12.8 2.5l.7.7-9 8.9-.7-.7 9-8.9z"/><path d="M9.7 0L16 6.2V0z"/></symbol><symbol id="icon-remove" viewBox="-296 388 18 18"><path d="M-291.7 396.1h9v2h-9z"/><path d="M-287 405.5c-4.7 0-8.5-3.8-8.5-8.5s3.8-8.5 8.5-8.5 8.5 3.8 8.5 8.5-3.8 8.5-8.5 8.5zm0-16c-4.1 0-7.5 3.4-7.5 7.5s3.4 7.5 7.5 7.5 7.5-3.4 7.5-7.5-3.4-7.5-7.5-7.5z"/></symbol><symbol id="icon-rss" viewBox="0 0 18 18"><path d="m.97480857 6.01583891.11675372.00378391c5.75903295.51984988 10.34261021 5.10537458 10.85988231 10.86480098.0494035.5500707-.3564674 1.0360406-.906538 1.0854441-.5500707.0494036-1.0360406-.3564673-1.08544412-.906538-.43079083-4.7965248-4.25151132-8.61886853-9.04770289-9.05180573-.55004837-.04965115-.95570047-.53580366-.90604933-1.08585203.04610464-.5107592.46858035-.89701345.96909831-.90983323zm1.52519143 6.95474179c1.38071187 0 2.5 1.1192881 2.5 2.5s-1.11928813 2.5-2.5 2.5-2.5-1.1192881-2.5-2.5 1.11928813-2.5 2.5-2.5zm-1.43253846-12.96884168c9.09581416.53242539 16.37540296 7.8163886 16.90205336 16.91294558.0319214.5513615-.389168 1.0242056-.9405294 1.056127-.5513615.0319214-1.0242057-.389168-1.0561271-.9405294-.4679958-8.08344784-6.93949306-14.55883389-15.02226722-15.03196077-.55134101-.03227286-.97212889-.50538538-.93985602-1.05672639.03227286-.551341.50538538-.97212888 1.05672638-.93985602z" fill-rule="evenodd"/></symbol><symbol id="icon-springer-arrow-left"><path d="M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z"/></symbol><symbol id="icon-springer-arrow-right"><path d="M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z"/></symbol><symbol id="icon-springer-collections" viewBox="3 3 32 32"><path fill-rule="evenodd" d="M25.583333,30.1249997 L25.583333,7.1207574 C25.583333,7.10772495 25.579812,7.10416665 25.5859851,7.10416665 L6.10400517,7.10571021 L6.10400517,30.1355179 C6.10400517,31.1064087 6.89406744,31.8958329 7.86448169,31.8958329 L26.057145,31.8958329 C25.7558021,31.374901 25.583333,30.7700915 25.583333,30.1249997 Z M4.33333333,30.1355179 L4.33333333,7.10571021 C4.33333333,6.12070047 5.12497502,5.33333333 6.10151452,5.33333333 L25.5859851,5.33333333 C26.5617372,5.33333333 27.3541664,6.13359035 27.3541664,7.1207574 L27.3541664,12.4166666 L32.6666663,12.4166666 L32.6666663,30.1098941 C32.6666663,32.0694626 31.0857174,33.6666663 29.1355179,33.6666663 L7.86448169,33.6666663 C5.91736809,33.6666663 4.33333333,32.0857174 4.33333333,30.1355179 Z M27.3541664,14.1874999 L27.3541664,30.1249997 C27.3541664,31.1030039 28.1469954,31.8958329 29.1249997,31.8958329 C30.1030039,31.8958329 30.8958329,31.1030039 30.8958329,30.1249997 L30.8958329,14.1874999 L27.3541664,14.1874999 Z M9.64583326,10.6458333 L22.0416665,10.6458333 L22.0416665,17.7291665 L9.64583326,17.7291665 L9.64583326,10.6458333 Z M11.4166666,12.4166666 L11.4166666,15.9583331 L20.2708331,15.9583331 L20.2708331,12.4166666 L11.4166666,12.4166666 Z M9.64583326,19.4999998 L22.0416665,19.4999998 L22.0416665,21.2708331 L9.64583326,21.2708331 L9.64583326,19.4999998 Z M9.64583326,23.0416665 L22.0416665,23.0416665 L22.0416665,24.8124997 L9.64583326,24.8124997 L9.64583326,23.0416665 Z M9.64583326,26.583333 L22.0416665,26.583333 L22.0416665,28.3541664 L9.64583326,28.3541664 L9.64583326,26.583333 Z"/></symbol><symbol id="icon-springer-download" viewBox="-301 390 9 14"><path d="M-301 395.6l4.5 5.1 4.5-5.1h-3V390h-3v5.6h-3zm0 6.5h9v1.9h-9z"/></symbol><symbol id="icon-springer-info" viewBox="0 0 24 24"><!--Generator: Sketch 63.1 (92452) - https://sketch.com--><g id="V&amp;I" stroke="none" stroke-width="1" fill-rule="evenodd"><g id="info" fill-rule="nonzero"><path d="M12,0 C18.627417,0 24,5.372583 24,12 C24,18.627417 18.627417,24 12,24 C5.372583,24 0,18.627417 0,12 C0,5.372583 5.372583,0 12,0 Z M12.5540543,9.1 L11.5540543,9.1 C11.0017696,9.1 10.5540543,9.54771525 10.5540543,10.1 L10.5540543,10.1 L10.5540543,18.1 C10.5540543,18.6522847 11.0017696,19.1 11.5540543,19.1 L11.5540543,19.1 L12.5540543,19.1 C13.1063391,19.1 13.5540543,18.6522847 13.5540543,18.1 L13.5540543,18.1 L13.5540543,10.1 C13.5540543,9.54771525 13.1063391,9.1 12.5540543,9.1 L12.5540543,9.1 Z M12,5 C11.5356863,5 11.1529412,5.14640523 10.8517647,5.43921569 C10.5505882,5.73202614 10.4,6.11546841 10.4,6.58954248 C10.4,7.06361656 10.5505882,7.45054466 10.8517647,7.7503268 C11.1529412,8.05010893 11.5356863,8.2 12,8.2 C12.4768627,8.2 12.8627451,8.05010893 13.1576471,7.7503268 C13.452549,7.45054466 13.6,7.06361656 13.6,6.58954248 C13.6,6.11546841 13.452549,5.73202614 13.1576471,5.43921569 C12.8627451,5.14640523 12.4768627,5 12,5 Z" id="Combined-Shape"/></g></g></symbol><symbol id="icon-springer-tick-circle" viewBox="0 0 24 24"><g id="Page-1" stroke="none" stroke-width="1" fill-rule="evenodd"><g id="springer-tick-circle" fill-rule="nonzero"><path d="M12,24 C5.372583,24 0,18.627417 0,12 C0,5.372583 5.372583,0 12,0 C18.627417,0 24,5.372583 24,12 C24,18.627417 18.627417,24 12,24 Z M7.657,10.79 C7.45285634,10.6137568 7.18569967,10.5283283 6.91717333,10.5534259 C6.648647,10.5785236 6.40194824,10.7119794 6.234,10.923 C5.87705269,11.3666969 5.93445559,12.0131419 6.364,12.387 L10.261,15.754 C10.6765468,16.112859 11.3037113,16.0695601 11.666,15.657 L17.759,8.713 C18.120307,8.27302248 18.0695334,7.62621189 17.644,7.248 C17.4414817,7.06995024 17.1751516,6.9821166 16.9064461,7.00476032 C16.6377406,7.02740404 16.3898655,7.15856958 16.22,7.368 L10.768,13.489 L7.657,10.79 Z" id="path-1"/></g></g></symbol><symbol id="icon-updates" viewBox="0 0 18 18"><g fill-rule="nonzero"><path d="M16.98 3.484h-.48c-2.52-.058-5.04 1.161-7.44 2.903-2.46-1.8-4.74-2.903-8.04-2.903-.3 0-.54.29-.54.58v9.813c0 .29.24.523.54.581 2.76.348 4.86 1.045 7.62 2.903.24.116.54.116.72 0 2.76-1.858 4.86-2.555 7.62-2.903.3-.058.54-.29.54-.58V4.064c0-.29-.24-.523-.54-.581zm-15.3 1.22c2.34 0 4.86 1.509 6.72 2.786v8.478c-2.34-1.394-4.38-2.09-6.72-2.439V4.703zm14.58 8.767c-2.34.348-4.38 1.045-6.72 2.439V7.374C12 5.632 14.1 4.645 16.26 4.645v8.826z"/><path d="M9 .058c-1.56 0-2.76 1.22-2.76 2.671C6.24 4.181 7.5 5.4 9 5.4c1.5 0 2.76-1.22 2.76-2.671 0-1.452-1.2-2.67-2.76-2.67zm0 4.413c-.96 0-1.8-.755-1.8-1.742C7.2 1.8 7.98.987 9 .987s1.8.755 1.8 1.742c0 .93-.84 1.742-1.8 1.742z"/></g></symbol></svg>
</div>


        

        

    <div class="u-vh-full">
        <a class="c-skip-link" href="#main-content">Skip to main content</a>
        
            
    
        <div class="u-hide u-show-following-ad"></div>
    
    <aside class="adsbox c-ad c-ad--728x90" data-component-mpu>
        <div class="c-ad__inner" >
            <p class="c-ad__label">Advertisement</p>
            <div id="div-gpt-ad-LB1"
                data-ad-type="LB1"
                data-pa11y-ignore
                data-gpt
                data-gpt-unitpath="/270604982/bmc/breast-cancer-research/articles"
                data-gpt-sizes="728x90,970x90"
                data-gpt-targeting="pos=LB1;doi=10.1186/bcr3322;type=article;kwrd=SUM159 Cell,Breast Cancer Cell Migration,Thiazolyl Blue Tetrazolium Bromide,SCP2 Cell,Triple Negative Human Breast Cancer;pmc=B11001,H33160,H59150;"
            >
                <noscript>
                    <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/270604982/bmc/breast-cancer-research/articles&amp;sz=728x90,970x90&amp;pos=LB1&amp;doi=10.1186/bcr3322&amp;type=article&amp;kwrd=SUM159 Cell,Breast Cancer Cell Migration,Thiazolyl Blue Tetrazolium Bromide,SCP2 Cell,Triple Negative Human Breast Cancer&amp;pmc=B11001,H33160,H59150&amp;">
                        <img data-test="gpt-advert-fallback-img"
                            src="//pubads.g.doubleclick.net/gampad/ad?iu=/270604982/bmc/breast-cancer-research/articles&amp;sz=728x90,970x90&amp;pos=LB1&amp;doi=10.1186/bcr3322&amp;type=article&amp;kwrd=SUM159 Cell,Breast Cancer Cell Migration,Thiazolyl Blue Tetrazolium Bromide,SCP2 Cell,Triple Negative Human Breast Cancer&amp;pmc=B11001,H33160,H59150&amp;"
                            alt="Advertisement"
                            width="728"
                            height="90">
                    </a>
                </noscript>
            </div>
        </div>
    </aside>

        
        

         
    
        <div id="membership-message-loader-desktop" class="placeholder" data-placeholder="/placeholder/v1/membership/message"></div>
    
    
        <div id="top" class="u-position-relative">
    <header class="c-header" data-test="publisher-header">
        <div class="c-header__container">
            <div class="c-header__brand u-mr-48" itemscope itemtype="http://schema.org/Organization" data-test="navbar-logo-header">
                <div class="c-logo">
    <a href="https://www.biomedcentral.com" itemprop="url">
        <img alt="BMC" itemprop="logo" width="76" height="18" role="img" src=/static/images/bmc/logos/logo-bmc-white-aj-be532aa3f0.svg>
        <div class="c-logo__strapline">
            <img alt="Part of Springer Nature" width="173" height="16" role="img" src=/static/images/bmc/logos/logo-bmc-white-strapline-sn-f224388d67.svg>
        </div>
    </a>
</div>

            </div>
            <div class="c-header__navigation">
                <button
                    type="button"
                    class="c-header__link u-button-reset u-mr-24"
                    data-expander
                    data-expander-target="#publisher-header-search"
                    data-expander-autofocus="firstTabbable"
                    data-test="header-search-button"
                    aria-controls="publisher-header-search"
                    aria-expanded="false">
                    <span class="u-display-flex u-align-items-center">
                        <span class="u-text-sm">Search</span>
                        <svg class="u-icon u-flex-static u-ml-8" aria-hidden="true" focusable="false">
                            <use xlink:href="#global-icon-search"></use>
                        </svg>
                    </span>
                </button>
                <nav>
                    <ul class="c-header__menu" data-enhanced-menu data-test="publisher-navigation">
                        
                            
                                <li class="c-header__item u-hide-at-lt-lg">
                                    <a class="c-header__link"
                                       href="//www.biomedcentral.com/journals">
                                        Explore journals
                                    </a>
                                </li>
                            
                                <li class="c-header__item u-hide-at-lt-lg">
                                    <a class="c-header__link"
                                       href="//www.biomedcentral.com/getpublished">
                                        Get published
                                    </a>
                                </li>
                            
                                <li class="c-header__item u-hide-at-lt-lg">
                                    <a class="c-header__link"
                                       href="//www.biomedcentral.com/about">
                                        About BMC
                                    </a>
                                </li>
                            
                        
                        <li class="c-header__item">
                            <a data-enhanced-account
                               class="c-header__link"
                               href="https://www.biomedcentral.com/account"
                               data-test="login-link">
                                My account
                            </a>
                        </li>
                    </ul>
                </nav>
            </div>
        </div>
    </header>
    <div class="c-popup-search u-js-hide" id="publisher-header-search">
        <div class="u-container">
            <div class="c-popup-search__container">
                <div class="ctx-search">
    <form role="search" class="c-form-field" method="GET" action="//www.biomedcentral.com/search" data-track="submit"
        data-track-category="Search and Results" data-track-action="Submit search" data-dynamic-track-label data-track-label="" data-test="global-search">
        <label for="publisherSearch" class="c-form-field__label">Search all BMC articles</label>
        <div class="u-display-flex">
            <input id="publisherSearch" class="c-form-field__input" data-search-input autocomplete="off" role="textbox" data-test="search-input" name="query" type="text" value=""/>
            <div>
                <button class="u-button" type="submit" data-test="search-submit-button">
    <span class="u-visually-hidden">Search</span>
    <svg class="u-icon u-flex-static" width="16" height="16" aria-hidden="true" focusable="false">
        <use xlink:href="#global-icon-search"></use>
    </svg>
</button>


            </div>
        </div>
        <input type="hidden" name="searchType" value="publisherSearch"/>
    </form>
</div>

            </div>
        </div>
    </div>
</div>

    

        
            <header class="c-journal-header c-journal-header--breast-cancer-research ctx-journal-header">
                <div class="u-container">
                    <div class="c-journal-header__inner ">
                        
                        <div class="c-journal-title" id="journalTitle">
                            <a href="/">
    
        
    
    <span class="c-journal-title__text ">Breast Cancer Research</span>
    
</a>
                        </div>
                        
                    </div>
                </div>
                <div class="c-navbar">
                    <div class="c-navbar__container">
                        
                            <div class="c-navbar__content">
                                <nav class="c-navbar__nav">
                                    <ul class="c-navbar__nav c-navbar__nav--journal" role="menu" data-test="site-navigation">
                                        
                                            <li class="c-navbar__item" role="menuitem">
                                                <a class="c-navbar__link" data-track="click" data-track-category="Home" data-track-action="Clicked journal navigation link" href='/'>Home</a>
                                            </li>
                                        
                                            <li class="c-navbar__item" role="menuitem">
                                                <a class="c-navbar__link" data-track="click" data-track-category="About" data-track-action="Clicked journal navigation link" href='/about'>About</a>
                                            </li>
                                        
                                            <li class="c-navbar__item" role="menuitem">
                                                <a class="c-navbar__link c-navbar__link--is-shown" data-track="click" data-track-category="Articles" data-track-action="Clicked journal navigation link" href='/articles'>Articles</a>
                                            </li>
                                        
                                            <li class="c-navbar__item" role="menuitem">
                                                <a class="c-navbar__link" data-track="click" data-track-category="Submission Guidelines" data-track-action="Clicked journal navigation link" href='/submission-guidelines'>Submission Guidelines</a>
                                            </li>
                                        
                                    </ul>
                                </nav>
                            </div>
                        
                    </div>
                </div>
                <div class="c-journal-header__identity c-journal-header__identity--midnight-purple">
                    
                </div>
            </header>
            
        

        <div class="u-container u-mt-32 u-mb-32 u-clearfix" id="main-content" data-component="article-container">

            <main class="c-article-main-column u-float-left js-main-column" data-track-component="article body">
                
    <div class="c-pdf-download u-clear-both">
        <a href="//breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3322.pdf" class="c-pdf-download__link" data-article-pdf="true"  data-readcube-pdf-url="true" data-test="pdf-link" data-draft-ignore="true" data-track="click" data-track-action="download pdf" data-track-label="link" data-track-external>
            <span>Download PDF</span>
            <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#global-icon-download"/></svg>
        </a>
    </div>

                <article lang="en">
                    <div class="c-article-header">
                        
    


                        <ul class="c-article-identifiers" data-test="article-identifier">
                            
    
        <li class="c-article-identifiers__item" data-test="article-category">Research article</li>
    
    
        <li class="c-article-identifiers__item">
            <span class="c-article-identifiers__open" data-test="open-access">Open Access</span>
        </li>
    
    

                            <li class="c-article-identifiers__item"><a href="#article-info" data-track="click" data-track-action="publication date" data-track-label="link">Published: <time datetime="2012-09-20">20 September 2012</time></a></li>
                        </ul>

                        <h1 class="c-article-title" data-test="article-title" data-article-title="">A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFÎ²-mediated breast cancer cell migration and invasion</h1>
                        <ul class="c-article-author-list js-etal-collapsed" data-etal="25" data-etal-small="3" data-test="authors-list" data-component-authors-activator="authors-list"><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Meiou-Dai" data-author-popup="auth-Meiou-Dai">Meiou Dai</a><sup class="u-js-hide"><a href="#Aff1">1</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Amal_A-Al_Odaini" data-author-popup="auth-Amal_A-Al_Odaini">Amal A Al-Odaini</a><sup class="u-js-hide"><a href="#Aff1">1</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Ani-Arakelian" data-author-popup="auth-Ani-Arakelian">Ani Arakelian</a><sup class="u-js-hide"><a href="#Aff2">2</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Shafaat_A-Rabbani" data-author-popup="auth-Shafaat_A-Rabbani">Shafaat A Rabbani</a><sup class="u-js-hide"><a href="#Aff2">2</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Suhad-Ali" data-author-popup="auth-Suhad-Ali">Suhad Ali</a><sup class="u-js-hide"><a href="#Aff1">1</a></sup> &amp; </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Jean_Jacques-Lebrun" data-author-popup="auth-Jean_Jacques-Lebrun" data-corresp-id="c1">Jean-Jacques Lebrun<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-email"></use></svg></a><sup class="u-js-hide"><a href="#Aff1">1</a></sup>Â </li></ul>
                        <p class="c-article-info-details" data-container-section="info">
                            
    <a data-test="journal-link" href="/"><i data-test="journal-title">Breast Cancer Research</i></a>

                            <b data-test="journal-volume"><span class="u-visually-hidden">volume</span>Â 14</b>, ArticleÂ number:Â <span data-test="article-number">3055</span> (<span data-test="article-publication-year">2012</span>)
            <a href="#citeas" class="c-article-info-details__cite-as u-hide-print" data-track="click" data-track-action="cite this article" data-track-label="link">Cite this article</a>
                        </p>
                        
    <div class="c-article-metrics-bar__wrapper u-clear-both">
        <ul class="c-article-metrics-bar u-list-reset">
            
                <li class=" c-article-metrics-bar__item">
                    <p class="c-article-metrics-bar__count">43k <span class="c-article-metrics-bar__label">Accesses</span></p>
                </li>
            
            
                <li class="c-article-metrics-bar__item">
                    <p class="c-article-metrics-bar__count">43 <span class="c-article-metrics-bar__label">Citations</span></p>
                </li>
            
            
                
                    <li class="c-article-metrics-bar__item">
                        <p class="c-article-metrics-bar__count">1 <span class="c-article-metrics-bar__label">Altmetric</span></p>
                    </li>
                
            
            <li class="c-article-metrics-bar__item">
                <p class="c-article-metrics-bar__details"><a href="/articles/10.1186/bcr3322/metrics" data-track="click" data-track-action="view metrics" data-track-label="link" rel="nofollow">Metrics <span class="u-visually-hidden">details</span></a></p>
            </li>
        </ul>
    </div>

                        
                        
    
        <div class="u-mb-8 c-status-message c-status-message--boxed c-status-message--info">
            <span class="c-status-message__icon">
                <svg class="u-icon" width="18" height="18" aria-hidden="true" focusable="false">
                    <use xlink:href="#icon-info"></use>
                </svg>
            </span>
            
                
                    <p>An <a href="/articles/10.1186/s13058-017-0832-7" class="relation-link" data-track="click" data-track-action="view linked article" data-track-label="link">Erratum</a> to this article was published on 28 March 2017</p>
                
            
        </div>
    

    

                        
                    </div>

                    <section aria-labelledby="Abs1_3055" data-title="Abstract" lang="en"><div class="c-article-section" id="Abs1_3055-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Abs1_3055">Abstract</h2><div class="c-article-section__content" id="Abs1_3055-content"><h3 class="c-article__sub-heading" data-test="abstract-sub-heading">Introduction</h3><p>Tumor cell migration and invasion are critical initiation steps in the process of breast cancer metastasis, the primary cause of breast cancer morbidity and death. Here we investigated the role of p21Cip1 (p21), a member of the core cell cycle machinery, in transforming growth factor-beta (TGFÎ²)-mediated breast cancer cell migration and invasion.</p><h3 class="c-article__sub-heading" data-test="abstract-sub-heading">Methods</h3><p>A mammary fat pad xenograft mouse model was used to assess the mammary tumor growth and local invasion. The triple negative human breast cancer cell lines MDA-MB231 and its sub-progenies SCP2 and SCP25, SUM159PT, SUM149PT, SUM229PE and SUM1315MO<sub>2</sub> were treated with 5 ng/ml TGFÎ² and the protein expression levels were measured by Western blot. Cell migration and invasion were examined using the scratch/wound healing and Transwell assay. TGFÎ² transcriptional activity was measured by a TGFÎ²/Smad reporter construct (CAGA12-luc) using luciferase assay. q-PCR was used for assessing TGFÎ² downstream target genes. The interactions among p21, p/CAF and Smad3 were performed by co-immunoprecipitation. In addition, Smad3 on DNA binding ability was measured by DNA immunoprecipitation using biotinylated Smad binding element DNA probes. Finally, the association among active TGFÎ²/Smad signaling, p21 and p/CAF with lymph node metastasis was examined by immunohistochemistry in tissue microarray containing 50 invasive ductal breast tumors, 25 of which are lymph node positive.</p><h3 class="c-article__sub-heading" data-test="abstract-sub-heading">Results</h3><p>We found p21 expression to correlate with poor overall and distant metastasis free survival in breast cancer patients. Furthermore, using xenograft animal models and <i>in vitro</i> studies, we found p21 to be essential for tumor cell invasion. The invasive effects of p21 were found to correlate with Smad3, and p/CAF interaction downstream of TGFÎ². p21 and p/CAF regulates TGFÎ²-mediated transcription of pro-metastatic genes by controlling Smad3 acetylation, DNA binding and transcriptional activity. In addition, we found that active TGFÎ²/Smad signaling correlates with high p21 and p/CAF expression levels and lymph node involvement using tissue microarrays from breast cancer patients.</p><h3 class="c-article__sub-heading" data-test="abstract-sub-heading">Conclusions</h3><p>Together these results highlight an important role for p21 and p/CAF in promoting breast cancer cell migration and invasion at the transcriptional level and may open new avenues for breast cancer therapy.</p></div></div></section>
                    
    


                    <section data-title="Introduction"><div class="c-article-section" id="Sec1_3055-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec1_3055">Introduction</h2><div class="c-article-section__content" id="Sec1_3055-content"><p>p21 was originally identified as a cell cycle regulator through inhibition of different cyclin/cyclin-dependent kinase complexes [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. &#xA;Cell 1993, 75:805â816." href="/articles/10.1186/bcr3322#ref-CR1_3055" id="ref-link-section-d109682214e686">1</a>]. p21 is a member of the Cip/Kip family of cell cycle inhibitors, which also includes p27Kip1 and p57Kip2 [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. &#xA;Nature 1993, 366:701â704." href="/articles/10.1186/bcr3322#ref-CR2_3055" id="ref-link-section-d109682214e689">2</a>â<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 4" title="Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, Elledge SJ: p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. &#xA;Genes Dev 1995, 9:650â662." href="/articles/10.1186/bcr3322#ref-CR4_3055" id="ref-link-section-d109682214e692">4</a>]. In addition to its role in cell cycle control, p21 is involved in the regulation of cellular senescence, gene transcription, apoptosis and actin cytoskeleton [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 5" title="Besson A, Assoian RK, Roberts JM: Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors? &#xA;Nat Rev Cancer 2004, 4:948â955." href="/articles/10.1186/bcr3322#ref-CR5_3055" id="ref-link-section-d109682214e695">5</a>â<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 7" title="Abbas T, Dutta A: p21 in cancer: intricate networks and multiple activities. &#xA;Nat Rev Cancer 2009, 9:400â414." href="/articles/10.1186/bcr3322#ref-CR7_3055" id="ref-link-section-d109682214e698">7</a>]. The role of p21 in breast cancer development and progression has not been fully investigated. While p21 is involved in cell cycle control and is a downstream target of the tumor suppressor p53, it does not fulfill the classic definition of a tumor suppressor. Germline or somatic mutations in the p21 gene are not common in human cancers [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 8" title="Shiohara M, el-Deiry WS, Wada M, Nakamaki T, Takeuchi S, Yang R, Chen DL, Vogelstein B, Koeffler HP: Absence of WAF1 mutations in a variety of human malignancies. &#xA;Blood 1994, 84:3781â3784." href="/articles/10.1186/bcr3322#ref-CR8_3055" id="ref-link-section-d109682214e702">8</a>]. Furthermore, <i>in vivo</i> studies using p21 knockout mice showed that, while loss of p21 expression efficiently blocked the ability of the cells to undergo G1 arrest following DNA damage, these animals developed normally [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 9" title="Deng C, Zhang P, Harper JW, Elledge SJ, Leder P: Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. &#xA;Cell 1995, 82:675â684." href="/articles/10.1186/bcr3322#ref-CR9_3055" id="ref-link-section-d109682214e708">9</a>]. Intriguingly, p21 is often overexpressed in aggressive tumors, including carcinomas of the pancreas, breast, prostate, ovary and cervix [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 10" title="Biankin AV, Kench JG, Morey AL, Lee CS, Biankin SA, Head DR, Hugh TB, Henshall SM, Sutherland RL: Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia. &#xA;Cancer Res 2001, 61:8830â8837." href="/articles/10.1186/bcr3322#ref-CR10_3055" id="ref-link-section-d109682214e711">10</a>â<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Aaltomaa S, Lipponen P, Eskelinen M, Ala-Opas M, Kosma VM: Prognostic value and expression of p21(waf1/cip1) protein in prostate cancer. &#xA;Prostate 1999, 39:8â15." href="/articles/10.1186/bcr3322#ref-CR13_3055" id="ref-link-section-d109682214e714">13</a>]. Together these observations suggest that the role played by p21 in cancer is more complex than initially thought and that, in addition to its well-known cell cycle regulatory effect, it may have uncharacterized roles in promoting carcinogenesis.</p><p>Tumor cell migration and invasion are critical steps in the metastatic process and are regulated by numerous tumor-secreted factors which modify the tumor microenvironment by acting on stromal recruitment and extracellular matrix (ECM) degradation, resulting in tumor cell migration and invasion [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Wels J, Kaplan RN, Rafii S, Lyden D: Migratory neighbors and distant invaders: tumor-associated niche cells. &#xA;Genes Dev 2008, 22:559â574." href="/articles/10.1186/bcr3322#ref-CR14_3055" id="ref-link-section-d109682214e720">14</a>]. Among these tumor-secreted factors, TGFÎ² has been shown to play a pivotal role in promoting tumor metastasis [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 15" title="Ikushima H, Miyazono K: TGFbeta signalling: a complex web in cancer progression. &#xA;Nat Rev Cancer 2010, 10:415â424." href="/articles/10.1186/bcr3322#ref-CR15_3055" id="ref-link-section-d109682214e723">15</a>]. The TGFÎ² family regulates asymmetric cell division and cell fate determination during embryogenesis and exerts profound effects on reproductive functions, immune responses, cell growth, bone formation, tissue remodeling and repair throughout adult life [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 16" title="Massague J: The transforming growth factor-beta family. &#xA;Annu Rev Cell Biol 1990, 6:597â641." href="/articles/10.1186/bcr3322#ref-CR16_3055" id="ref-link-section-d109682214e726">16</a>]. The effects of TGFÎ² in breast cancer are complex. TGFÎ² is thought to play a dual role in breast cancer progression, acting as a tumor suppressor in normal and early carcinoma, and as a pro-metastatic factor in aggressive carcinoma [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 17" title="Padua D, Massague J: Roles of TGFbeta in metastasis. &#xA;Cell Res 2009, 19:89â102." href="/articles/10.1186/bcr3322#ref-CR17_3055" id="ref-link-section-d109682214e729">17</a>]. The growth inhibitory effects of TGFÎ² are known to be mediated through transcriptional repression of the c-myc gene [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="Chen CR, Kang Y, Massague J: Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program. &#xA;Proc Natl Acad Sci USA 2001, 98:992â999." href="/articles/10.1186/bcr3322#ref-CR18_3055" id="ref-link-section-d109682214e732">18</a>] and induction of the cell cycle inhibitors p15Ink4b (p15) and p21, leading to G1 arrest [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 19" title="Hannon GJ, Beach D: p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. &#xA;Nature 1994, 371:257â261." href="/articles/10.1186/bcr3322#ref-CR19_3055" id="ref-link-section-d109682214e736">19</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 20" title="Li CY, Suardet L, Little JB: Potential role of WAF1/Cip1/p21 as a mediator of TGF-beta cytoinhibitory effect. &#xA;J Biol Chem 1995, 270:4971â4974." href="/articles/10.1186/bcr3322#ref-CR20_3055" id="ref-link-section-d109682214e739">20</a>]. During tumor progression, however, the loss of TGFÎ² growth-inhibitory effects is frequently due to defects in c-myc and p15 regulation by TGFÎ² [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="Chen CR, Kang Y, Massague J: Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program. &#xA;Proc Natl Acad Sci USA 2001, 98:992â999." href="/articles/10.1186/bcr3322#ref-CR18_3055" id="ref-link-section-d109682214e742">18</a>]. Meanwhile, other TGFÎ² responses prevail, unrelated to growth inhibition and favoring tumor progression and metastasis [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 21" title="Derynck R, Akhurst RJ, Balmain A: TGF-beta signaling in tumor suppression and cancer progression. &#xA;Nat Genet 2001, 29:117â129." href="/articles/10.1186/bcr3322#ref-CR21_3055" id="ref-link-section-d109682214e745">21</a>â<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Humbert L, Neel JC, Lebrun JJ: Targeting TGF-beta signaling in human cancer therapy. &#xA;Trends Cell Mol Biol 2010, 5:69â107." href="/articles/10.1186/bcr3322#ref-CR25_3055" id="ref-link-section-d109682214e748">25</a>]. Indeed, TGFÎ² induces degradation of the ECM, inhibits cell adhesion and stimulates cell migration and invasion, thereby promoting tumor metastasis [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 21" title="Derynck R, Akhurst RJ, Balmain A: TGF-beta signaling in tumor suppression and cancer progression. &#xA;Nat Genet 2001, 29:117â129." href="/articles/10.1186/bcr3322#ref-CR21_3055" id="ref-link-section-d109682214e751">21</a>â<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Wakefield LM, Roberts AB: TGF-beta signaling: positive and negative effects on tumorigenesis. &#xA;Curr Opin Genet Dev 2002, 12:22â29." href="/articles/10.1186/bcr3322#ref-CR23_3055" id="ref-link-section-d109682214e755">23</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Humbert L, Neel JC, Lebrun JJ: Targeting TGF-beta signaling in human cancer therapy. &#xA;Trends Cell Mol Biol 2010, 5:69â107." href="/articles/10.1186/bcr3322#ref-CR25_3055" id="ref-link-section-d109682214e758">25</a>]. Moreover, during cancer progression, tumor cells secrete increasing quantities of TGFÎ², which in turn alter the stroma environment, leading to stimulation of tumor angiogenesis and causing local and systemic immunosuppression, thus further contributing to tumor progression and metastasis [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 21" title="Derynck R, Akhurst RJ, Balmain A: TGF-beta signaling in tumor suppression and cancer progression. &#xA;Nat Genet 2001, 29:117â129." href="/articles/10.1186/bcr3322#ref-CR21_3055" id="ref-link-section-d109682214e761">21</a>â<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Wakefield LM, Roberts AB: TGF-beta signaling: positive and negative effects on tumorigenesis. &#xA;Curr Opin Genet Dev 2002, 12:22â29." href="/articles/10.1186/bcr3322#ref-CR23_3055" id="ref-link-section-d109682214e764">23</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Humbert L, Neel JC, Lebrun JJ: Targeting TGF-beta signaling in human cancer therapy. &#xA;Trends Cell Mol Biol 2010, 5:69â107." href="/articles/10.1186/bcr3322#ref-CR25_3055" id="ref-link-section-d109682214e767">25</a>]. Together these studies highlight an important role for TGFÎ² in advanced breast cancer. However, the function for p21 downstream of TGFÎ² has not been described in breast cancer.</p><p>In this study, we found that high p21 expression correlates with poor survival in breast cancer patients. The expression of p21 is required to promote tumor cell migration and invasion <i>in vitro</i> and local invasion <i>in vivo</i>. Furthermore, p21 expression is tightly regulated by TGFÎ²/Smad3 signaling in a panel of human basal-like triple negative breast cancer cell lines. We found p21 to physically interact with Smad3 and the histone acetyltransferase p/CAF in response to TGFÎ² and identified p21 and p/CAF as key regulators of TGFÎ²-mediated breast cancer cell migration and invasion. We also showed that p21 and p/CAF regulate TGFÎ² transcriptional activity on multiple tumor-promoting target genes by controlling Smad3 acetylation and Smad3 occupancy on its DNA binding elements. Immunohistochemical analysis of tissue arrays from breast cancer patients revealed a significant correlation between active TGFÎ²/Smad3 signaling and high expression levels of both p21 and p/CAF in lymph node-positive invasive ductal carcinomas. Together, our findings identified p21 and p/CAF as critical regulators of cell migration and invasion downstream of TGFÎ²/Smad3 pathway in advanced breast cancer.</p></div></div></section><section data-title="Methods"><div class="c-article-section" id="Sec2_3055-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec2_3055">Methods</h2><div class="c-article-section__content" id="Sec2_3055-content"><h3 class="c-article__sub-heading" id="Sec3_3055">Cell culture and transfection</h3><p>Human breast carcinoma MDA-MB231, SCP2 and SCP25 cells (provided by Dr. Joan MassaguÃ©) and HEK293 cells were grown in DMEM supplemented with 10% fetal bovine serum (FBS) and 2 mM L-glutamine at 37Â°C in 5% CO<sub>2</sub>. SUM149PT, SUM159PT and SUM229PE (provided by Dr. Stephen P Ethier) were grown in F-12 HAM'S nutrient mixture (HyClone Laboratories, Inc. Logan, Utah, USA) supplemented with 5% FBS, 5 Âµg/ml insulin (Sigma-Aldrich, St. Louis, MO, USA), 1 Âµg/ml hydrocortisone (Sigma) at 37Â°C in 5% CO<sub>2</sub>. SUM1315MO<sub>2</sub> were grown in F-12 HAM'S nutrient mixture (HyClone) supplemented with 5% FBS, 5 Âµg/ml insulin (Sigma), 10 ng/ml epidermal growth factor (EGF) (Sigma) at 37Â°C in 5% CO<sub>2</sub>.</p><p>Cells were transfected with different p21, p/CAF, Smad2 and Smad3 siRNAs (Sigma), 6Ã myc- Smad2, myc-Smad3, p/CAF (Addgene plasmid 8941) [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 26" title="Yang XJ, Ogryzko VV, Nishikawa J, Howard BH, Nakatani Y: A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. &#xA;Nature 1996, 382:319â324." href="/articles/10.1186/bcr3322#ref-CR26_3055" id="ref-link-section-d109682214e802">26</a>] and Flag-tagged human p21 cDNAs (Addgene plasmid 16240) [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 27" title="Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC: Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. &#xA;Nat Cell Biol 2001, 3:245â252." href="/articles/10.1186/bcr3322#ref-CR27_3055" id="ref-link-section-d109682214e805">27</a>] using Lipofectamineâ¢ 2000 reagent (Invitrogen, Carlsbad, CA, USA ), according to the manufacturer's protocol. MDA and SCPs cells were serum-starved for 24 hrs and stimulated or not with 5 ng/ml TGFÎ²1 (PeproTech, Rocky Hill, NJ, USA) in DMEM supplemented with 2 mM L-glutamine. For stable cell line generation, SCP2 cells were transfected with p21 shRNA (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and pools of stable cells were selected with 10 ng/ml puromycin (Invitrogen). SUM159PT cells were serum-starved for 24 hrs in the absence of insulin and hydrocortisone before TGFÎ²1 stimulation.</p><h3 class="c-article__sub-heading" id="Sec4_3055">Western blot analysis and immunoprecipitation</h3><p>Cells were lysed in cold extraction buffer (10 mM Tris-HCl, pH 7.5, 5 mM EDTA, 150 mM NaCl, 30 mM sodium pyrophosphate, 50 mM sodium fluoride, 1 mM sodium orthovanadate, 1% Triton X-100) containing protease inhibitors (1 mM phenylmethylsulfonyl fluoride, 10 Âµg/ml leupeptin hydrochloride, 10 Âµg/ml aprotinin and 10 Âµg/ml pepstatin A). The lysates were then centrifuged at 14,000 rpm for 15 minutes at 4Â°C. Protein content was measured using BCA protein assay kit (Thermo Scientific, Rockford, IL, USA). Equal protein was analyzed by Western blot using mouse anti-p21 (F5), mouse anti-c-myc, mouse anti-p15, rabbit anti-Smad2/3 (1:1,000 dilution, Santa Cruz Biotechnology), phospho-cofilin and cofilin antibodies (1:1,000 dilution, Millipore, Billerica, MA, USA), and followed by secondary antibodies goat anti-mouse or rabbit. Immunoprecipitations were performed overnight at 4Â°C using antibodies against p300/CBP (Santa Cruz Biotechnology), p/CAF (Abcam<sup>Â®</sup>, Cambridge, MA, USA) and p21. Protein G-Sepharose (GE Healthcare Bio-Sciences, Piscataway, NJ, USA) was added for 1 hr at 4Â°C, and washed four times with cold lysis buffer. The immunocomplexes were boiled with 2Ã sodium dodecyl sulfate (SDS) Laemmli sample buffer for five minutes and subjected to immunoblotting.</p><h3 class="c-article__sub-heading" id="Sec5_3055">Histone proteins extraction</h3><p>Total histone proteins were extracted as previously described [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 28" title="Shechter D, Dormann HL, Allis CD, Hake SB: Extraction, purification and analysis of histones. &#xA;Nat Protoc 2007, 2:1445â1457." href="/articles/10.1186/bcr3322#ref-CR28_3055" id="ref-link-section-d109682214e826">28</a>]. Briefly, 80% confluent of SCP2 cells from a 100-mm tissue culture plate were serum-starved for 24 hrs and stimulated with or without 5 ng/ml TGFÎ² or 1 ÂµM trichostatin A (TSA). SCP2 cells were harvested and resuspended in cold hypotonic lysis buffer containing 10 mM Tris-HCl, pH 8.0, 1 mM KCl, 1.5 mM MgCl<sub>2</sub>, 1 mM DTT, protease inhibitors, 1 ÂµM TSA and 10 mM sodium butyrate. Cell lysates were rotated at 4Â°C for 30 minutes and then centrifuged at 10,000 g, 4Â°C, for 10 minutes. The supernatants were discarded and nuclei pellets were resuspended in 400 Âµl of 0.4 N H<sub>2</sub>SO<sub>4</sub> and incubated overnight on a rotator at 4Â°C. Samples were centrifuged at 16,000 g for 10 minutes and supernatants containing histones were transferred into a fresh tube. A total of 132 Âµl trichloroacetic acid was added drop by drop to the histone solution, inverted several times and then incubated on ice for 30 minutes. The histone precipitates were centrifuged at 16,000 g for 10 minutes and pellets were washed twice with ice-cold acetone and the histone pellets were air dried for 20 minutes. Total histone proteins were subjected to Western blot analysis using an acetylated lysine antibody (Millipore).</p><h3 class="c-article__sub-heading" id="Sec6_3055">DNA affinity precipitation assay</h3><p>SCP2 cells transiently transfected with the indicated siRNAs were stimulated with TGFÎ² for 30 minutes. Cell lysate were extracted in cold lysis buffer containing 10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 30 mM sodium pyrophosphate, 1 mM sodium orthovanadate and protease inhibitors as described above. A total of 5 Âµg Poly (dI-dC) competitor (Sigma) was incubated with 1 mg of total cell lysate for 30 minutes at 4Â°C. A total of 500 pmol of double-stranded oligonucleotides (IDT) was added and incubated with cell lysates for two hours at 4Â°C. Streptavidin-agarose beads (65 Âµl; Sigma) were added, incubated overnight at 4Â°C and then washed three times with cold lysis buffer. The streptavidin-agarose beads containing biotinylated oligonucleotides and protein complex were boiled with 2Ã SDS Laemmli sample buffer for five minutes and subjected to immunoblotting. The sequences of biotin labeled double-strand oligonucleotides (IDT) were previously described [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="Lonn P, van der Heide LP, Dahl M, Hellman U, Heldin CH, Moustakas A: PARP-1 attenuates Smad-mediated transcription. &#xA;Mol Cell 2010, 40:521â532." href="/articles/10.1186/bcr3322#ref-CR29_3055" id="ref-link-section-d109682214e843">29</a>]. For Smad binding element oligonucleotide (4Ã SBE), Sense: biotin-5'-CAGACAGTCAGACAGTCAGACAGTCAGACAGT-3', antisense: 5'-ACTGTCTGACTGTCTGACTGTCTGACTGTCTG-3'. For control oligonucleotide, sense: biotin-5'-GCCCAGGCGCACCTGCTCCGATATCAATATCCGGC-3', anti-sense, 5'- GCCGGATATTGATATCGGAGCAGGTGCGCCTGGGC-3'.</p><h3 class="c-article__sub-heading" id="Sec7_3055">Luciferase assays</h3><p>SCP2 cells were transiently co-transfected with 50 nM Scr siRNA, 50 nM p21 siRNA or 0.5 Âµg flag-tagged p21 cDNA in combination with 0.3 Âµg SBE reporter construct (CAGA12-luc) and 0.1 Âµg pCMV-Î²-gal. Transfected cells were then stimulated with or without 5 ng/ml TGFÎ² for 16 hrs. Luciferase activity of CAGA12-luc was measured (EG &amp; G Berthold luminometer, Berthold Technologies, Bad Wildbad, Baden-WÃ¼rttemberg, Germany) and normalized to Î²-galactosidase activity.</p><h3 class="c-article__sub-heading" id="Sec8_3055">Real-Time PCR</h3><p>Total RNA was extracted using TRIzol reagents (Invitrogen). Reverse transcription of total RNA using random primers was carried out using M-MLV reverse transcriptase (Invitrogen) as per the manufacturer's instructions. Real-time PCRs were carried out using SsoFastâ¢EvaGreen<sup>Â®</sup> Supermix (Bio-Rad, Hercules, CA, USA) in a Rotor Gene 6000 PCR detection system (MBI Lab Equipment, Montreal Biotech Inc. Kirkland, PQ, Canada). PCR conditions were as follows: 95Â°C for 30 s, 40 cycles (95Â°C for 5 s and 60Â°C for 20 s). The primer sequences were as follows: <i>IL8</i> forward primer, GCAGAGGCCACCTGGATTGTGC; reverse primer, TGGCATGTTGCAGGCTCCTCAGAA; <i>IL6</i> forward primer, CTCCCCTCCAGGAGCCCAGC; reverse primer, GCAGGGAAGGCAGCAGGCAA; <i>PLAU</i> forward primer, GCCCTGGTTTGCGGCCATCT; reverse primer, CGCACACCTGCCCTCCTTGG; <i>MMP9</i> forward primer, TGGACACGCACGACGTCTTCC; reverse primer, TAGGTCACGTAGCCCACTTGGTCC; <i>PTGS2</i> forward primer, AGCTTTCACCAACGGGCTGGG; reverse primer, AAGACCTCCTGCCCCACAGCAA; <i>TGFBI</i> forward primer, CGGCTGCTGCTGAAAGCCGACCA; reverse primer, GGTCGGGGCCAAAAGCGTGT; p21 forward primer, TGTCCGCGAGGATGCGTGTTC; reverse primer, GCAGCCCGCCATTAGCGCAT; <i>GAPDH</i> forward primer, GCCTCAAGATCATCAGCAATGCCT; reverse primer, TGTGGTCATGAGTCCTTCCACGAT.</p><h3 class="c-article__sub-heading" id="Sec9_3055">Thiazolyl blue tetrazolium bromide (MTT) assay</h3><p>A total of 100 Âµl of cell suspension (1Ã 10<sup>5</sup> cells/ml in DMEM supplemented with 1% FBS) was stimulated or not in the presence or absence of 5 ng/ml TGFÎ² and cultured in 96-well plates for two days. After two days, 25 Âµl 5 mg/ml MTT solution (Sigma) was added to each well and incubated for two hours. A total of 200 Âµl of dimethyl sulfoxide (DMSO) was added to each well and mixed well. The absorbance at 570 nm was measured on a plate reader.</p><h3 class="c-article__sub-heading" id="Sec10_3055">Cell cycle analysis</h3><p>SCP2 cells were stimulated with TGFÎ² for 0, 2, 6 and 24 hrs. Cells were then fixed with 70% ethanol overnight, treated with 20 Âµg/ml RNase (Sigma), and stained with 0.5 mg/ml propidium iodide (Santa Cruz Biotechnology). DNA content was determined using a FACScan flow cytometry analyzer.</p><h3 class="c-article__sub-heading" id="Sec11_3055">Kinetic cell migration assay</h3><p>Cells were transfected with different siRNAs and plated in Essen ImageLock 96-well plates (Essen Bioscience, Ann Arbor, Michigan, USA) at 50,000 cells per well. The use of ImageLock 96-well plates ensures that images/videos of the wound are automatically taken at the exact same location by the IncuCyteâ¢software (Essen Bioscience). Cells were then serum-starved for six hours and confluent cell layers were scratched using the Essen Wound maker to generate approximately 800 Âµm width wounds. After wounding, cells were washed two times with PBS and stimulated in the presence or the absence of 5 ng/ml of TGFÎ². ImageLock 96-well plates were then placed into IncuCyte (Essen Bioscience) and imaged every hour for 24 hrs. The data were analyzed by three integrated metrics: wound width, wound confluence or relative wound density automatically measured by the IncuCyte software.</p><h3 class="c-article__sub-heading" id="Sec12_3055">Matrigel invasion assay</h3><p>For the Transwell assays, 30 Âµl of growth factor reduced (GFR) Matrigel (BD Biosciences, diluted 1:3 in pre-chilled H<sub>2</sub>O) was coated onto each insert of 24-Tranwell invasion plate (8-Âµm pore size; BD Biosciences) and incubated for two hours in the cell culture incubator. SCP2 or SUM159PT (6 Ã 10<sup>4</sup> cells/insert) were seeded on Transwell Insert coated GFR-Matrigel and cells in the upper chamber were stimulated or not with 5 ng/ml TGFÎ² for 24 hrs. For SCP2 cells, bottom chambers contained 10% FBS in DMEM medium. For SUM159PT cells, bottom chambers were added to F-12 HAM'S medium with 5% FBS. After 24 hrs, cells from the upper chamber were removed by cotton swab and cells invaded through GFR-Matrigel were fixed with 3.7% formaldehyde for 10 minutes and then stained with 0.2% crystal violet for 20 minutes. Images of the invading cells were photographed using an inverted 4Ã or 10Ã microscope and total cell numbers were counted and quantified by Image J software (National Institute of Health, Bethesda, Maryland, USA).</p><h3 class="c-article__sub-heading" id="Sec13_3055">Immunofluorescence microscopy</h3><p>Cells were grown on coverslips at 50% confluence, stimulated or not with TGFÎ² overnight. Cells were then fixed with 3.7% formaldehyde for 10 minutes and permeabilized in 0.1% Triton X-100 for 3 minutes, washed with PBS and blocked for 1 hr in 2% BSA. Cells were then incubated with anti-p21 antibody for one hour, washed with PBS and incubated with the secondary antibody Alexa FluorÂ®568 goat anti-rabbit IgG (1:800 dilution; Invitrogen) for one hour. Stained coverslips were mounted with SlowFadeÂ® Gold antifade reagent with DAPI (Invitrogen). Confocal analysis was performed using a Zeiss LSM 510 Meta Axiovert confocal microscope (Carl Zeiss, Oberkochen, Baden-WÃ¼rttemberg, Germany) using 63Ã objective.</p><h3 class="c-article__sub-heading" id="Sec14_3055">Immunohistochemistry, scoring and statistical analysis</h3><p>Tissue sections (5 Âµm) from breast carcinoma microarray slides (BCR961 and T088, Biomax) were deparaffinized and rehydrated. The patient characteristics are in Table S1 (Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3322#MOESM1">1</a>). The slides were then placed in 10 mM citrate buffer (pH 6.0) and boiled at 95Â°C for 15 minutes. The primary antibodies used for immunohistochemistry staining were AE1/AE3 (Thermo Scientific), p21 (c-19, Santa Cruz Biotechnology), p/CAF (ab12188, Abcam), phospho-Smad3 (Cell Signaling). HRP Polymer &amp; DAB Plus Chromogen (Thermo Scientific) was used for detection of p21, p/CAF and phospho-Smad3. The slides were then counter stained with hematoxylin (Vector Laboratories, Burlingame, CA, USA) and dehydrated and mounted for microscopic examination. All images were scanned by ScanScope digital scanners (Aperio, Vista, CA, USA). All samples were reviewed and scored by a pathologist. The staining for p21, p/CAF and phospho-Smad3 was scored from 0 to 4 as follows: 0, no staining; 1, &lt;25% tumor cells stained weakly; 2, 25 to 50% tumor cells stained moderately; 3, &gt;50% tumor cells stained moderately; 4, &gt;50% tumor cells stained strongly.</p><p>Correlations between phospho-Smad3, p/CAF and p21 were examined by the Pearson correlation test using SPSS 19 software (IBM, Armonk, NY, USA). Associations between these protein expressions and lymph node status were assessed by Fisher's exact test. <i>P</i>-value (two-sided) &lt;0.05 was considered statistically significant.</p><h3 class="c-article__sub-heading" id="Sec15_3055">Mammary fat pad and intratibia injections of nude mice</h3><p>Four- to six-week old female Balb/c nude mice were obtained from Charles River (Charles River Laboratories International, Wilmington, MA, USA) and used as a model for primary mammary tumor formation and local invasion. The animal study was approved by the ethics committee and all the experimental animal protocols were in accordance with the McGill University Animal Care. Following the administration of an anesthetic cocktail of ketamine (50 mg/kg), xylazine (5 mg/kg) and acepromazine (1 mg/kg) injected intramuscularly into the mice, parental and shRNA p21 SCP2 cells were inoculated at 5Ã 10<sup>5</sup> cells per mouse in 100 Î¼l of saline (20% Matrigel) with a 30-gauge needle into the mammary pad. The tumor size was measured once a week using a caliper. Tumor volume was determined according to the formula: tumor volume = shorter diameter<sup>2</sup> Ã longer diameter/2. Sets of mice (eight per group) were sacrificed at eight weeks post-injection to examine invasiveness of the primary tumor. At the end of these studies, mammary tumors with surrounding fat pad and tissues were fixed in 10% neutral-buffered formalin for one day. Sections of mammary tumor were embedded in Tissue-Tek O.C.T. (VWR International, Radnor, PA, USA) compound and 9 Âµm thick sections were stained with hematoxylin and eosin. Images of the tumors were photographed by light microscope using 10Ã and 20Ã objectives.</p><p>For intratibia injections, parental and shRNA p21 SCP2 cells (2.0Ã 10<sup>6</sup>) were injected intramuscularly into the left tibia of two group mice (eight per group). The mice were monitored weekly for tumor burden. Digital radiography of the hind limbs of all animals was used to monitor the development of skeletal lesions at four, six and eight weeks post-injection in a MX-20 cabinet X-ray system (Faxitron Bioptics, Tucson, Arizona, USA). On Week 8, radiographs of anesthetized mice were taken and the osteolytic lesion area was analyzed as previously described [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 30" title="Yang M, Burton DW, Geller J, Hillegonds DJ, Hastings RH, Deftos LJ, Hoffman RM: The bisphosphonate olpadronate inhibits skeletal prostate cancer progression in a green fluorescent protein nude mouse model. &#xA;Clin Cancer Res 2006, 12:2602â2606." href="/articles/10.1186/bcr3322#ref-CR30_3055" id="ref-link-section-d109682214e964">30</a>]. The score of lesion area was measured as 0, no lesions; 1, minor lesions; 2, small lesions; 3, significant lesions with minor break of margins (1% to 10% of bone surface damaged); 4, significant lesions with major break in peripheral lesions (&gt;10% of bone surface damaged).</p><h3 class="c-article__sub-heading" id="Sec16_3055">Statistical analyses</h3><p>Student's <i>t</i>-test was used and differences between groups were considered significant at *<i>P</i> &lt; 0.05.</p></div></div></section><section data-title="Results"><div class="c-article-section" id="Sec17_3055-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec17_3055">Results</h2><div class="c-article-section__content" id="Sec17_3055-content"><h3 class="c-article__sub-heading" id="Sec18_3055">p21 expression correlates with poor survival in breast cancer patients</h3><p>Previous studies have suggested that higher expression of cytoplasmic p21 correlated with poor prognosis in breast carcinomas [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 31" title="Winters ZE, Hunt NC, Bradburn MJ, Royds JA, Turley H, Harris AL, Norbury CJ: Subcellular localisation of cyclin B, Cdc2 and p21(WAF1/CIP1) in breast cancer. association with prognosis. &#xA;Eur J Cancer 2001, 37:2405â2412." href="/articles/10.1186/bcr3322#ref-CR31_3055" id="ref-link-section-d109682214e994">31</a>â<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 33" title="Winters ZE, Leek RD, Bradburn MJ, Norbury CJ, Harris AL: Cytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/neu in breast cancer and is an independent predictor of prognosis. &#xA;Breast Cancer Res 2003, 5:R242â249." href="/articles/10.1186/bcr3322#ref-CR33_3055" id="ref-link-section-d109682214e997">33</a>]. To further explore the correlation of p21 gene expression level with clinical outcome in breast cancer patients, we utilized a recently published gene profiling database of breast cancer patients to assess p21 gene expression in overall survival (OS) and distant metastasis-free survival (DMFS) outcomes [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 34" title="Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, Szallasi Z: An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. &#xA;Breast Cancer Res Treat 2010, 123:725â731." href="/articles/10.1186/bcr3322#ref-CR34_3055" id="ref-link-section-d109682214e1000">34</a>]. We analyzed the prognostic value according to the median, upper and lower quartile expression levels of p21 in the 20-year follow-up for OS (353 patients) and DMFS (761 patients). As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig1">1A-C</a> (left panels), elevated p21 expression significantly correlated with poor OS in both median (Hazard Ratio (HR), 1.7; 1.1 to 2.6; <i>P</i> = 0.012) and upper quartile (HR, 2.1; 1.3 to 3.2; <i>P</i> = 0.0016), but not in the lower quartile (HR, 1.17; 0.77 to 1.78; <i>P</i> = 0.47). Furthermore, higher p21 levels showed a similar pattern (HR, 1.3; 0.97 to 1.74; <i>P</i> = 0.075) in DMFS (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig1">1A-C</a>, right panels). After 20 years follow-up, patients who are free of distant metastasis showed reduced expression of the p21 gene and a better survival rate. Although the prediction did not show statistically significant results in the median expression, the <i>P</i>-value of the p21 upper quartile (HR, 1.5; 1.1 to 2.1; <i>P</i> = 0.0099) did reach statistical significance (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig1">1B</a>, right panel). We also analyzed the relationship of p21 expression and clinical outcomes in both estrogen receptor positive (ER+) and negative (ER-) breast cancer patients. p21 expression is highest in patients with poor prognosis regardless of ER status (Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3322#MOESM2">2</a>, Figure S1). Even though one cannot rule out that elevated p21 levels could also be found in the stroma rather than the tumor cells themselves, these data demonstrate that high p21 expression correlates with poor clinical outcomes and suggest that elevated p21 expression may play a role in promoting tumor progression.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-1" data-title="Figure 1"><figure><figcaption><b id="Fig1" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 1</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/bcr3322/figures/1" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_Fig1_HTML.jpg?as=webp"><img aria-describedby="Fig1" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_Fig1_HTML.jpg" alt="figure 1" loading="lazy"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-1-desc"><p>
   <b>High p21 expression correlates with poor survival in breast cancer patients</b>. <b>A-C</b>, The relationship of higher p21 expression and breast cancer outcome was assessed by Kaplan-Meier survival analysis. The survival rates were analyzed using three different and separate splits of the patients, based on p21 expression levels (A, median; B, upper quartile; C, lower quartile). For each split, the patients were then divided into high and low groups with respect to p21 expression. Overall survival (left panels) and distant metastasis-free survival (right panels) correlate with p21 gene expression. Number of breast cancer patients at risk with higher expression (red) and lower expression (black) of p21 at the indicated time points.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/bcr3322/figures/1" data-track-dest="link:Figure1 Full size image" aria-label="Full size image figure 1" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div>
<h3 class="c-article__sub-heading" id="Sec19_3055">Silencing p21 prevents breast tumor local invasion <i>in vivo</i> and cancer cell migration and invasion <i>in vitro</i> 
</h3><p>To investigate the contribution of p21 to tumor formation and progression in breast cancer, we used a bone-metastatic cell line SCP2, a sub-progeny of the human triple negative breast cancer MDA-MB231 (hereafter referred to as MDA) cells [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 35" title="Kang Y, He W, Tulley S, Gupta GP, Serganova I, Chen CR, Manova-Todorova K, Blasberg R, Gerald WL, Massague J: Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. &#xA;Proc Natl Acad Sci USA 2005, 102:13909â13914." href="/articles/10.1186/bcr3322#ref-CR35_3055" id="ref-link-section-d109682214e1075">35</a>]. We first assessed the effect of suppressing p21 on tumor growth using a mammary fat pad xenograft mouse model. A specific p21 shRNA was stably transfected to generate a pool of p21-deficient SCP2 cells. Knockdown of p21 using shRNA efficiently reduced p21 protein expression, as compared to parental SCP2 cells (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig2">2A</a>). Parental and shRNA p21 SCP2 cells were orthotopically injected into the mammary fat pad of female Balb/c nude mice (eight mice per group). Tumor growth was monitored weekly. There was no difference in the rate of primary tumor formation or tumor size between animals injected with parental or p21-deficient cells (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig2">2B</a>), suggesting p21 is not likely involved in tumor formation. Next, we evaluated the effect of p21 depletion on tumor invasiveness, a critical step for early tumor progression. Intact tumors were taken with the overlaying skin and surrounding deep tissues and analyzed by a pathologist. Tumor invasiveness was assessed by determining the extent of infiltration of cancer cells to the surrounding tissue (stroma, fat pad, skin and muscle tissue), as previously described [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 36" title="Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, Wang ZC, Brock JE, Richardson AL, Weinberg RA: A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. &#xA;Cell 2009, 137:1032â1046." href="/articles/10.1186/bcr3322#ref-CR36_3055" id="ref-link-section-d109682214e1084">36</a>]. As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig2">2C</a> (left panels), tumors from the parental SCP2 group displayed no clear margin with the surrounding tissues and were deeply invading into nearby structures. In contrast, tumors derived from animals transplanted with p21-depleted SCP2 cells formed a well-encapsulated tumor mass that did not invade the surrounding tissues (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig2">2C</a>, right panels), strongly suggesting that p21 plays an important role in tumor invasion. This was confirmed <i>in vitro</i>, as p21 gene silencing in SCP2 cells inhibited both cell migration and invasion (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig2">2D</a> and <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig2">2E</a>, respectively).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-2" data-title="Figure 2"><figure><figcaption><b id="Fig2" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 2</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/bcr3322/figures/2" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_Fig2_HTML.jpg?as=webp"><img aria-describedby="Fig2" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_Fig2_HTML.jpg" alt="figure 2" loading="lazy"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-2-desc"><p>
   <b>Silencing p21 prevents breast tumor local invasion</b> 
   <b><i>in vivo</i></b> 
   <b>and cancer cell migration and invasion</b>. <b>A</b>, Total lysates from parental and shRNA p21 SCP2 cells were analyzed by immunoblotting for the protein levels of p21 and Î²-tubulin. <b>B</b>, Parental and shRNA p21 SCP2 cells were injected into the mammary glands of four- to six-week-old female Balb/c nude mice. The size of mammary tumor was measured from two sets of mice (eight per group; error bars indicate SEM). <b>C</b>, Representative photographs show hematoxylin and eosin staining of the mammary gland (tumor and fat pad) of 12- to 15-month-old mice. <b>D</b> and <b>E</b>, Transwell cell migration (left panel) and GFR-Matrigel invasion assay (right panel) of parental and shRNA p21 SCP2 cells were performed. Graphs show total migrated and invaded cell number counted by Image J (error bars indicate SEM; n = 3 independent experiments). Student's unpaired <i>t</i>-test was used to compare parental vs. shRNA p21 SCP2 groups. Differences were considered significant at *<i>P</i> &lt; 0.05.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/bcr3322/figures/2" data-track-dest="link:Figure2 Full size image" aria-label="Full size image figure 2" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div>
<p>As shown in Figure S2A (Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3322#MOESM3">3</a>), none of the animals in which parental or p21-depleted SCP2 cells (eight per group) were injected into the mammary fat pad developed any bone lesions after two months, the date at which mice had to be sacrificed due to the tumor size. This timing may have been insufficient for tumor cells to grow into visible distant lesions in the mouse [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 37" title="Fidler IJ: The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. &#xA;Nat Rev Cancer 2003, 3:453â458." href="/articles/10.1186/bcr3322#ref-CR37_3055" id="ref-link-section-d109682214e1159">37</a>]. Thus, to investigate whether p21 is involved in the later stage of breast cancer progression, we examined its involvement in the development of bone osteolytic lesions using an intratibia injection model of parental and p21-deficient SCP2 cells in female Balb/c nude mice. By by-passing the early steps of metastasis, this experimental model allows for the assessment of tumor cell metastasis and survival in the bone marrow [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 38" title="Zhang XH, Wang Q, Gerald W, Hudis CA, Norton L, Smid M, Foekens JA, Massague J: Latent bone metastasis in breast cancer tied to Src-dependent survival signals. &#xA;Cancer Cell 2009, 16:67â78." href="/articles/10.1186/bcr3322#ref-CR38_3055" id="ref-link-section-d109682214e1162">38</a>]. As shown in Figure S2B, C (Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3322#MOESM3">3</a>), following X-ray examination of the bones, both groups of mice developed secondary tumors that caused severe osteolytic bone lesions, suggesting that p21 does not affect the later stages of bone metastasis. Collectively, these results indicate that while p21 is required for breast cancer cells to acquire an invasive phenotype, its effect is restricted to the earlier stages of tumor metastasis, namely induction of local cell invasion from the tumor to the surrounding tissues.</p><h3 class="c-article__sub-heading" id="Sec20_3055">TGFÎ² induces p21 expression in migratory and invasive human breast cancer cells</h3><p>p21 expression is tightly controlled by multiple signaling pathways [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 7" title="Abbas T, Dutta A: p21 in cancer: intricate networks and multiple activities. &#xA;Nat Rev Cancer 2009, 9:400â414." href="/articles/10.1186/bcr3322#ref-CR7_3055" id="ref-link-section-d109682214e1176">7</a>]. Among these and of particular interest is the TGFÎ²/Smad signaling pathway [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 15" title="Ikushima H, Miyazono K: TGFbeta signalling: a complex web in cancer progression. &#xA;Nat Rev Cancer 2010, 10:415â424." href="/articles/10.1186/bcr3322#ref-CR15_3055" id="ref-link-section-d109682214e1179">15</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Humbert L, Neel JC, Lebrun JJ: Targeting TGF-beta signaling in human cancer therapy. &#xA;Trends Cell Mol Biol 2010, 5:69â107." href="/articles/10.1186/bcr3322#ref-CR25_3055" id="ref-link-section-d109682214e1182">25</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF: Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. &#xA;Proc Natl Acad Sci USA 1995, 92:5545â5549." href="/articles/10.1186/bcr3322#ref-CR39_3055" id="ref-link-section-d109682214e1185">39</a>]. Therefore, we examined the effect of TGFÎ² on the expression levels of p21 in several basal-like triple negative human breast cancer cell lines. These include the ductal adenocarcinoma MDA and its sub-progenies (SCP2 and SCP25) [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 40" title="Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M, Ponomarev V, Gerald WL, Blasberg R, Massague J: Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. &#xA;J Clin Invest 2005, 115:44â55." href="/articles/10.1186/bcr3322#ref-CR40_3055" id="ref-link-section-d109682214e1188">40</a>], an invasive ductal carcinoma SUM159PT (hereafter referred to as SUM159) derived from a patient with anaplastic carcinoma, an inflammatory invasive ductal carcinoma SUM149PT (SUM149), a pleural effusion derived SUM229PE (SUM229) and tumor cells derived from metastatic nodule of a patient with infiltrating ductal carcinoma SUM1315MO<sub>2</sub> (SUM1315) [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 41" title="Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, Speed T, Spellman PT, DeVries S, Lapuk A, Wang NJ, Kuo WL, Stilwell JL, Pinkel D, Albertson DG, Waldman FM, McCormick F, Dickson RB, Johnson MD, Lippman M, Ethier S, Gazdar A, Gray JW: A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. &#xA;Cancer Cell 2006, 10:515â527." href="/articles/10.1186/bcr3322#ref-CR41_3055" id="ref-link-section-d109682214e1194">41</a>]. As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig3">3A, B</a>, with the exception of SUM1315, TGFÎ² strongly induced p21 mRNA and protein levels in these cell lines. Interestingly, TGFÎ² showed no regulatory effect on the expression levels of other cell cycle regulatory genes, such as c-myc and p15 (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig3">3C</a>), consistent with a loss of the TGFÎ² growth inhibitory responses in these cells (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig3">3C</a>). Although p21 is a cell cycle inhibitor, the TGFÎ²-induced increases in p21 protein levels did not translate into growth inhibition by TGFÎ² (Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3322#MOESM4">4</a>, Figure S3A), nor did it lead to G1 arrest in these breast cancer cells (Figure S3B). We next investigated the mechanisms by which TGFÎ² regulates p21 protein levels. As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig3">3D</a>, the TGFÎ² type I receptor (TÎ²RI) inhibitor SB431542 blocked TGFÎ²-induced p21 protein expression, indicating that TGFÎ² regulation of p21 expression is mediated through the TGFÎ² receptor signaling cascade. Furthermore, we found this effect to be Smad-dependent and Smad3-specific, as TGFÎ² induced both phosphorylation of Smad2 and Smad3 (Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3322#MOESM4">4</a>, Figure S3C), but was unable to induce p21 protein levels in MDA cells depleted of Smad3 but not of Smad2 (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig3">3E</a>). Collectively, these data indicate that TGFÎ² potently induces p21 expression in a Smad3-dependent manner without affecting cell growth or cell cycle progression in invasive human basal-type breast cancer cells.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-3" data-title="Figure 3"><figure><figcaption><b id="Fig3" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 3</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/bcr3322/figures/3" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_Fig3_HTML.jpg?as=webp"><img aria-describedby="Fig3" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_Fig3_HTML.jpg" alt="figure 3" loading="lazy"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-3-desc"><p>
   <b>TGFÎ² induces p21 expression in migratory and invasive human breast cancer cells</b>. <b>A</b>, Real-time PCR was performed to measure the mRNA level of p21 gene (error bars indicate SD; n = 3 independent experiments) for the indicated cell lines. <b>B</b>, Cells were treated with or without 5 ng/ml TGFÎ² for the indicated times. Total cell lysates were analyzed for p21 and Î²-tubulin protein levels by Western blotting. <b>C</b>, Total cell lysates were analyzed for c-myc, p15 and Î²-tubulin protein levels by Western blotting. <b>D</b>, SCP25 cells were pretreated with 10 ÂµM TGFÎ² type I receptor (TÎ²RI) inhibitor (SB431542) or vehicle (DMSO) for 30 minutes and then stimulated with TGFÎ². Total cell lysates were analyzed for p21 and Î²-tubulin protein levels by Western blotting. <b>E</b>, MDA cells were transfected with 40 nM Scrambled (Scr), Smad2 or Smad3 siRNAs in response to TGFÎ². Total cell lysates were analyzed for Smad2/3, p21 and Î²-tubulin protein levels by Western blotting.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/bcr3322/figures/3" data-track-dest="link:Figure3 Full size image" aria-label="Full size image figure 3" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div>
<h3 class="c-article__sub-heading" id="Sec21_3055">p21 expression is required for TGFÎ²-mediated cell migration</h3><p>TGFÎ² is an important modulator of cell motility in breast cancer [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Humbert L, Neel JC, Lebrun JJ: Targeting TGF-beta signaling in human cancer therapy. &#xA;Trends Cell Mol Biol 2010, 5:69â107." href="/articles/10.1186/bcr3322#ref-CR25_3055" id="ref-link-section-d109682214e1265">25</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 42" title="Tsapara A, Luthert P, Greenwood J, Hill CS, Matter K, Balda MS: The RhoA activator GEF-H1/Lfc is a transforming growth factor-beta target gene and effector that regulates alpha-smooth muscle actin expression and cell migration. &#xA;Mol Biol Cell 2010, 21:860â870." href="/articles/10.1186/bcr3322#ref-CR42_3055" id="ref-link-section-d109682214e1268">42</a>]. Thus, we investigated whether p21 could act downstream of TGFÎ² to promote cell migration. We first examined the effect of TGFÎ² on cell migration dynamics using the scratch/wound healing assay coupled to quantitative time-lapsed imaging (Essen IncuCyteâ¢). Cell migration was measured by three integrated metrics: wound width, wound confluence and relative wound density, using the IncuCyte software. As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig4">4A, B</a>, TGFÎ² potently induced cell migration in MDA, SCP2 and SUM149. As a negative control, we also used SUM1315 in which TGFÎ² did not regulate p21 expression. As expected, there was no effect of TGFÎ² on cell migration in SUM1315 cells (Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3322#MOESM5">5</a>, Figure S4A, B).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-4" data-title="Figure 4"><figure><figcaption><b id="Fig4" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 4</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/bcr3322/figures/4" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_Fig4_HTML.jpg?as=webp"><img aria-describedby="Fig4" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_Fig4_HTML.jpg" alt="figure 4" loading="lazy"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-4-desc"><p>
   <b>p21 expression is required for TGFÎ²-mediated cell migration</b>. <b>A</b>, Representative images of phase contrast and wound mask of indicated cell lines stimulated with TGFÎ² in scratch/wound healing assay. The initial wound mask (black) and wound closure (grey) were measured using the Essen Instruments Scratch Wound Module. <b>B</b>, The time course of cell migration for the indicated cell lines was quantified using the relative wound density metrics at two-hour time intervals (error bars indicate SEM; n = 3 independent experiments). <b>C</b>, SCP2 cells were transfected with Scr or p21 siRNAs and then stimulated with or without TGFÎ² for 24 hrs. Total cell lysates were analyzed for p21 and Î²-tubulin by Western blotting. <b>D</b>, Representative images of phase contrast (top panels) and wound mask (bottom panels) of transfected SCP2 cells with the indicated siRNAs in scratch/wound healing assay. <b>E</b>, The time course of transfected SCP2 cell migration was quantified using the relative wound density metrics at two-hour time intervals (error bars indicate SEM; n = 3 independent experiments).</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/bcr3322/figures/4" data-track-dest="link:Figure4 Full size image" aria-label="Full size image figure 4" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div>
<p>To then investigate whether p21 is required for TGFÎ²-induced cell migration, we knocked down p21 expression using two specific siRNAs in SCP2 cells and assessed the effect of TGFÎ² on cell migration dynamics by the scratch/wound healing assay. As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig4">4C</a>, TGFÎ² induced p21 expression in both mock and scrambled (Scr) siRNA transfected cells, while this effect was blocked in cells transfected with either p21 siRNAs, confirming the specificity and efficacy of our p21 siRNAs. Importantly, we found that while TGFÎ² potently induced cell migration in mock and Scr siRNA transfected SCP2 cells, this effect was completely blocked in cells in which p21 expression was depleted (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig4">4D, E</a>). The effect of p21 siRNAs on TGFÎ²-induced cell migration was similar to that observed when cells were transfected with a siRNA against Smad3, used here as a positive control (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig4">4D, E</a>). We also confirmed that these effects on cell migration were not secondary to changes in cell growth, as silencing of p21 expression had no effect on cell growth and proliferation (Figure S4C). These results demonstrate that TGFÎ²-mediated migration of human breast cancer cells is dependent on TGFÎ²-induced p21 expression.</p><h3 class="c-article__sub-heading" id="Sec22_3055">p21 expression is required for TGFÎ²-mediated cell invasion</h3><p>To examine the role of p21 in TGFÎ²-induced tumor cell invasion, SCP2 cells were transiently transfected with a Scr siRNA, a p21 siRNA or a Smad3 siRNA. The invasive potential of the cells was assessed using a GFR-Matrigel Transwell assay. As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig5">5A, B</a>, in mock and Scr siRNA transfected breast cancer cells, TGFÎ² significantly promoted cell invasion through the Matrigel and this effect was completely blocked in the absence of p21. Importantly, the inhibitory effect of the p21 siRNA on TGFÎ²-induced cell invasion was comparable to the effect of the Smad3 siRNA. To demonstrate the specificity of the p21 effect, we performed a rescue experiment. SCP2 cells in which endogenous p21 expression was silenced were transfected or not with a flag-tagged p21 cDNA (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig5">5C</a>). In this setup, overexpression of the flag-p21 overrode the siRNA effect and restored p21 protein level (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig5">5C</a>) as well as TGFÎ²-induced cell invasion through the GFR-Matrigel barrier (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig5">5D</a>), indicating this effect is specifically mediated through p21. To avoid the limitation of the use of a single cell line, we also assessed the pro-invasive effect of p21 in SUM159 cells. Overexpressing or blocking p21 gene expression in these cells did not alter their growth in response to TGFÎ² (Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3322#MOESM6">6</a>, Figure S5). Importantly, as shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig5">5E, F</a>, we found SUM159 to be highly responsive to TGFÎ²-induced cell invasion. However, in the absence of p21 expression, the TGFÎ² pro-invasive effect was blocked, while overexpression of p21 potentiated this effect, similar to what was observed in SCP2 cells. Our results demonstrate that TGFÎ²-mediated migration and invasion of human breast cancer cells are dependent on TGFÎ²-induced p21 expression. Interestingly, the p21 effects are not limited to TGFÎ² signaling as blocking p21 expression also affected serum and EGF-induced cell invasion (Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3322#MOESM7">7</a>, Figure S6). These results suggest that p21 plays a broad regulatory role in breast cancer cell invasion and may also explain the strong phenotype observed <i>in vivo</i>, on local tumor cell invasion, following p21 gene silencing (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig2">2C</a>).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-5" data-title="Figure 5"><figure><figcaption><b id="Fig5" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 5</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/bcr3322/figures/5" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_Fig5_HTML.jpg?as=webp"><img aria-describedby="Fig5" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_Fig5_HTML.jpg" alt="figure 5" loading="lazy"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-5-desc"><p>
   <b>p21 expression is required for TGFÎ²-mediated cell invasion</b>. <b>A</b>, SCP2 cells were transfected with the indicated siRNAs and cultured in the presence or absence of TGFÎ². GFR-Matrigel coated Transwell invasion assay was performed and images of the invading cells were photographed. <b>B</b>, Total cell number was counted by Image J and fold induction was quantified (error bars indicate SD; n = 3 independent experiments). <b>C</b>, SCP2 cells were transfected with a Scr or p21 siRNA as well as a flag-tagged p21 cDNA in the presence or the absence of TGFÎ². p21 protein levels were then analyzed by Western blotting. <b>D</b>, Cell invasion was assessed using the Transwell Invasion assay. The number of invaded cells was counted by Image J (error bars indicate SD; n = 3 independent experiments). <b>E</b>, Cell invasion of transfected SUM159 was assessed using the Transwell Invasion assay. <b>F</b>, Total cell number was counted by Image J and fold induction was quantified (error bars indicate SD; n = 3 independent experiments).</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/bcr3322/figures/5" data-track-dest="link:Figure5 Full size image" aria-label="Full size image figure 5" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div>
<h3 class="c-article__sub-heading" id="Sec23_3055">p21 interacts with Smad3 and modulates TGFÎ²-induced transcriptional activity and downstream genes involved in cell invasion</h3><p>It has been previously shown that cytoplasmic p21 regulates actin cytoskeleton through binding and inhibiting ROCK1, resulting in decreased phosphorylation of actin-depolymerizing protein cofilin and increased cell migration in NIH3T3 fibroblasts and HeLa cells [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 43" title="Starostina NG, Simpliciano JM, McGuirk MA, Kipreos ET: CRL2(LRR-1) targets a CDK inhibitor for cell cycle control in C. elegans and actin-based motility regulation in human cells. &#xA;Dev Cell 2010, 19:753â764." href="/articles/10.1186/bcr3322#ref-CR43_3055" id="ref-link-section-d109682214e1413">43</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 44" title="Lee S, Helfman DM: Cytoplasmic p21Cip1 is involved in Ras-induced inhibition of the ROCK/LIMK/cofilin pathway. &#xA;J Biol Chem 2004, 279:1885â1891." href="/articles/10.1186/bcr3322#ref-CR44_3055" id="ref-link-section-d109682214e1416">44</a>]. Therefore, we examined the phosphorylation and total protein expression levels of cofilin in breast cancer cells in response to TGFÎ². As shown in Figure S7A (Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3322#MOESM8">8</a>), TGFÎ² has no effect on the phosphorylation of cofilin. As cytoplasmic p21 contributes to regulate cofilin, we then examined the localization of p21 under the stimulation of TGFÎ². Treatment with TGFÎ² caused accumulation of p21 in the nucleus in a time-dependent manner (Figure S7B). This suggests that TGFÎ²-induced and p21-driven cell migration and invasion in human breast cancer cells are not mediated through the ROCK/LIMK/cofilin pathway. Besides its function as a cell cycle regulator, p21 has also been shown to interact with multiple transcription factors [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 7" title="Abbas T, Dutta A: p21 in cancer: intricate networks and multiple activities. &#xA;Nat Rev Cancer 2009, 9:400â414." href="/articles/10.1186/bcr3322#ref-CR7_3055" id="ref-link-section-d109682214e1422">7</a>] to selectively inhibit or induce expression of sets of genes involved in distinct biological functions, such as mitosis, DNA repair, survival and ECM components [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 45" title="Chang BD, Watanabe K, Broude EV, Fang J, Poole JC, Kalinichenko TV, Roninson IB: Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. &#xA;Proc Natl Acad Sci USA 2000, 97:4291â4296." href="/articles/10.1186/bcr3322#ref-CR45_3055" id="ref-link-section-d109682214e1425">45</a>]. Thus, we investigated whether p21 could interact with the Smad proteins to regulate the TGFÎ² pro-invasive effects. Smad/p21 interactions were analyzed by co-immunoprecipitation studies in HEK293 and SCP2 cells co-transfected with myc-Smad2, myc-Smad3 and flag-p21. As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig6">6A</a>, while we could not detect any ligand-induced association between Smad2 and p21, we found TGFÎ² to clearly induce complex formation between Smad3 and p21 in the two cell lines. To assess the impact of the p21/Smad3 interaction on TGFÎ² signaling, we then examined the effect of p21 on TGFÎ²-induced Smad3 activity. As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig6">6B</a>, we found that knocking down p21 did not affect TGFÎ²-induced Smad3 phosphorylation. However, using a TGFÎ²/Smad transcriptional reporter construct (CAGA12-luc), we found that p21 is required for TGFÎ²-induced Smad transcriptional activity. Indeed, as shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig6">6C</a>, p21 gene silencing abolished TGFÎ²-induced luciferase activity of the Smad reporter construct. Conversely, CAGA12-luc activity was markedly potentiated in SCP2 cells overexpressing p21 in response to TGFÎ². These results indicate that TGFÎ² induces a complex formation between p21 and Smad3 and that while p21 does not affect the earlier stages of Smad3 activation (that is, phosphorylation), it is required for TGFÎ²-mediated Smad transcriptional activity.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-6" data-title="Figure 6"><figure><figcaption><b id="Fig6" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 6</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/bcr3322/figures/6" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_Fig6_HTML.jpg?as=webp"><img aria-describedby="Fig6" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_Fig6_HTML.jpg" alt="figure 6" loading="lazy"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-6-desc"><p>
   <b>p21 interacts with Smad3 and modulates TGFÎ²-induced transcriptional activity</b>. <b>A</b>, HEK293 and SCP2 cells were co-transfected with myc-Smad2, myc-Smad3 and flag-p21. Transfected cells were stimulated TGFÎ² for 8 hrs. Cell lysates were immunoprecipitated with an anti-flag antibody and analyzed by immunoblotting using Smad2/3 and p21 antibodies. <b>B</b>, Transfected MDA cells were immunoblotting by phospho-Smad3 (p-Smad3), Smad2/3 and Î²-tubulin antibodies in response to TGFÎ² for 30 minutes. <b>C</b>, SCP2 cells were co-transfected with either mock, Scr siRNA, p21 siRNA or flag-tagged p21 construct (p21 cDNA) and SBE promoter construct (CAGA12-luc). Transfected cells were stimulated with or without TGFÎ² for 16 hrs. Luciferase activity of CAGA12-luc was measured and normalized to Î²-galactosidase (error bars indicate SEM; n = 3 independent experiments). <b>D</b> and <b>E</b>, SUM159 and SCP2 cells were treated with or without TGFÎ² for the indicated times. The mRNA levels of indicated genes were then analyzed by real-time PCR (error bars indicate SEM; n = 3 independent experiments).</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/bcr3322/figures/6" data-track-dest="link:Figure6 Full size image" aria-label="Full size image figure 6" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div>
<p>We next performed gene profiling experiments in parental and p21-deficient SCP2 cells, using transiently transfected p21 siRNA as well as stably transfected p21 shRNA. Our arbitrary cutoff was set up at a minimum of two-fold induction. This led us to identify multiple p21-dependent TGFÎ² target genes, among which were selected those known to be associated with the tumor metastasis process. This shortlist included five candidate target genes: interleukin 6 (<i>IL6</i>), chemokine (<i>IL8</i>), prostaglandin-endoperoxide synthase 2 (<i>PTGS2</i>), plasminogen activator (<i>PLAU</i>) and matrix metalloproteinase (<i>MMP9</i>) [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 46" title="Mantovani A, Allavena P, Sica A, Balkwill F: Cancer-related inflammation. &#xA;Nature 2008, 454:436â444." href="/articles/10.1186/bcr3322#ref-CR46_3055" id="ref-link-section-d109682214e1495">46</a>]. To confirm that these genes were TGFÎ² downstream targets, SCP2 and SUM159 cells were stimulated or not with TGFÎ² and mRNA levels for these target genes were analyzed by quantitative real-time PCR (q-PCR). As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig6">6D, E</a>, TGFÎ² significantly increased the mRNA levels of <i>IL6</i>, <i>IL8</i>, <i>PTGS2</i>, <i>PLAU</i> and <i>MMP9</i> in a time-dependent manner in both cell lines.</p><p>To then address the role of p21 in the transcriptional regulation of these genes by TGFÎ², we examined the effects of either silencing (using siRNA) or overexpressing p21 cDNA in SUM159 cells. As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig7">7A</a>, knocking down p21 gene expression blocked the TGFÎ² transcriptional regulation of <i>IL6</i>, <i>IL8</i>, <i>PLAU</i>, <i>MMP9</i> and <i>PTGS2</i>, indicating that p21 is required for TGFÎ² to induce expression of these target genes. The same results were obtained in another breast cancer cell line (SCP2; data not shown). On the other hand, p21 overexpression in these cell lines potentiated the TGFÎ² transcriptional effects on these target genes. As a negative control and to ensure specificity of our results, we also analyzed the effect of silencing p21 on the TGFÎ²-mediated increase in transforming growth factor beta induced (<i>TGFBI</i>) mRNA. TGFÎ² regulated <i>TGFBI</i> mRNA independently of p21 (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig7">7B</a>).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-7" data-title="Figure 7"><figure><figcaption><b id="Fig7" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 7</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/bcr3322/figures/7" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_Fig7_HTML.jpg?as=webp"><img aria-describedby="Fig7" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_Fig7_HTML.jpg" alt="figure 7" loading="lazy"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-7-desc"><p>
   <b>p21 regulates TGFÎ²-induced downstream genes involved in cell invasion</b>. <b>A</b>, SUM159 cells were transfected with Scr or p21 siRNA as well as p21 cDNA. Cells were then treated with or without TGFÎ² and the mRNA levels of indicated genes were analyzed by real-time PCR (error bars indicate SEM; n = 3 independent experiments). <b>B</b>, SUM159 cells transfected with Scr siRNA and p21 siRNA were treated with TGFÎ² for the indicated times. The mRNA level of <i>TGFBI</i> gene was measured by real-time PCR (error bars indicate SEM; n = 3 independent experiments). <b>C</b>, SCP2 cells were transfected with the indicated siRNAs. Cell invasion was assessed using the Transwell Invasion assay. <b>D</b>, Total cell number was counted by Image J and number of invaded cells was quantified (error bars indicate SEM; n = 3 independent experiments).</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/bcr3322/figures/7" data-track-dest="link:Figure7 Full size image" aria-label="Full size image figure 7" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div>
<p>To address the contribution of these identified p21-dependent TGFÎ² target genes (<i>IL6</i>, <i>IL8</i>, <i>PLAU</i>, <i>MMP9</i> and <i>PTGS2</i>) in regulating cell invasion, we silenced their gene expression using specific siRNAs. As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig7">7C, D</a>, inhibition of all five target genes impaired TGFÎ²-induced cell invasion, to a different extent. While depletion of <i>IL6</i>, <i>PLAU</i> and <i>MMP9</i> drastically antagonized the TGFÎ² response, inhibition of <i>PTGS2</i> and <i>IL8</i> showed a moderate inhibitory effect. Moreover, examination of the siRNA effect on basal cell invasion indicated that <i>IL6</i> and <i>PLAU</i> did not affect basal invasion, suggesting that they may be specifically required for the TGFÎ² pro-invasive response. On the other hand, inhibition of <i>MMP9</i>, <i>PTGS2</i> and <i>IL8</i> clearly affected basal cell invasion suggesting that these target genes have a broader effect on cell invasion, not limited to the TGFÎ² signaling pathway. Together, these results indicate that even though all five genes are important for TGFÎ² signaling leading to cell invasion, <i>IL6</i>, <i>PLAU</i> and <i>MMP9</i> exert more predominant roles.</p><h3 class="c-article__sub-heading" id="Sec24_3055">p21/p/CAF regulates TGFÎ² transcriptional activity and Smad3 DNA binding</h3><p>p21 has been implicated in the control of gene transcription by associating with various transcription factors [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 7" title="Abbas T, Dutta A: p21 in cancer: intricate networks and multiple activities. &#xA;Nat Rev Cancer 2009, 9:400â414." href="/articles/10.1186/bcr3322#ref-CR7_3055" id="ref-link-section-d109682214e1657">7</a>], but also regulates estrogen receptor-Î±-dependent gene expression by activating p300-CREBBP-driven (CBP) [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 47" title="Snowden AW, Anderson LA, Webster GA, Perkins ND: A novel transcriptional repression domain mediates p21(WAF1/CIP1) induction of p300 transactivation. &#xA;Mol Cell Biol 2000, 20:2676â2686." href="/articles/10.1186/bcr3322#ref-CR47_3055" id="ref-link-section-d109682214e1660">47</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 48" title="Fritah A, Saucier C, Mester J, Redeuilh G, Sabbah M: p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha. &#xA;Mol Cell Biol 2005, 25:2419â2430." href="/articles/10.1186/bcr3322#ref-CR48_3055" id="ref-link-section-d109682214e1663">48</a>]. Gene transcription downstream of TGFÎ² signaling is also regulated by acetyltransferases, such as p300/CBP and p300/CBP-associated factor (p/CAF), a member of another HAT family, the so-called GCN5-related N-acetyl transferases [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 49" title="Nagy Z, Tora L: Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation. &#xA;Oncogene 2007, 26:5341â5357." href="/articles/10.1186/bcr3322#ref-CR49_3055" id="ref-link-section-d109682214e1666">49</a>â<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 52" title="Cocolakis E, Dai M, Drevet L, Ho J, Haines E, Ali S, Lebrun JJ: Smad signaling antagonizes STAT5-mediated gene transcription and mammary epithelial cell differentiation. &#xA;J Biol Chem 2008, 283:1293â1307." href="/articles/10.1186/bcr3322#ref-CR52_3055" id="ref-link-section-d109682214e1669">52</a>]. Thus, we examined whether p21 could associate with either p300/CBP or p/CAF in response to TGFÎ². Interestingly, we found that while TGFÎ² did not induce association between p21 and p300/CBP, it strongly induced complex formation between p21 and p/CAF in both SCP2 and SUM159 breast cancer cells (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig8">8A</a>, left and right panels).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-8" data-title="Figure 8"><figure><figcaption><b id="Fig8" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 8</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/bcr3322/figures/8" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_Fig8_HTML.jpg?as=webp"><img aria-describedby="Fig8" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_Fig8_HTML.jpg" alt="figure 8" loading="lazy"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-8-desc"><p>
   <b>p21/p/CAF regulates TGFÎ² transcriptional activity and Smad3 occupancy on SBE</b>. <b>A</b>, SCP2 and SUM159 cells were treated with TGFÎ². Cell lysates were analyzed by co-immunoprecipitation using specific antibodies, as indicated. <b>B</b>, HEK293 cells were co-transfected with myc-Smad2, myc-Smad3 and flag-p21 with or without p/CAF siRNA. Transfected cells were stimulated with TGFÎ² for eight hours. Cell lysates were immunoprecipitated with an anti-flag antibody and analyzed by immunoblotting using Smad2/3 and flag antibodies. <b>C</b> and <b>D</b>, SUM159 cells were transfected with Scr or p/CAF siRNAs as well as a flag-tagged p21 cDNA, treated with or without TGFÎ². The mRNA levels of indicated genes were analyzed by real-time PCR (error bars indicate SEM; n = 3 independent experiments). <b>E</b>, SCP2 cells transfected with Scr and p/CAF siRNA were stimulated with or without TGFÎ². Cell invasion was quantified by relative TGFÎ² fold induction (error bars indicate SEM; n = 3 independent experiments). <b>F</b>, Transfected SCP2 cells were subjected to immunoblotting p/CAF and Î²-tubulin. <b>G</b>, HEK293 cells were co-transfected with myc-Smad3, myc-Smad2 and p/CAF. Immunoprecipitated Smad2/3 using an anti-myc antibody was subjected to Western blotting. <b>H</b>, DNA precipitation (DNA IP) was performed using biotinylated control and 4Ã CAGA SBE oligonucleotides, following by streptavidin precipitation. Western blotting of Smad3 and p/CAF is shown. <b>I</b>, SCP2 cells were transfected with p21 or p/CAF siRNAs. Samples were subjected to DNA IP and immunoblotting of Smad3. <b>J</b>, Transfected SCP2 cells were stimulated with or without TGFÎ² for 16 hrs. Luciferase activity of CAGA12-luc was measured and normalized to Î²-galactosidase (error bars indicated SEM; n =3 independent experiments).</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/bcr3322/figures/8" data-track-dest="link:Figure8 Full size image" aria-label="Full size image figure 8" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div>
<p>A previous report indicated that p/CAF directly binds to Smad3 [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 50" title="Itoh S, Ericsson J, Nishikawa J, Heldin CH, Ten Dijke P: The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling. &#xA;Nucleic Acids Res 2000, 28:4291â4298." href="/articles/10.1186/bcr3322#ref-CR50_3055" id="ref-link-section-d109682214e1732">50</a>]. As we have shown that TGFÎ² induces complex formation between Smad3 and p21 (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig6">6A</a>), we investigated whether endogenous p/CAF is also required for Smad3 association with p21. For this, HEK293 cells were co-transfected with myc-Smad2, myc-Smad3 and flag-p21 with or without p/CAF siRNA to block expression of endogenous p/CAF. As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig8">8B</a>, TGFÎ² induced complex formation between p21 and Smad3, independently of Smad2. Interestingly, depletion of p/CAF completely prevented this interaction, indicating that endogenous p/CAF is required for Smad3 interaction with p21.</p><p>To investigate whether p/CAF is necessary for the regulation of p21-dependent TGFÎ² downstream target genes, SUM159 cells were transiently transfected with flag-tagged p21 in the presence or the absence of two different p/CAF siRNAs. The gene expression of p/CAF (also known as K(lysine) acetyltransferase 2B, KAT2B) was measured to verify the efficiency of p/CAF knockdown by q-PCR (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig8">8C</a>). Overexpression of p21 potentiated induction of <i>IL6</i>, <i>IL8</i> and <i>PTGS2</i> mRNA by TGFÎ². However, these effects were significantly blocked when p/CAF gene expression was silenced, indicating that p/CAF is required for p21-dependent gene expression of the TGFÎ² targets (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig8">8D</a>). The requirement of p/CAF downstream of TGFÎ² was further investigated using the Transwell Matrigel assay. As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig8">8E</a>, knocking down p/CAF gene expression significantly impaired TGFÎ²-induced cell invasion. Efficiency of the siRNA was verified by Western blotting (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig8">8F</a>).</p><p>Because acetyltransferase p/CAF regulates gene transcription by acetylating histones and transcription factors [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 49" title="Nagy Z, Tora L: Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation. &#xA;Oncogene 2007, 26:5341â5357." href="/articles/10.1186/bcr3322#ref-CR49_3055" id="ref-link-section-d109682214e1769">49</a>], we then assessed whether TGFÎ² could induce global changes in histone acetylation in breast cancer cells. For this, total histone proteins were extracted from SCP2 cells, treated or not with TGFÎ² and subjected to immunoblotting using an acetylated lysine antibody. As shown in Figure S8 (Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3322#MOESM9">9</a>), TGFÎ² had no effect on global histone acetylation while TSA, a histone deacetylase inhibitor, showed a marked increase in the acetylation levels. This suggested that the functional relevance of the p/CAF recruitment to the p21/Smad complex may be more directed towards acetylation of specific targets rather than global histone modifications. To address this, we examined whether p/CAF could acetylate p21 and/or the Smads. Interestingly, we found that p/CAF is capable of interacting with Smad2 and Smad3, leading to an increased acetylation of both Smad proteins (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig8">8G</a>). Moreover, the acetylation is specific to Smad2 and Smad3, as p21 did not show any increased acetylation by p/CAF (data not shown). Smad3 acetylation has been suggested to be required for its DNA binding activity [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 51" title="Simonsson M, Kanduri M, Gronroos E, Heldin CH, Ericsson J: The DNA binding activities of Smad2 and Smad3 are regulated by coactivator-mediated acetylation. &#xA;J Biol Chem 2006, 281:39870â39880." href="/articles/10.1186/bcr3322#ref-CR51_3055" id="ref-link-section-d109682214e1778">51</a>]. Thus, this led us to investigate whether p/CAF could associate with DNA-bound Smad3, by DNA immunoprecipitation (DNA IP) using biotinylated control and biotinylated Smad binding element (4Ã CAGA) DNA probes. As shown in the Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig8">8H</a>, we found TGFÎ² to specifically induce binding of both Smad3 and p/CAF to DNA. Furthermore, we found that gene silencing of p/CAF and p21, using siRNAs, prevented Smad3 binding to the SBE (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig8">8I</a>), suggesting that both p21 and p/CAF are required for Smad3 DNA binding and Smad3-mediated transcriptional activity. Having shown that p21 is indeed required for Smad3-mediated transcriptional activity (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig6">6C</a>), we then assessed the effect of knocking down p/CAF on Smad3 transcriptional activity using the CAGA12-luc reporter construct. As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig8">8J</a>, the results clearly indicate that p/CAF is required for TGFÎ²-induced Smad3 transcriptional activity.</p><p>Collectively, these data indicate that p21 and p/CAF regulate TGFÎ² transcriptional activity by controlling Smad3 occupancy on its DNA binding elements. TGFÎ² induces a complex formation between Smad3, p21 and p/CAF, further leading to Smad3 acetylation by p/CAF. Furthermore, both p21 and p/CAF are required for Smad3 DNA binding and Smad3-mediated transcriptional activity, highlighting a novel mechanism by which the p21/p/CAF/Smad3 complex contribute to the activation of TGFÎ² target gene transcription.</p><h3 class="c-article__sub-heading" id="Sec25_3055">High expression of p/CAF/p21/p-Smad3 is associated with lymph node positivity</h3><p>Lymph node involvement is an important prognostic indicator in clinical breast cancer outcomes [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 53" title="de Boer M, van Deurzen CH, van Dijck JA, Borm GF, van Diest PJ, Adang EM, Nortier JW, Rutgers EJ, Seynaeve C, Menke-Pluymers MB, Bult P, Tjan-Heijnen VC: Micrometastases or isolated tumor cells and the outcome of breast cancer. &#xA;N Engl J Med 2009, 361:653â663." href="/articles/10.1186/bcr3322#ref-CR53_3055" id="ref-link-section-d109682214e1805">53</a>]. High expression of TGFÎ²1 is correlated with a high incidence of lymph node metastasis [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 54" title="Dalal BI, Keown PA, Greenberg AH: Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma. &#xA;Am J Pathol 1993, 143:381â389." href="/articles/10.1186/bcr3322#ref-CR54_3055" id="ref-link-section-d109682214e1808">54</a>]. To examine the association among active TGFÎ²/Smad signaling, p21 and p/CAF with lymph node metastasis, we performed immunohistochemistry to measure the expression levels of serine 423/425 phosphorylated Smad3 (pSmad3), p21 and p/CAF in tissue microarray containing 50 invasive ductal breast tumors, 25 of which are lymph node positive. The immunoreactivity for pSmad3, p21 and p/CAF protein expression in tumor cells was graded and described in Methods. We considered a score of 0 to 2 as a low phosphorylation/expression level and a score of 3 to 4 as a high phosphorylation/expression level. As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig9">9A, B</a>, lymph node negative patients showed low levels of pSmad3, p21 and p/CAF expressions, whereas a significant enrichment of high pSmad3 (68%), p21 (68%) and p/CAF (80%) was observed in patients with positive lymph nodes (<i>P</i> = 0.009, <i>P</i> = 0.004, and <i>P</i> = 0.001, respectively). To distinguish between tumor cells and stroma, we used a cytokeratin antibody (AE1/AE3), a cell marker specific to neoplastic cells of epithelial origin. As shown in Figure S9 (Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3322#MOESM10">10</a>), p21 is specifically expressed at a higher level in breast tumor cells but not in stroma cells. We also examined the relationships between pSmad3 levels and p/CAF protein expression with p21 protein levels, using the Pearson's correlation test. As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig9">9C</a>, our results clearly indicate that high levels of phosphorylated Smad3 and p/CAF expression significantly correlate with high p21 protein expression. Collectively, these data indicate that active TGFÎ²/Smad3 signaling is associated with high p21 and p/CAF protein expression levels and significantly correlates with lymph node metastasis in breast cancer.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-9" data-title="Figure 9"><figure><figcaption><b id="Fig9" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 9</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/bcr3322/figures/9" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_Fig9_HTML.jpg?as=webp"><img aria-describedby="Fig9" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_Fig9_HTML.jpg" alt="figure 9" loading="lazy"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-9-desc"><p>
   <b>High expression of p/CAF/p21/pSmad3 is associated with lymph node positivity</b>. <b>A</b>, Representative immunohistochemistry images of pSmad3, p21 and p/CAF in breast cancer tissue microarray samples. <b>B</b>, Overall pSmad3, p21 and p/CAF immunohistochemistry staining intensity between lymph node negative (LN-) and positive (LN+) tissues. <b>C</b>, Percentage of case distribution according to immunoreactivity of pSmad3, p21 and p/CAF in tumor cells, the score for negative (0), low (1 to 2) and high (3 to 4).</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/bcr3322/figures/9" data-track-dest="link:Figure9 Full size image" aria-label="Full size image figure 9" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div>
</div></div></section><section data-title="Discussion"><div class="c-article-section" id="Sec26_3055-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec26_3055">Discussion</h2><div class="c-article-section__content" id="Sec26_3055-content"><p>While p21 was initially characterized as an important cell cycle inhibitor, recent studies suggest that cytoplasmic p21 has anti-apoptotic and actin cytoskeleton regulatory functions [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 27" title="Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC: Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. &#xA;Nat Cell Biol 2001, 3:245â252." href="/articles/10.1186/bcr3322#ref-CR27_3055" id="ref-link-section-d109682214e1870">27</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 43" title="Starostina NG, Simpliciano JM, McGuirk MA, Kipreos ET: CRL2(LRR-1) targets a CDK inhibitor for cell cycle control in C. elegans and actin-based motility regulation in human cells. &#xA;Dev Cell 2010, 19:753â764." href="/articles/10.1186/bcr3322#ref-CR43_3055" id="ref-link-section-d109682214e1873">43</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 55" title="Tanaka H, Yamashita T, Asada M, Mizutani S, Yoshikawa H, Tohyama M: Cytoplasmic p21(Cip1/WAF1) regulates neurite remodeling by inhibiting Rho-kinase activity. &#xA;J Cell Biol 2002, 158:321â329." href="/articles/10.1186/bcr3322#ref-CR55_3055" id="ref-link-section-d109682214e1876">55</a>]. The accumulation of cytoplasmic p21 is associated with Ras and HER2/neu activated tumorigenic transformation [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 32" title="Xia W, Chen JS, Zhou X, Sun PR, Lee DF, Liao Y, Zhou BP, Hung MC: Phosphorylation/cytoplasmic localization of p21Cip1/WAF1 is associated with HER2/neu overexpression and provides a novel combination predictor for poor prognosis in breast cancer patients. &#xA;Clin Cancer Res 2004, 10:3815â3824." href="/articles/10.1186/bcr3322#ref-CR32_3055" id="ref-link-section-d109682214e1879">32</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 44" title="Lee S, Helfman DM: Cytoplasmic p21Cip1 is involved in Ras-induced inhibition of the ROCK/LIMK/cofilin pathway. &#xA;J Biol Chem 2004, 279:1885â1891." href="/articles/10.1186/bcr3322#ref-CR44_3055" id="ref-link-section-d109682214e1882">44</a>]. Moreover, overexpression of p21 is associated with poor prognosis of many types of cancer. However, the function of p21 in breast cancer has not been established. In our study, we assessed p21 levels with clinical outcomes in breast cancer patients. High p21 expression correlates with poor overall survival and distant metastasis free survival. Furthermore, using an <i>in vivo</i> model of mammary fat pad transplantation of metastatic human breast cancer cells in mice, we showed that while silencing p21 gene expression did not affect the primary tumor formation, it potently prevented primary tumor cells to invade into surrounding tissues. Together, our results provide evidence of a tumor-promoting role for p21 in primary tumor local invasion.</p><p>Previous studies have indicated that during breast cancer progression, TGFÎ² cytostatic responses are lost while pro-migratory and pro-invasive effects are maintained [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 56" title="Shi Y, Massague J: Mechanisms of TGF-beta signaling from cell membrane to the nucleus. &#xA;Cell 2003, 113:685â700." href="/articles/10.1186/bcr3322#ref-CR56_3055" id="ref-link-section-d109682214e1892">56</a>]. Here, we found that all invasive breast cancer cell lines tested were resistant to growth inhibition by TGFÎ² and that while TGFÎ² did not induce any change in p15 or c-myc expression levels, it strongly up-regulated p21 expression arguing that in advanced breast cancer p21 functions independently of cell cycle regulation. This is in contrast to the effect observed in human immortalized the keratinocyte cell line HaCaT, where TGFÎ²-mediated p21 gene expression leads to cell cycle arrest [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF: Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. &#xA;Proc Natl Acad Sci USA 1995, 92:5545â5549." href="/articles/10.1186/bcr3322#ref-CR39_3055" id="ref-link-section-d109682214e1895">39</a>]. Indeed, we found that the induction of p21 in invasive breast cancer cells is required for the pro-migratory and pro-invasive effects of TGFÎ². In accordance with these results, depletion of p21 did not modulate primary tumor growth <i>in vivo</i> but strongly blocked tumor invasion capacity. These findings together support the notion of a direct oncogenic role for p21 in breast cancer progression.</p><p>We further report that the TGFÎ²-mediated increase in p21 expression is Smad-dependent and Smad3 specific. This is interesting in light of previous reports indicating that overexpression of a dominant negative form of Smad3 reduced the ability of cancer cells to metastasize [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 57" title="Tian F, DaCosta Byfield S, Parks WT, Yoo S, Felici A, Tang B, Piek E, Wakefield LM, Roberts AB: Reduction in Smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines. &#xA;Cancer Res 2003, 63:8284â8292." href="/articles/10.1186/bcr3322#ref-CR57_3055" id="ref-link-section-d109682214e1904">57</a>] and that Smad3, but not Smad2, promotes breast cancer metastasis in mice [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 58" title="Petersen M, Pardali E, van der Horst G, Cheung H, van den Hoogen C, van der Pluijm G, Ten Dijke P: Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis. &#xA;Oncogene &#xA;29:1351â1361." href="/articles/10.1186/bcr3322#ref-CR58_3055" id="ref-link-section-d109682214e1907">58</a>]. Furthermore, while Smad2 mutations in cancer have been described, no mutations in Smad3 or p21 have yet been reported. Together these data suggest that in breast cancer Smad3 pro-invasive functions are mediated by p21 and that targeting p21 may prove useful to improve the clinical course of metastatic patients.</p><p>Tumor cell migration and invasion are critical initiation steps in the process of breast cancer metastasis. It has been suggested that cytoplasmic p21 regulates ROCK/LIMK/cofilin pathway to promote cell migration; however, we found that TGFÎ² had no effect on regulating cofilin activity in breast cancer cells. In our studies, we identified a novel role for p21 in the transcriptional regulation of TGFÎ²/Smad3 signaling through the interaction of p21 and Smad3 in invasive breast cancer cells. The interaction between p21 and Smad3 was p/CAF-dependent, but whether this interaction is direct will require further investigation. Furthermore, the effects of p21 on cell migration and invasion are mediated through interactions with Smad3 and p/CAF, which in turn modulate Smad3 acetylation, DNA binding and transcriptional activity, as well as gene transcription of several TGFÎ² pro-invasive downstream target genes. It will be interesting to further investigate whether p21 is selective for the pro-oncogenic activity of TGFÎ² or whether it is also required for the transcriptional regulation of other types of TGFÎ² responses and target genes. Taken together, our results demonstrate that p21 is both a direct transcriptional target of TGFÎ² and a co-stimulatory factor of Smad3 in regulation of pro-invasive genes in breast cancer cells (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3322#Fig10">10</a>).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-10" data-title="Figure 10"><figure><figcaption><b id="Fig10" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 10</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/bcr3322/figures/10" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_Fig10_HTML.jpg?as=webp"><img aria-describedby="Fig10" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_Fig10_HTML.jpg" alt="figure 10" loading="lazy"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-10-desc"><p>
<b>Model of pro-invasive function for the cell cycle regulator p21 in human breast cancer</b>. The role of p21 as both a direct transcriptional target of TGFÎ² and a co-stimulatory factor of p/CAF/Smad3 in regulation of pro-invasive genes in triple negative breast cancer cells.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/bcr3322/figures/10" data-track-dest="link:Figure10 Full size image" aria-label="Full size image figure 10" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div>
<p>Finally, we investigated the clinical relevance of TGFÎ²-mediated p21/p/CAF pathway in breast cancer. The prognosis of breast carcinomas is related to various clinical and pathological parameters. Axillary lymph node metastasis is one of the most important prognostic parameters in the absence of distant metastasis. There is a sharp difference in survival rate between patients with positive and negative lymph nodes. In our studies, we found a significant association of active TGFÎ²/Smad3 signaling, p21 and p/CAF expression with lymph node positivity, making them potential useful prognosis markers for lymph node metastasis.</p></div></div></section><section data-title="Conclusion"><div class="c-article-section" id="Sec27_3055-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec27_3055">Conclusion</h2><div class="c-article-section__content" id="Sec27_3055-content"><p>In this study, we described a pro-invasive function for the cell cycle regulator p21 in human breast cancer. High expression of p21 positively correlated with poor overall and distant metastasis-free survival outcomes in breast cancer patients. We identified p21 as a novel downstream regulator of TGFÎ²-mediated breast cancer cell migration and invasion. We found p21 to interact with Smad3 and the acetyltransferase p/CAF and to regulate the Smad transcriptional activity, as well as gene transcription of several TGFÎ²-induced pro-metastatic genes. These results highlight an important role for p21/p/CAF in TGFÎ²-induced breast cancer cell migration and invasion at the transcriptional level.</p></div></div></section>
                    <section data-title="Abbreviations"><div class="c-article-section" id="abbreviations-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="abbreviations">Abbreviations</h2><div class="c-article-section__content" id="abbreviations-content"><dl class="c-abbreviation_list"><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>BSA:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>bovine serum albumin</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>DMEM:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Dulbecco's modified Eagle's medium</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>DMFS:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>distant metastasis free survival</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>DMSO:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>dimethyl sulfoxide</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>ECM:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>extracellular matrix</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>p15:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>p15Ink4b</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>EGF:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>epidermal growth factor</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>ER:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>estrogen receptor</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>FBS:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>fetal bovine serum</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>GFR:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>growth factor reduced</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>IL6:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>interleukin 6</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>MMP9:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>matrix metalloproteinase 9</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>MTT:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>thiazolyl blue tetrazolium bromide</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>OS:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>overall survival</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>p21:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>p21Cip1</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>p/CAF:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>p300/CBP-associated factor</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>PLAU:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>plasminogen activator</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>PTGS2:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>prostaglandin-endoperoxide synthase 2</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>SDS:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>sodium dodecyl sulphate</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>TÎ²RI:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>TGFÎ² type I receptor</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>TGFÎ²:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>transforming growth factor-beta</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>TSA:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>trichostatin A</p>
                  </dd></dl></div></div></section><div id="MagazineFulltextArticleBodySuffix"><section aria-labelledby="Bib1" data-title="References"><div class="c-article-section" id="Bib1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Bib1">References</h2><div class="c-article-section__content" id="Bib1-content"><div data-container-section="references"><ol class="c-article-references"><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="1."><p class="c-article-references__text" id="ref-CR1_3055">Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: <b>The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.</b> 
<i>Cell</i> 1993, <b>75:</b>805â816.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2cXhtVShsLk%3D" aria-label="CAS reference 1">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2F0092-8674%2893%2990499-G" aria-label="Article reference 1">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8242751" aria-label="PubMed reference 1" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 1" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20p21%20Cdk-interacting%20protein%20Cip1%20is%20a%20potent%20inhibitor%20of%20G1%20cyclin-dependent%20kinases&amp;journal=Cell&amp;volume=75&amp;pages=805-816&amp;publication_year=1993&amp;author=Harper%2CJW&amp;author=Adami%2CGR&amp;author=Wei%2CN&amp;author=Keyomarsi%2CK&amp;author=Elledge%2CSJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="2."><p class="c-article-references__text" id="ref-CR2_3055">Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: <b>p21 is a universal inhibitor of cyclin kinases.</b> 
<i>Nature</i> 1993, <b>366:</b>701â704.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2cXhsFOhtbw%3D" aria-label="CAS reference 2">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2F366701a0" aria-label="Article reference 2">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8259214" aria-label="PubMed reference 2" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 2" href="http://scholar.google.com/scholar_lookup?&amp;title=p21%20is%20a%20universal%20inhibitor%20of%20cyclin%20kinases&amp;journal=Nature&amp;volume=366&amp;pages=701-704&amp;publication_year=1993&amp;author=Xiong%2CY&amp;author=Hannon%2CGJ&amp;author=Zhang%2CH&amp;author=Casso%2CD&amp;author=Kobayashi%2CR&amp;author=Beach%2CD">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="3."><p class="c-article-references__text" id="ref-CR3_3055">Toyoshima H, Hunter T: <b>p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.</b> 
<i>Cell</i> 1994, <b>78:</b>67â74.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2cXmsVOmurw%3D" aria-label="CAS reference 3">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2F0092-8674%2894%2990573-8" aria-label="Article reference 3">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8033213" aria-label="PubMed reference 3" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 3" href="http://scholar.google.com/scholar_lookup?&amp;title=p27%2C%20a%20novel%20inhibitor%20of%20G1%20cyclin-Cdk%20protein%20kinase%20activity%2C%20is%20related%20to%20p21&amp;journal=Cell&amp;volume=78&amp;pages=67-74&amp;publication_year=1994&amp;author=Toyoshima%2CH&amp;author=Hunter%2CT">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="4."><p class="c-article-references__text" id="ref-CR4_3055">Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, Elledge SJ: <b>p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.</b> 
<i>Genes Dev</i> 1995, <b>9:</b>650â662.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2MXltVWqs7k%3D" aria-label="CAS reference 4">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1101%2Fgad.9.6.650" aria-label="Article reference 4">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=7729684" aria-label="PubMed reference 4" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 4" href="http://scholar.google.com/scholar_lookup?&amp;title=p57KIP2%2C%20a%20structurally%20distinct%20member%20of%20the%20p21CIP1%20Cdk%20inhibitor%20family%2C%20is%20a%20candidate%20tumor%20suppressor%20gene&amp;journal=Genes%20Dev&amp;volume=9&amp;pages=650-662&amp;publication_year=1995&amp;author=Matsuoka%2CS&amp;author=Edwards%2CMC&amp;author=Bai%2CC&amp;author=Parker%2CS&amp;author=Zhang%2CP&amp;author=Baldini%2CA&amp;author=Harper%2CJW&amp;author=Elledge%2CSJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="5."><p class="c-article-references__text" id="ref-CR5_3055">Besson A, Assoian RK, Roberts JM: <b>Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors?</b> 
<i>Nat Rev Cancer</i> 2004, <b>4:</b>948â955.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2cXhtVarsLjM" aria-label="CAS reference 5">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fnrc1501" aria-label="Article reference 5">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15573116" aria-label="PubMed reference 5" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 5" href="http://scholar.google.com/scholar_lookup?&amp;title=Regulation%20of%20the%20cytoskeleton%3A%20an%20oncogenic%20function%20for%20CDK%20inhibitors%3F&amp;journal=Nat%20Rev%20Cancer&amp;volume=4&amp;pages=948-955&amp;publication_year=2004&amp;author=Besson%2CA&amp;author=Assoian%2CRK&amp;author=Roberts%2CJM">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="6."><p class="c-article-references__text" id="ref-CR6_3055">Besson A, Dowdy SF, Roberts JM: <b>CDK inhibitors: cell cycle regulators and beyond.</b> 
<i>Dev Cell</i> 2008, <b>14:</b>159â169.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXit1Ojsrc%3D" aria-label="CAS reference 6">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2Fj.devcel.2008.01.013" aria-label="Article reference 6">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18267085" aria-label="PubMed reference 6" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 6" href="http://scholar.google.com/scholar_lookup?&amp;title=CDK%20inhibitors%3A%20cell%20cycle%20regulators%20and%20beyond&amp;journal=Dev%20Cell&amp;volume=14&amp;pages=159-169&amp;publication_year=2008&amp;author=Besson%2CA&amp;author=Dowdy%2CSF&amp;author=Roberts%2CJM">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="7."><p class="c-article-references__text" id="ref-CR7_3055">Abbas T, Dutta A: <b>p21 in cancer: intricate networks and multiple activities.</b> 
<i>Nat Rev Cancer</i> 2009, <b>9:</b>400â414.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXlvFShsb4%3D" aria-label="CAS reference 7">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fnrc2657" aria-label="Article reference 7">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19440234" aria-label="PubMed reference 7" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2722839" aria-label="PubMed Central reference 7" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 7" href="http://scholar.google.com/scholar_lookup?&amp;title=p21%20in%20cancer%3A%20intricate%20networks%20and%20multiple%20activities&amp;journal=Nat%20Rev%20Cancer&amp;volume=9&amp;pages=400-414&amp;publication_year=2009&amp;author=Abbas%2CT&amp;author=Dutta%2CA">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="8."><p class="c-article-references__text" id="ref-CR8_3055">Shiohara M, el-Deiry WS, Wada M, Nakamaki T, Takeuchi S, Yang R, Chen DL, Vogelstein B, Koeffler HP: <b>Absence of WAF1 mutations in a variety of human malignancies.</b> 
<i>Blood</i> 1994, <b>84:</b>3781â3784.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2MXisVGjtLk%3D" aria-label="CAS reference 8">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=7949134" aria-label="PubMed reference 8" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 8" href="http://scholar.google.com/scholar_lookup?&amp;title=Absence%20of%20WAF1%20mutations%20in%20a%20variety%20of%20human%20malignancies&amp;journal=Blood&amp;volume=84&amp;pages=3781-3784&amp;publication_year=1994&amp;author=Shiohara%2CM&amp;author=el-Deiry%2CWS&amp;author=Wada%2CM&amp;author=Nakamaki%2CT&amp;author=Takeuchi%2CS&amp;author=Yang%2CR&amp;author=Chen%2CDL&amp;author=Vogelstein%2CB&amp;author=Koeffler%2CHP">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="9."><p class="c-article-references__text" id="ref-CR9_3055">Deng C, Zhang P, Harper JW, Elledge SJ, Leder P: <b>Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control.</b> 
<i>Cell</i> 1995, <b>82:</b>675â684.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2MXnvVWmtbo%3D" aria-label="CAS reference 9">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2F0092-8674%2895%2990039-X" aria-label="Article reference 9">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=7664346" aria-label="PubMed reference 9" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 9" href="http://scholar.google.com/scholar_lookup?&amp;title=Mice%20lacking%20p21CIP1%2FWAF1%20undergo%20normal%20development%2C%20but%20are%20defective%20in%20G1%20checkpoint%20control&amp;journal=Cell&amp;volume=82&amp;pages=675-684&amp;publication_year=1995&amp;author=Deng%2CC&amp;author=Zhang%2CP&amp;author=Harper%2CJW&amp;author=Elledge%2CSJ&amp;author=Leder%2CP">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="10."><p class="c-article-references__text" id="ref-CR10_3055">Biankin AV, Kench JG, Morey AL, Lee CS, Biankin SA, Head DR, Hugh TB, Henshall SM, Sutherland RL: <b>Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia.</b> 
<i>Cancer Res</i> 2001, <b>61:</b>8830â8837.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD38Xht1OmtA%3D%3D" aria-label="CAS reference 10">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11751405" aria-label="PubMed reference 10" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 10" href="http://scholar.google.com/scholar_lookup?&amp;title=Overexpression%20of%20p21%28WAF1%2FCIP1%29%20is%20an%20early%20event%20in%20the%20development%20of%20pancreatic%20intraepithelial%20neoplasia&amp;journal=Cancer%20Res&amp;volume=61&amp;pages=8830-8837&amp;publication_year=2001&amp;author=Biankin%2CAV&amp;author=Kench%2CJG&amp;author=Morey%2CAL&amp;author=Lee%2CCS&amp;author=Biankin%2CSA&amp;author=Head%2CDR&amp;author=Hugh%2CTB&amp;author=Henshall%2CSM&amp;author=Sutherland%2CRL">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="11."><p class="c-article-references__text" id="ref-CR11_3055">Cheung TH, Lo KW, Yu MM, Yim SF, Poon CS, Chung TK, Wong YF: <b>Aberrant expression of p21(WAF1/CIP1) and p27(KIP1) in cervical carcinoma.</b> 
<i>Cancer Lett</i> 2001, <b>172:</b>93â98.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3MXms12lurk%3D" aria-label="CAS reference 11">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2FS0304-3835%2801%2900624-3" aria-label="Article reference 11">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11595134" aria-label="PubMed reference 11" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 11" href="http://scholar.google.com/scholar_lookup?&amp;title=Aberrant%20expression%20of%20p21%28WAF1%2FCIP1%29%20and%20p27%28KIP1%29%20in%20cervical%20carcinoma&amp;journal=Cancer%20Lett&amp;volume=172&amp;pages=93-98&amp;publication_year=2001&amp;author=Cheung%2CTH&amp;author=Lo%2CKW&amp;author=Yu%2CMM&amp;author=Yim%2CSF&amp;author=Poon%2CCS&amp;author=Chung%2CTK&amp;author=Wong%2CYF">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="12."><p class="c-article-references__text" id="ref-CR12_3055">Ferrandina G, Stoler A, Fagotti A, Fanfani F, Sacco R, De Pasqua A, Mancuso S, Scambia G: <b>p21WAF1/CIP1 protein expression in primary ovarian cancer.</b> 
<i>Int J Oncol</i> 2000, <b>17:</b>1231â1235.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3cXos1Onurg%3D" aria-label="CAS reference 12">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11078810" aria-label="PubMed reference 12" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 12" href="http://scholar.google.com/scholar_lookup?&amp;title=p21WAF1%2FCIP1%20protein%20expression%20in%20primary%20ovarian%20cancer&amp;journal=Int%20J%20Oncol&amp;volume=17&amp;pages=1231-1235&amp;publication_year=2000&amp;author=Ferrandina%2CG&amp;author=Stoler%2CA&amp;author=Fagotti%2CA&amp;author=Fanfani%2CF&amp;author=Sacco%2CR&amp;author=De%20Pasqua%2CA&amp;author=Mancuso%2CS&amp;author=Scambia%2CG">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="13."><p class="c-article-references__text" id="ref-CR13_3055">Aaltomaa S, Lipponen P, Eskelinen M, Ala-Opas M, Kosma VM: <b>Prognostic value and expression of p21(waf1/cip1) protein in prostate cancer.</b> 
<i>Prostate</i> 1999, <b>39:</b>8â15.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:STN:280:DyaK1M3js1Cnuw%3D%3D" aria-label="CAS reference 13">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1002%2F%28SICI%291097-0045%2819990401%2939%3A1%3C8%3A%3AAID-PROS2%3E3.0.CO%3B2-N" aria-label="Article reference 13">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=10221260" aria-label="PubMed reference 13" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 13" href="http://scholar.google.com/scholar_lookup?&amp;title=Prognostic%20value%20and%20expression%20of%20p21%28waf1%2Fcip1%29%20protein%20in%20prostate%20cancer&amp;journal=Prostate&amp;volume=39&amp;pages=8-15&amp;publication_year=1999&amp;author=Aaltomaa%2CS&amp;author=Lipponen%2CP&amp;author=Eskelinen%2CM&amp;author=Ala-Opas%2CM&amp;author=Kosma%2CVM">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="14."><p class="c-article-references__text" id="ref-CR14_3055">Wels J, Kaplan RN, Rafii S, Lyden D: <b>Migratory neighbors and distant invaders: tumor-associated niche cells.</b> 
<i>Genes Dev</i> 2008, <b>22:</b>559â574.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXjsVKnt7s%3D" aria-label="CAS reference 14">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1101%2Fgad.1636908" aria-label="Article reference 14">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18316475" aria-label="PubMed reference 14" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731657" aria-label="PubMed Central reference 14" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 14" href="http://scholar.google.com/scholar_lookup?&amp;title=Migratory%20neighbors%20and%20distant%20invaders%3A%20tumor-associated%20niche%20cells&amp;journal=Genes%20Dev&amp;volume=22&amp;pages=559-574&amp;publication_year=2008&amp;author=Wels%2CJ&amp;author=Kaplan%2CRN&amp;author=Rafii%2CS&amp;author=Lyden%2CD">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="15."><p class="c-article-references__text" id="ref-CR15_3055">Ikushima H, Miyazono K: <b>TGFbeta signalling: a complex web in cancer progression.</b> 
<i>Nat Rev Cancer</i> 2010, <b>10:</b>415â424.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3cXmsVWntLc%3D" aria-label="CAS reference 15">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fnrc2853" aria-label="Article reference 15">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20495575" aria-label="PubMed reference 15" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 15" href="http://scholar.google.com/scholar_lookup?&amp;title=TGFbeta%20signalling%3A%20a%20complex%20web%20in%20cancer%20progression&amp;journal=Nat%20Rev%20Cancer&amp;volume=10&amp;pages=415-424&amp;publication_year=2010&amp;author=Ikushima%2CH&amp;author=Miyazono%2CK">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="16."><p class="c-article-references__text" id="ref-CR16_3055">Massague J: <b>The transforming growth factor-beta family.</b> 
<i>Annu Rev Cell Biol</i> 1990, <b>6:</b>597â641.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK3MXltVKjtrc%3D" aria-label="CAS reference 16">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1146%2Fannurev.cb.06.110190.003121" aria-label="Article reference 16">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=2177343" aria-label="PubMed reference 16" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 16" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20transforming%20growth%20factor-beta%20family&amp;journal=Annu%20Rev%20Cell%20Biol&amp;volume=6&amp;pages=597-641&amp;publication_year=1990&amp;author=Massague%2CJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="17."><p class="c-article-references__text" id="ref-CR17_3055">Padua D, Massague J: <b>Roles of TGFbeta in metastasis.</b> 
<i>Cell Res</i> 2009, <b>19:</b>89â102.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXht1GgsA%3D%3D" aria-label="CAS reference 17">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fcr.2008.316" aria-label="Article reference 17">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19050696" aria-label="PubMed reference 17" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 17" href="http://scholar.google.com/scholar_lookup?&amp;title=Roles%20of%20TGFbeta%20in%20metastasis&amp;journal=Cell%20Res&amp;volume=19&amp;pages=89-102&amp;publication_year=2009&amp;author=Padua%2CD&amp;author=Massague%2CJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="18."><p class="c-article-references__text" id="ref-CR18_3055">Chen CR, Kang Y, Massague J: <b>Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program.</b> 
<i>Proc Natl Acad Sci USA</i> 2001, <b>98:</b>992â999.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3MXht1Sms7Y%3D" aria-label="CAS reference 18">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1073%2Fpnas.98.3.992" aria-label="Article reference 18">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11158583" aria-label="PubMed reference 18" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC14697" aria-label="PubMed Central reference 18" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 18" href="http://scholar.google.com/scholar_lookup?&amp;title=Defective%20repression%20of%20c-myc%20in%20breast%20cancer%20cells%3A%20A%20loss%20at%20the%20core%20of%20the%20transforming%20growth%20factor%20beta%20growth%20arrest%20program&amp;journal=Proc%20Natl%20Acad%20Sci%20USA&amp;volume=98&amp;pages=992-999&amp;publication_year=2001&amp;author=Chen%2CCR&amp;author=Kang%2CY&amp;author=Massague%2CJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="19."><p class="c-article-references__text" id="ref-CR19_3055">Hannon GJ, Beach D: <b>p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest.</b> 
<i>Nature</i> 1994, <b>371:</b>257â261.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2cXmsVOqsbk%3D" aria-label="CAS reference 19">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2F371257a0" aria-label="Article reference 19">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8078588" aria-label="PubMed reference 19" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 19" href="http://scholar.google.com/scholar_lookup?&amp;title=p15INK4B%20is%20a%20potential%20effector%20of%20TGF-beta-induced%20cell%20cycle%20arrest&amp;journal=Nature&amp;volume=371&amp;pages=257-261&amp;publication_year=1994&amp;author=Hannon%2CGJ&amp;author=Beach%2CD">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="20."><p class="c-article-references__text" id="ref-CR20_3055">Li CY, Suardet L, Little JB: <b>Potential role of WAF1/Cip1/p21 as a mediator of TGF-beta cytoinhibitory effect.</b> 
<i>J Biol Chem</i> 1995, <b>270:</b>4971â4974.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2MXksVSlsLg%3D" aria-label="CAS reference 20">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1074%2Fjbc.270.10.4971" aria-label="Article reference 20">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=7890601" aria-label="PubMed reference 20" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 20" href="http://scholar.google.com/scholar_lookup?&amp;title=Potential%20role%20of%20WAF1%2FCip1%2Fp21%20as%20a%20mediator%20of%20TGF-beta%20cytoinhibitory%20effect&amp;journal=J%20Biol%20Chem&amp;volume=270&amp;pages=4971-4974&amp;publication_year=1995&amp;author=Li%2CCY&amp;author=Suardet%2CL&amp;author=Little%2CJB">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="21."><p class="c-article-references__text" id="ref-CR21_3055">Derynck R, Akhurst RJ, Balmain A: <b>TGF-beta signaling in tumor suppression and cancer progression.</b> 
<i>Nat Genet</i> 2001, <b>29:</b>117â129.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3MXnsFKgt7c%3D" aria-label="CAS reference 21">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fng1001-117" aria-label="Article reference 21">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11586292" aria-label="PubMed reference 21" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 21" href="http://scholar.google.com/scholar_lookup?&amp;title=TGF-beta%20signaling%20in%20tumor%20suppression%20and%20cancer%20progression&amp;journal=Nat%20Genet&amp;volume=29&amp;pages=117-129&amp;publication_year=2001&amp;author=Derynck%2CR&amp;author=Akhurst%2CRJ&amp;author=Balmain%2CA">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="22."><p class="c-article-references__text" id="ref-CR22_3055">Akhurst RJ, Derynck R: <b>TGF-beta signaling in cancer -- a double-edged sword.</b> 
<i>Trends Cell Biol</i> 2001, <b>11:</b>S44â51.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3MXnvFGrsb8%3D" aria-label="CAS reference 22">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11684442" aria-label="PubMed reference 22" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 22" href="http://scholar.google.com/scholar_lookup?&amp;title=TGF-beta%20signaling%20in%20cancer%20--%20a%20double-edged%20sword&amp;journal=Trends%20Cell%20Biol&amp;volume=11&amp;pages=S44-51&amp;publication_year=2001&amp;author=Akhurst%2CRJ&amp;author=Derynck%2CR">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="23."><p class="c-article-references__text" id="ref-CR23_3055">Wakefield LM, Roberts AB: <b>TGF-beta signaling: positive and negative effects on tumorigenesis.</b> 
<i>Curr Opin Genet Dev</i> 2002, <b>12:</b>22â29.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD38XktFGmtw%3D%3D" aria-label="CAS reference 23">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2FS0959-437X%2801%2900259-3" aria-label="Article reference 23">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11790550" aria-label="PubMed reference 23" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 23" href="http://scholar.google.com/scholar_lookup?&amp;title=TGF-beta%20signaling%3A%20positive%20and%20negative%20effects%20on%20tumorigenesis&amp;journal=Curr%20Opin%20Genet%20Dev&amp;volume=12&amp;pages=22-29&amp;publication_year=2002&amp;author=Wakefield%2CLM&amp;author=Roberts%2CAB">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="24."><p class="c-article-references__text" id="ref-CR24_3055">Tang B, Vu M, Booker T, Santner SJ, Miller FR, Anver MR, Wakefield LM: <b>TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression.</b> 
<i>J Clin Invest</i> 2003, <b>112:</b>1116â1124.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3sXnvFGrsbo%3D" aria-label="CAS reference 24">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1172%2FJCI200318899" aria-label="Article reference 24">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=14523048" aria-label="PubMed reference 24" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC198530" aria-label="PubMed Central reference 24" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 24" href="http://scholar.google.com/scholar_lookup?&amp;title=TGF-beta%20switches%20from%20tumor%20suppressor%20to%20prometastatic%20factor%20in%20a%20model%20of%20breast%20cancer%20progression&amp;journal=J%20Clin%20Invest&amp;volume=112&amp;pages=1116-1124&amp;publication_year=2003&amp;author=Tang%2CB&amp;author=Vu%2CM&amp;author=Booker%2CT&amp;author=Santner%2CSJ&amp;author=Miller%2CFR&amp;author=Anver%2CMR&amp;author=Wakefield%2CLM">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="25."><p class="c-article-references__text" id="ref-CR25_3055">Humbert L, Neel JC, Lebrun JJ: <b>Targeting TGF-beta signaling in human cancer therapy.</b> 
<i>Trends Cell Mol Biol</i> 2010, <b>5:</b>69â107.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXpvFWgtLg%3D" aria-label="CAS reference 25">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 25" href="http://scholar.google.com/scholar_lookup?&amp;title=Targeting%20TGF-beta%20signaling%20in%20human%20cancer%20therapy&amp;journal=Trends%20Cell%20Mol%20Biol&amp;volume=5&amp;pages=69-107&amp;publication_year=2010&amp;author=Humbert%2CL&amp;author=Neel%2CJC&amp;author=Lebrun%2CJJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="26."><p class="c-article-references__text" id="ref-CR26_3055">Yang XJ, Ogryzko VV, Nishikawa J, Howard BH, Nakatani Y: <b>A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A.</b> 
<i>Nature</i> 1996, <b>382:</b>319â324.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK28Xks1Wgurc%3D" aria-label="CAS reference 26">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2F382319a0" aria-label="Article reference 26">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8684459" aria-label="PubMed reference 26" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 26" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20p300%2FCBP-associated%20factor%20that%20competes%20with%20the%20adenoviral%20oncoprotein%20E1A&amp;journal=Nature&amp;volume=382&amp;pages=319-324&amp;publication_year=1996&amp;author=Yang%2CXJ&amp;author=Ogryzko%2CVV&amp;author=Nishikawa%2CJ&amp;author=Howard%2CBH&amp;author=Nakatani%2CY">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="27."><p class="c-article-references__text" id="ref-CR27_3055">Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC: <b>Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells.</b> 
<i>Nat Cell Biol</i> 2001, <b>3:</b>245â252.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3MXitFegurk%3D" aria-label="CAS reference 27">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2F35060032" aria-label="Article reference 27">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11231573" aria-label="PubMed reference 27" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 27" href="http://scholar.google.com/scholar_lookup?&amp;title=Cytoplasmic%20localization%20of%20p21Cip1%2FWAF1%20by%20Akt-induced%20phosphorylation%20in%20HER-2%2Fneu-overexpressing%20cells&amp;journal=Nat%20Cell%20Biol&amp;volume=3&amp;pages=245-252&amp;publication_year=2001&amp;author=Zhou%2CBP&amp;author=Liao%2CY&amp;author=Xia%2CW&amp;author=Spohn%2CB&amp;author=Lee%2CMH&amp;author=Hung%2CMC">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="28."><p class="c-article-references__text" id="ref-CR28_3055">Shechter D, Dormann HL, Allis CD, Hake SB: <b>Extraction, purification and analysis of histones.</b> 
<i>Nat Protoc</i> 2007, <b>2:</b>1445â1457.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2sXhtFagsLnL" aria-label="CAS reference 28">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fnprot.2007.202" aria-label="Article reference 28">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=17545981" aria-label="PubMed reference 28" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 28" href="http://scholar.google.com/scholar_lookup?&amp;title=Extraction%2C%20purification%20and%20analysis%20of%20histones&amp;journal=Nat%20Protoc&amp;volume=2&amp;pages=1445-1457&amp;publication_year=2007&amp;author=Shechter%2CD&amp;author=Dormann%2CHL&amp;author=Allis%2CCD&amp;author=Hake%2CSB">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="29."><p class="c-article-references__text" id="ref-CR29_3055">Lonn P, van der Heide LP, Dahl M, Hellman U, Heldin CH, Moustakas A: <b>PARP-1 attenuates Smad-mediated transcription.</b> 
<i>Mol Cell</i> 2010, <b>40:</b>521â532.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2Fj.molcel.2010.10.029" aria-label="Article reference 29">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21095583" aria-label="PubMed reference 29" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 29" href="http://scholar.google.com/scholar_lookup?&amp;title=PARP-1%20attenuates%20Smad-mediated%20transcription&amp;journal=Mol%20Cell&amp;volume=40&amp;pages=521-532&amp;publication_year=2010&amp;author=Lonn%2CP&amp;author=van%20der%20Heide%2CLP&amp;author=Dahl%2CM&amp;author=Hellman%2CU&amp;author=Heldin%2CCH&amp;author=Moustakas%2CA">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="30."><p class="c-article-references__text" id="ref-CR30_3055">Yang M, Burton DW, Geller J, Hillegonds DJ, Hastings RH, Deftos LJ, Hoffman RM: <b>The bisphosphonate olpadronate inhibits skeletal prostate cancer progression in a green fluorescent protein nude mouse model.</b> 
<i>Clin Cancer Res</i> 2006, <b>12:</b>2602â2606.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD28XjvVaksr0%3D" aria-label="CAS reference 30">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1158%2F1078-0432.CCR-05-2050" aria-label="Article reference 30">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16638872" aria-label="PubMed reference 30" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 30" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20bisphosphonate%20olpadronate%20inhibits%20skeletal%20prostate%20cancer%20progression%20in%20a%20green%20fluorescent%20protein%20nude%20mouse%20model&amp;journal=Clin%20Cancer%20Res&amp;volume=12&amp;pages=2602-2606&amp;publication_year=2006&amp;author=Yang%2CM&amp;author=Burton%2CDW&amp;author=Geller%2CJ&amp;author=Hillegonds%2CDJ&amp;author=Hastings%2CRH&amp;author=Deftos%2CLJ&amp;author=Hoffman%2CRM">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="31."><p class="c-article-references__text" id="ref-CR31_3055">Winters ZE, Hunt NC, Bradburn MJ, Royds JA, Turley H, Harris AL, Norbury CJ: <b>Subcellular localisation of cyclin B, Cdc2 and p21(WAF1/CIP1) in breast cancer. association with prognosis.</b> 
<i>Eur J Cancer</i> 2001, <b>37:</b>2405â2412.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3MXosFKgtb0%3D" aria-label="CAS reference 31">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2FS0959-8049%2801%2900327-6" aria-label="Article reference 31">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11720835" aria-label="PubMed reference 31" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 31" href="http://scholar.google.com/scholar_lookup?&amp;title=Subcellular%20localisation%20of%20cyclin%20B%2C%20Cdc2%20and%20p21%28WAF1%2FCIP1%29%20in%20breast%20cancer.%20association%20with%20prognosis&amp;journal=Eur%20J%20Cancer&amp;volume=37&amp;pages=2405-2412&amp;publication_year=2001&amp;author=Winters%2CZE&amp;author=Hunt%2CNC&amp;author=Bradburn%2CMJ&amp;author=Royds%2CJA&amp;author=Turley%2CH&amp;author=Harris%2CAL&amp;author=Norbury%2CCJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="32."><p class="c-article-references__text" id="ref-CR32_3055">Xia W, Chen JS, Zhou X, Sun PR, Lee DF, Liao Y, Zhou BP, Hung MC: <b>Phosphorylation/cytoplasmic localization of p21Cip1/WAF1 is associated with HER2/neu overexpression and provides a novel combination predictor for poor prognosis in breast cancer patients.</b> 
<i>Clin Cancer Res</i> 2004, <b>10:</b>3815â3824.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2cXksVKnt70%3D" aria-label="CAS reference 32">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1158%2F1078-0432.CCR-03-0527" aria-label="Article reference 32">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15173090" aria-label="PubMed reference 32" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 32" href="http://scholar.google.com/scholar_lookup?&amp;title=Phosphorylation%2Fcytoplasmic%20localization%20of%20p21Cip1%2FWAF1%20is%20associated%20with%20HER2%2Fneu%20overexpression%20and%20provides%20a%20novel%20combination%20predictor%20for%20poor%20prognosis%20in%20breast%20cancer%20patients&amp;journal=Clin%20Cancer%20Res&amp;volume=10&amp;pages=3815-3824&amp;publication_year=2004&amp;author=Xia%2CW&amp;author=Chen%2CJS&amp;author=Zhou%2CX&amp;author=Sun%2CPR&amp;author=Lee%2CDF&amp;author=Liao%2CY&amp;author=Zhou%2CBP&amp;author=Hung%2CMC">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="33."><p class="c-article-references__text" id="ref-CR33_3055">Winters ZE, Leek RD, Bradburn MJ, Norbury CJ, Harris AL: <b>Cytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/neu in breast cancer and is an independent predictor of prognosis.</b> 
<i>Breast Cancer Res</i> 2003, <b>5:</b>R242â249.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3sXptFKksrs%3D" aria-label="CAS reference 33">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1186%2Fbcr654" aria-label="Article reference 33">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=14580260" aria-label="PubMed reference 33" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC314414" aria-label="PubMed Central reference 33" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 33" href="http://scholar.google.com/scholar_lookup?&amp;title=Cytoplasmic%20p21WAF1%2FCIP1%20expression%20is%20correlated%20with%20HER-2%2Fneu%20in%20breast%20cancer%20and%20is%20an%20independent%20predictor%20of%20prognosis&amp;journal=Breast%20Cancer%20Res&amp;volume=5&amp;pages=R242-249&amp;publication_year=2003&amp;author=Winters%2CZE&amp;author=Leek%2CRD&amp;author=Bradburn%2CMJ&amp;author=Norbury%2CCJ&amp;author=Harris%2CAL">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="34."><p class="c-article-references__text" id="ref-CR34_3055">Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, Szallasi Z: <b>An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.</b> 
<i>Breast Cancer Res Treat</i> 2010, <b>123:</b>725â731.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1007%2Fs10549-009-0674-9" aria-label="Article reference 34">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20020197" aria-label="PubMed reference 34" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 34" href="http://scholar.google.com/scholar_lookup?&amp;title=An%20online%20survival%20analysis%20tool%20to%20rapidly%20assess%20the%20effect%20of%2022%2C277%20genes%20on%20breast%20cancer%20prognosis%20using%20microarray%20data%20of%201%2C809%20patients&amp;journal=Breast%20Cancer%20Res%20Treat&amp;volume=123&amp;pages=725-731&amp;publication_year=2010&amp;author=Gyorffy%2CB&amp;author=Lanczky%2CA&amp;author=Eklund%2CAC&amp;author=Denkert%2CC&amp;author=Budczies%2CJ&amp;author=Li%2CQ&amp;author=Szallasi%2CZ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="35."><p class="c-article-references__text" id="ref-CR35_3055">Kang Y, He W, Tulley S, Gupta GP, Serganova I, Chen CR, Manova-Todorova K, Blasberg R, Gerald WL, Massague J: <b>Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway.</b> 
<i>Proc Natl Acad Sci USA</i> 2005, <b>102:</b>13909â13914.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2MXhtVOqsbjM" aria-label="CAS reference 35">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1073%2Fpnas.0506517102" aria-label="Article reference 35">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16172383" aria-label="PubMed reference 35" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1236573" aria-label="PubMed Central reference 35" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 35" href="http://scholar.google.com/scholar_lookup?&amp;title=Breast%20cancer%20bone%20metastasis%20mediated%20by%20the%20Smad%20tumor%20suppressor%20pathway&amp;journal=Proc%20Natl%20Acad%20Sci%20USA&amp;volume=102&amp;pages=13909-13914&amp;publication_year=2005&amp;author=Kang%2CY&amp;author=He%2CW&amp;author=Tulley%2CS&amp;author=Gupta%2CGP&amp;author=Serganova%2CI&amp;author=Chen%2CCR&amp;author=Manova-Todorova%2CK&amp;author=Blasberg%2CR&amp;author=Gerald%2CWL&amp;author=Massague%2CJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="36."><p class="c-article-references__text" id="ref-CR36_3055">Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, Wang ZC, Brock JE, Richardson AL, Weinberg RA: <b>A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis.</b> 
<i>Cell</i> 2009, <b>137:</b>1032â1046.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXps1eiurY%3D" aria-label="CAS reference 36">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2Fj.cell.2009.03.047" aria-label="Article reference 36">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19524507" aria-label="PubMed reference 36" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766609" aria-label="PubMed Central reference 36" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 36" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20pleiotropically%20acting%20microRNA%2C%20miR-31%2C%20inhibits%20breast%20cancer%20metastasis&amp;journal=Cell&amp;volume=137&amp;pages=1032-1046&amp;publication_year=2009&amp;author=Valastyan%2CS&amp;author=Reinhardt%2CF&amp;author=Benaich%2CN&amp;author=Calogrias%2CD&amp;author=Szasz%2CAM&amp;author=Wang%2CZC&amp;author=Brock%2CJE&amp;author=Richardson%2CAL&amp;author=Weinberg%2CRA">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="37."><p class="c-article-references__text" id="ref-CR37_3055">Fidler IJ: <b>The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited.</b> 
<i>Nat Rev Cancer</i> 2003, <b>3:</b>453â458.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3sXktFOnsbg%3D" aria-label="CAS reference 37">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fnrc1098" aria-label="Article reference 37">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=12778135" aria-label="PubMed reference 37" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 37" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20pathogenesis%20of%20cancer%20metastasis%3A%20the%20%27seed%20and%20soil%27%20hypothesis%20revisited&amp;journal=Nat%20Rev%20Cancer&amp;volume=3&amp;pages=453-458&amp;publication_year=2003&amp;author=Fidler%2CIJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="38."><p class="c-article-references__text" id="ref-CR38_3055">Zhang XH, Wang Q, Gerald W, Hudis CA, Norton L, Smid M, Foekens JA, Massague J: <b>Latent bone metastasis in breast cancer tied to Src-dependent survival signals.</b> 
<i>Cancer Cell</i> 2009, <b>16:</b>67â78.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXhtVWnsL7I" aria-label="CAS reference 38">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2Fj.ccr.2009.05.017" aria-label="Article reference 38">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19573813" aria-label="PubMed reference 38" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2749247" aria-label="PubMed Central reference 38" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 38" href="http://scholar.google.com/scholar_lookup?&amp;title=Latent%20bone%20metastasis%20in%20breast%20cancer%20tied%20to%20Src-dependent%20survival%20signals&amp;journal=Cancer%20Cell&amp;volume=16&amp;pages=67-78&amp;publication_year=2009&amp;author=Zhang%2CXH&amp;author=Wang%2CQ&amp;author=Gerald%2CW&amp;author=Hudis%2CCA&amp;author=Norton%2CL&amp;author=Smid%2CM&amp;author=Foekens%2CJA&amp;author=Massague%2CJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="39."><p class="c-article-references__text" id="ref-CR39_3055">Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF: <b>Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism.</b> 
<i>Proc Natl Acad Sci USA</i> 1995, <b>92:</b>5545â5549.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2MXmtFOgsLo%3D" aria-label="CAS reference 39">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1073%2Fpnas.92.12.5545" aria-label="Article reference 39">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=7777546" aria-label="PubMed reference 39" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC41732" aria-label="PubMed Central reference 39" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 39" href="http://scholar.google.com/scholar_lookup?&amp;title=Transforming%20growth%20factor%20beta%20induces%20the%20cyclin-dependent%20kinase%20inhibitor%20p21%20through%20a%20p53-independent%20mechanism&amp;journal=Proc%20Natl%20Acad%20Sci%20USA&amp;volume=92&amp;pages=5545-5549&amp;publication_year=1995&amp;author=Datto%2CMB&amp;author=Li%2CY&amp;author=Panus%2CJF&amp;author=Howe%2CDJ&amp;author=Xiong%2CY&amp;author=Wang%2CXF">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="40."><p class="c-article-references__text" id="ref-CR40_3055">Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M, Ponomarev V, Gerald WL, Blasberg R, Massague J: <b>Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors.</b> 
<i>J Clin Invest</i> 2005, <b>115:</b>44â55.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2MXis1eluw%3D%3D" aria-label="CAS reference 40">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1172%2FJCI22320" aria-label="Article reference 40">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15630443" aria-label="PubMed reference 40" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC539194" aria-label="PubMed Central reference 40" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 40" href="http://scholar.google.com/scholar_lookup?&amp;title=Distinct%20organ-specific%20metastatic%20potential%20of%20individual%20breast%20cancer%20cells%20and%20primary%20tumors&amp;journal=J%20Clin%20Invest&amp;volume=115&amp;pages=44-55&amp;publication_year=2005&amp;author=Minn%2CAJ&amp;author=Kang%2CY&amp;author=Serganova%2CI&amp;author=Gupta%2CGP&amp;author=Giri%2CDD&amp;author=Doubrovin%2CM&amp;author=Ponomarev%2CV&amp;author=Gerald%2CWL&amp;author=Blasberg%2CR&amp;author=Massague%2CJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="41."><p class="c-article-references__text" id="ref-CR41_3055">Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, Speed T, Spellman PT, DeVries S, Lapuk A, Wang NJ, Kuo WL, Stilwell JL, Pinkel D, Albertson DG, Waldman FM, McCormick F, Dickson RB, Johnson MD, Lippman M, Ethier S, Gazdar A, Gray JW: <b>A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.</b> 
<i>Cancer Cell</i> 2006, <b>10:</b>515â527.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD28XhtlCnsrbE" aria-label="CAS reference 41">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2Fj.ccr.2006.10.008" aria-label="Article reference 41">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=17157791" aria-label="PubMed reference 41" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730521" aria-label="PubMed Central reference 41" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 41" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20collection%20of%20breast%20cancer%20cell%20lines%20for%20the%20study%20of%20functionally%20distinct%20cancer%20subtypes&amp;journal=Cancer%20Cell&amp;volume=10&amp;pages=515-527&amp;publication_year=2006&amp;author=Neve%2CRM&amp;author=Chin%2CK&amp;author=Fridlyand%2CJ&amp;author=Yeh%2CJ&amp;author=Baehner%2CFL&amp;author=Fevr%2CT&amp;author=Clark%2CL&amp;author=Bayani%2CN&amp;author=Coppe%2CJP&amp;author=Tong%2CF&amp;author=Speed%2CT&amp;author=Spellman%2CPT&amp;author=DeVries%2CS&amp;author=Lapuk%2CA&amp;author=Wang%2CNJ&amp;author=Kuo%2CWL&amp;author=Stilwell%2CJL&amp;author=Pinkel%2CD&amp;author=Albertson%2CDG&amp;author=Waldman%2CFM&amp;author=McCormick%2CF&amp;author=Dickson%2CRB&amp;author=Johnson%2CMD&amp;author=Lippman%2CM&amp;author=Ethier%2CS&amp;author=Gazdar%2CA&amp;author=Gray%2CJW">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="42."><p class="c-article-references__text" id="ref-CR42_3055">Tsapara A, Luthert P, Greenwood J, Hill CS, Matter K, Balda MS: <b>The RhoA activator GEF-H1/Lfc is a transforming growth factor-beta target gene and effector that regulates alpha-smooth muscle actin expression and cell migration.</b> 
<i>Mol Biol Cell</i> 2010, <b>21:</b>860â870.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3cXjs1eqs78%3D" aria-label="CAS reference 42">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1091%2Fmbc.E09-07-0567" aria-label="Article reference 42">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20089843" aria-label="PubMed reference 42" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2836967" aria-label="PubMed Central reference 42" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 42" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20RhoA%20activator%20GEF-H1%2FLfc%20is%20a%20transforming%20growth%20factor-beta%20target%20gene%20and%20effector%20that%20regulates%20alpha-smooth%20muscle%20actin%20expression%20and%20cell%20migration&amp;journal=Mol%20Biol%20Cell&amp;volume=21&amp;pages=860-870&amp;publication_year=2010&amp;author=Tsapara%2CA&amp;author=Luthert%2CP&amp;author=Greenwood%2CJ&amp;author=Hill%2CCS&amp;author=Matter%2CK&amp;author=Balda%2CMS">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="43."><p class="c-article-references__text" id="ref-CR43_3055">Starostina NG, Simpliciano JM, McGuirk MA, Kipreos ET: <b>CRL2(LRR-1) targets a CDK inhibitor for cell cycle control in C. elegans and actin-based motility regulation in human cells.</b> 
<i>Dev Cell</i> 2010, <b>19:</b>753â764.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3cXhsValsLnJ" aria-label="CAS reference 43">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2Fj.devcel.2010.10.013" aria-label="Article reference 43">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21074724" aria-label="PubMed reference 43" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3053091" aria-label="PubMed Central reference 43" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 43" href="http://scholar.google.com/scholar_lookup?&amp;title=CRL2%28LRR-1%29%20targets%20a%20CDK%20inhibitor%20for%20cell%20cycle%20control%20in%20C.%20elegans%20and%20actin-based%20motility%20regulation%20in%20human%20cells&amp;journal=Dev%20Cell&amp;volume=19&amp;pages=753-764&amp;publication_year=2010&amp;author=Starostina%2CNG&amp;author=Simpliciano%2CJM&amp;author=McGuirk%2CMA&amp;author=Kipreos%2CET">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="44."><p class="c-article-references__text" id="ref-CR44_3055">Lee S, Helfman DM: <b>Cytoplasmic p21Cip1 is involved in Ras-induced inhibition of the ROCK/LIMK/cofilin pathway.</b> 
<i>J Biol Chem</i> 2004, <b>279:</b>1885â1891.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2cXisF2lug%3D%3D" aria-label="CAS reference 44">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1074%2Fjbc.M306968200" aria-label="Article reference 44">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=14559914" aria-label="PubMed reference 44" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 44" href="http://scholar.google.com/scholar_lookup?&amp;title=Cytoplasmic%20p21Cip1%20is%20involved%20in%20Ras-induced%20inhibition%20of%20the%20ROCK%2FLIMK%2Fcofilin%20pathway&amp;journal=J%20Biol%20Chem&amp;volume=279&amp;pages=1885-1891&amp;publication_year=2004&amp;author=Lee%2CS&amp;author=Helfman%2CDM">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="45."><p class="c-article-references__text" id="ref-CR45_3055">Chang BD, Watanabe K, Broude EV, Fang J, Poole JC, Kalinichenko TV, Roninson IB: <b>Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases.</b> 
<i>Proc Natl Acad Sci USA</i> 2000, <b>97:</b>4291â4296.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3cXislSnsrs%3D" aria-label="CAS reference 45">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1073%2Fpnas.97.8.4291" aria-label="Article reference 45">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=10760295" aria-label="PubMed reference 45" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC18232" aria-label="PubMed Central reference 45" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 45" href="http://scholar.google.com/scholar_lookup?&amp;title=Effects%20of%20p21Waf1%2FCip1%2FSdi1%20on%20cellular%20gene%20expression%3A%20implications%20for%20carcinogenesis%2C%20senescence%2C%20and%20age-related%20diseases&amp;journal=Proc%20Natl%20Acad%20Sci%20USA&amp;volume=97&amp;pages=4291-4296&amp;publication_year=2000&amp;author=Chang%2CBD&amp;author=Watanabe%2CK&amp;author=Broude%2CEV&amp;author=Fang%2CJ&amp;author=Poole%2CJC&amp;author=Kalinichenko%2CTV&amp;author=Roninson%2CIB">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="46."><p class="c-article-references__text" id="ref-CR46_3055">Mantovani A, Allavena P, Sica A, Balkwill F: <b>Cancer-related inflammation.</b> 
<i>Nature</i> 2008, <b>454:</b>436â444.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXovV2mtbg%3D" aria-label="CAS reference 46">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fnature07205" aria-label="Article reference 46">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18650914" aria-label="PubMed reference 46" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 46" href="http://scholar.google.com/scholar_lookup?&amp;title=Cancer-related%20inflammation&amp;journal=Nature&amp;volume=454&amp;pages=436-444&amp;publication_year=2008&amp;author=Mantovani%2CA&amp;author=Allavena%2CP&amp;author=Sica%2CA&amp;author=Balkwill%2CF">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="47."><p class="c-article-references__text" id="ref-CR47_3055">Snowden AW, Anderson LA, Webster GA, Perkins ND: <b>A novel transcriptional repression domain mediates p21(WAF1/CIP1) induction of p300 transactivation.</b> 
<i>Mol Cell Biol</i> 2000, <b>20:</b>2676â2686.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3cXit1ymurY%3D" aria-label="CAS reference 47">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1128%2FMCB.20.8.2676-2686.2000" aria-label="Article reference 47">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=10733570" aria-label="PubMed reference 47" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC85483" aria-label="PubMed Central reference 47" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 47" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20novel%20transcriptional%20repression%20domain%20mediates%20p21%28WAF1%2FCIP1%29%20induction%20of%20p300%20transactivation&amp;journal=Mol%20Cell%20Biol&amp;volume=20&amp;pages=2676-2686&amp;publication_year=2000&amp;author=Snowden%2CAW&amp;author=Anderson%2CLA&amp;author=Webster%2CGA&amp;author=Perkins%2CND">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="48."><p class="c-article-references__text" id="ref-CR48_3055">Fritah A, Saucier C, Mester J, Redeuilh G, Sabbah M: <b>p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha.</b> 
<i>Mol Cell Biol</i> 2005, <b>25:</b>2419â2430.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2MXisVOiurk%3D" aria-label="CAS reference 48">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1128%2FMCB.25.6.2419-2430.2005" aria-label="Article reference 48">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15743834" aria-label="PubMed reference 48" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1061593" aria-label="PubMed Central reference 48" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 48" href="http://scholar.google.com/scholar_lookup?&amp;title=p21WAF1%2FCIP1%20selectively%20controls%20the%20transcriptional%20activity%20of%20estrogen%20receptor%20alpha&amp;journal=Mol%20Cell%20Biol&amp;volume=25&amp;pages=2419-2430&amp;publication_year=2005&amp;author=Fritah%2CA&amp;author=Saucier%2CC&amp;author=Mester%2CJ&amp;author=Redeuilh%2CG&amp;author=Sabbah%2CM">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="49."><p class="c-article-references__text" id="ref-CR49_3055">Nagy Z, Tora L: <b>Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation.</b> 
<i>Oncogene</i> 2007, <b>26:</b>5341â5357.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2sXovFeku7w%3D" aria-label="CAS reference 49">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fsj.onc.1210604" aria-label="Article reference 49">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=17694077" aria-label="PubMed reference 49" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 49" href="http://scholar.google.com/scholar_lookup?&amp;title=Distinct%20GCN5%2FPCAF-containing%20complexes%20function%20as%20co-activators%20and%20are%20involved%20in%20transcription%20factor%20and%20global%20histone%20acetylation&amp;journal=Oncogene&amp;volume=26&amp;pages=5341-5357&amp;publication_year=2007&amp;author=Nagy%2CZ&amp;author=Tora%2CL">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="50."><p class="c-article-references__text" id="ref-CR50_3055">Itoh S, Ericsson J, Nishikawa J, Heldin CH, Ten Dijke P: <b>The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.</b> 
<i>Nucleic Acids Res</i> 2000, <b>28:</b>4291â4298.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3cXovFOjsbg%3D" aria-label="CAS reference 50">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1093%2Fnar%2F28.21.4291" aria-label="Article reference 50">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11058129" aria-label="PubMed reference 50" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC113149" aria-label="PubMed Central reference 50" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 50" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20transcriptional%20co-activator%20P%2FCAF%20potentiates%20TGF-beta%2FSmad%20signaling&amp;journal=Nucleic%20Acids%20Res&amp;volume=28&amp;pages=4291-4298&amp;publication_year=2000&amp;author=Itoh%2CS&amp;author=Ericsson%2CJ&amp;author=Nishikawa%2CJ&amp;author=Heldin%2CCH&amp;author=Ten%20Dijke%2CP">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="51."><p class="c-article-references__text" id="ref-CR51_3055">Simonsson M, Kanduri M, Gronroos E, Heldin CH, Ericsson J: <b>The DNA binding activities of Smad2 and Smad3 are regulated by coactivator-mediated acetylation.</b> 
<i>J Biol Chem</i> 2006, <b>281:</b>39870â39880.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD28XhtlCrtrbE" aria-label="CAS reference 51">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1074%2Fjbc.M607868200" aria-label="Article reference 51">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=17074756" aria-label="PubMed reference 51" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 51" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20DNA%20binding%20activities%20of%20Smad2%20and%20Smad3%20are%20regulated%20by%20coactivator-mediated%20acetylation&amp;journal=J%20Biol%20Chem&amp;volume=281&amp;pages=39870-39880&amp;publication_year=2006&amp;author=Simonsson%2CM&amp;author=Kanduri%2CM&amp;author=Gronroos%2CE&amp;author=Heldin%2CCH&amp;author=Ericsson%2CJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="52."><p class="c-article-references__text" id="ref-CR52_3055">Cocolakis E, Dai M, Drevet L, Ho J, Haines E, Ali S, Lebrun JJ: <b>Smad signaling antagonizes STAT5-mediated gene transcription and mammary epithelial cell differentiation.</b> 
<i>J Biol Chem</i> 2008, <b>283:</b>1293â1307.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXks1elug%3D%3D" aria-label="CAS reference 52">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1074%2Fjbc.M707492200" aria-label="Article reference 52">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18024957" aria-label="PubMed reference 52" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 52" href="http://scholar.google.com/scholar_lookup?&amp;title=Smad%20signaling%20antagonizes%20STAT5-mediated%20gene%20transcription%20and%20mammary%20epithelial%20cell%20differentiation&amp;journal=J%20Biol%20Chem&amp;volume=283&amp;pages=1293-1307&amp;publication_year=2008&amp;author=Cocolakis%2CE&amp;author=Dai%2CM&amp;author=Drevet%2CL&amp;author=Ho%2CJ&amp;author=Haines%2CE&amp;author=Ali%2CS&amp;author=Lebrun%2CJJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="53."><p class="c-article-references__text" id="ref-CR53_3055">de Boer M, van Deurzen CH, van Dijck JA, Borm GF, van Diest PJ, Adang EM, Nortier JW, Rutgers EJ, Seynaeve C, Menke-Pluymers MB, Bult P, Tjan-Heijnen VC: <b>Micrometastases or isolated tumor cells and the outcome of breast cancer.</b> 
<i>N Engl J Med</i> 2009, <b>361:</b>653â663.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXpvFOjt74%3D" aria-label="CAS reference 53">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1056%2FNEJMoa0904832" aria-label="Article reference 53">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19675329" aria-label="PubMed reference 53" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 53" href="http://scholar.google.com/scholar_lookup?&amp;title=Micrometastases%20or%20isolated%20tumor%20cells%20and%20the%20outcome%20of%20breast%20cancer&amp;journal=N%20Engl%20J%20Med&amp;volume=361&amp;pages=653-663&amp;publication_year=2009&amp;author=de%20Boer%2CM&amp;author=van%20Deurzen%2CCH&amp;author=van%20Dijck%2CJA&amp;author=Borm%2CGF&amp;author=van%20Diest%2CPJ&amp;author=Adang%2CEM&amp;author=Nortier%2CJW&amp;author=Rutgers%2CEJ&amp;author=Seynaeve%2CC&amp;author=Menke-Pluymers%2CMB&amp;author=Bult%2CP&amp;author=Tjan-Heijnen%2CVC">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="54."><p class="c-article-references__text" id="ref-CR54_3055">Dalal BI, Keown PA, Greenberg AH: <b>Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma.</b> 
<i>Am J Pathol</i> 1993, <b>143:</b>381â389.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:STN:280:DyaK3szktlWqtw%3D%3D" aria-label="CAS reference 54">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8393616" aria-label="PubMed reference 54" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1887030" aria-label="PubMed Central reference 54" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 54" href="http://scholar.google.com/scholar_lookup?&amp;title=Immunocytochemical%20localization%20of%20secreted%20transforming%20growth%20factor-beta%201%20to%20the%20advancing%20edges%20of%20primary%20tumors%20and%20to%20lymph%20node%20metastases%20of%20human%20mammary%20carcinoma&amp;journal=Am%20J%20Pathol&amp;volume=143&amp;pages=381-389&amp;publication_year=1993&amp;author=Dalal%2CBI&amp;author=Keown%2CPA&amp;author=Greenberg%2CAH">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="55."><p class="c-article-references__text" id="ref-CR55_3055">Tanaka H, Yamashita T, Asada M, Mizutani S, Yoshikawa H, Tohyama M: <b>Cytoplasmic p21(Cip1/WAF1) regulates neurite remodeling by inhibiting Rho-kinase activity.</b> 
<i>J Cell Biol</i> 2002, <b>158:</b>321â329.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD38Xls1Shs7o%3D" aria-label="CAS reference 55">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1083%2Fjcb.200202071" aria-label="Article reference 55">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=12119358" aria-label="PubMed reference 55" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2173114" aria-label="PubMed Central reference 55" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 55" href="http://scholar.google.com/scholar_lookup?&amp;title=Cytoplasmic%20p21%28Cip1%2FWAF1%29%20regulates%20neurite%20remodeling%20by%20inhibiting%20Rho-kinase%20activity&amp;journal=J%20Cell%20Biol&amp;volume=158&amp;pages=321-329&amp;publication_year=2002&amp;author=Tanaka%2CH&amp;author=Yamashita%2CT&amp;author=Asada%2CM&amp;author=Mizutani%2CS&amp;author=Yoshikawa%2CH&amp;author=Tohyama%2CM">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="56."><p class="c-article-references__text" id="ref-CR56_3055">Shi Y, Massague J: <b>Mechanisms of TGF-beta signaling from cell membrane to the nucleus.</b> 
<i>Cell</i> 2003, <b>113:</b>685â700.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3sXkvVekt7o%3D" aria-label="CAS reference 56">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2FS0092-8674%2803%2900432-X" aria-label="Article reference 56">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=12809600" aria-label="PubMed reference 56" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 56" href="http://scholar.google.com/scholar_lookup?&amp;title=Mechanisms%20of%20TGF-beta%20signaling%20from%20cell%20membrane%20to%20the%20nucleus&amp;journal=Cell&amp;volume=113&amp;pages=685-700&amp;publication_year=2003&amp;author=Shi%2CY&amp;author=Massague%2CJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="57."><p class="c-article-references__text" id="ref-CR57_3055">Tian F, DaCosta Byfield S, Parks WT, Yoo S, Felici A, Tang B, Piek E, Wakefield LM, Roberts AB: <b>Reduction in Smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.</b> 
<i>Cancer Res</i> 2003, <b>63:</b>8284â8292.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3sXpvVagt7Y%3D" aria-label="CAS reference 57">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=14678987" aria-label="PubMed reference 57" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 57" href="http://scholar.google.com/scholar_lookup?&amp;title=Reduction%20in%20Smad2%2F3%20signaling%20enhances%20tumorigenesis%20but%20suppresses%20metastasis%20of%20breast%20cancer%20cell%20lines&amp;journal=Cancer%20Res&amp;volume=63&amp;pages=8284-8292&amp;publication_year=2003&amp;author=Tian%2CF&amp;author=DaCosta%20Byfield%2CS&amp;author=Parks%2CWT&amp;author=Yoo%2CS&amp;author=Felici%2CA&amp;author=Tang%2CB&amp;author=Piek%2CE&amp;author=Wakefield%2CLM&amp;author=Roberts%2CAB">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="58."><p class="c-article-references__text" id="ref-CR58_3055">Petersen M, Pardali E, van der Horst G, Cheung H, van den Hoogen C, van der Pluijm G, Ten Dijke P: <b>Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis.</b> 
<i>Oncogene</i> 
<b>29:</b>1351â1361.</p></li></ol><p class="c-article-references__download u-hide-print"><a data-track="click" data-track-action="download citation references" data-track-label="link" href="https://citation-needed.springer.com/v2/references/10.1186/bcr3322?format=refman&amp;flavour=references">Download references<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-download"></use></svg></a></p></div></div></div></section></div><section data-title="Acknowledgements"><div class="c-article-section" id="Ack1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Ack1">Acknowledgements</h2><div class="c-article-section__content" id="Ack1-content"><p>This work was supported by a Canadian Institutes for Health Research (CIHR) grant (fund code 230670 to JJL). Ms. M. Dai is supported by a Fonds de la recherche en santÃ© du QuÃ©bec (FRSQ) Scholarship Award. JJ Lebrun is the recipient of a McGill Sir William Dawson Research Chair.</p><p>We thank Dr. Joan MassaguÃ© for kindly providing us the MDA, SCP2 and SCP25 cell lines and Dr. Stephen P Ethier for kindly providing us the SUM1315MO<sub>2,</sub> SUM149PT, SUM229PE and SUM159PT cell lines. We also thank Ms Juliana Korah for critical reading of the manuscript.</p></div></div></section><section aria-labelledby="author-information" data-title="Author information"><div class="c-article-section" id="author-information-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="author-information">Author information</h2><div class="c-article-section__content" id="author-information-content"><h3 class="c-article__sub-heading" id="affiliations">Affiliations</h3><ol class="c-article-author-affiliation__list"><li id="Aff1"><p class="c-article-author-affiliation__address">Division of Medical Oncology, Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, QC, Canada</p><p class="c-article-author-affiliation__authors-list">Meiou Dai,Â Amal A Al-Odaini,Â Suhad AliÂ &amp;Â Jean-Jacques Lebrun</p></li><li id="Aff2"><p class="c-article-author-affiliation__address">Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, QC, Canada</p><p class="c-article-author-affiliation__authors-list">Ani ArakelianÂ &amp;Â Shafaat A Rabbani</p></li></ol><div class="u-js-hide u-hide-print" data-test="author-info"><span class="c-article__sub-heading">Authors</span><ol class="c-article-authors-search u-list-reset"><li id="auth-Meiou-Dai"><span class="c-article-authors-search__title u-h3 js-search-name">Meiou Dai</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="https://www.biomedcentral.com/search?query=author%23%22Meiou%20Dai%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Meiou%20Dai" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide">Â </span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Meiou%20Dai%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-Amal_A-Al_Odaini"><span class="c-article-authors-search__title u-h3 js-search-name">Amal A Al-Odaini</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="https://www.biomedcentral.com/search?query=author%23%22Amal%20A%20Al-Odaini%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Amal%20A%20Al-Odaini" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide">Â </span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Amal%20A%20Al-Odaini%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-Ani-Arakelian"><span class="c-article-authors-search__title u-h3 js-search-name">Ani Arakelian</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="https://www.biomedcentral.com/search?query=author%23%22Ani%20Arakelian%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Ani%20Arakelian" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide">Â </span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Ani%20Arakelian%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-Shafaat_A-Rabbani"><span class="c-article-authors-search__title u-h3 js-search-name">Shafaat A Rabbani</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="https://www.biomedcentral.com/search?query=author%23%22Shafaat%20A%20Rabbani%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Shafaat%20A%20Rabbani" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide">Â </span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Shafaat%20A%20Rabbani%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-Suhad-Ali"><span class="c-article-authors-search__title u-h3 js-search-name">Suhad Ali</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="https://www.biomedcentral.com/search?query=author%23%22Suhad%20Ali%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Suhad%20Ali" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide">Â </span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Suhad%20Ali%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-Jean_Jacques-Lebrun"><span class="c-article-authors-search__title u-h3 js-search-name">Jean-Jacques Lebrun</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="https://www.biomedcentral.com/search?query=author%23%22Jean-Jacques%20Lebrun%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Jean-Jacques%20Lebrun" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide">Â </span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Jean-Jacques%20Lebrun%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li></ol></div><h3 class="c-article__sub-heading" id="corresponding-author">Corresponding author</h3><p id="corresponding-author-list">Correspondence to
                <a id="corresp-c1" href="mailto:jj.lebrun@mcgill.ca">Jean-Jacques Lebrun</a>.</p></div></div></section><section data-title="Additional information"><div class="c-article-section" id="additional-information-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="additional-information">Additional information</h2><div class="c-article-section__content" id="additional-information-content"><h3 class="c-article__sub-heading">Competing interests</h3><p>The authors declare that they have no competing interests.</p><h3 class="c-article__sub-heading">Authors' contributions</h3><p>MD and JJL designed the experiments and wrote the manuscript. SAR and SA assisted in editing the manuscript. MD and JJL were involved in all the experiments, data analysis and interpretation. AAA analyzed the tissue microarray data and tumor local invasiveness. SAR and AA performed <i>in vivo</i> studies and analyzed the mammary tumor growth. All authors read and approved the final manuscript.</p><p>An erratum to this article is available at <a href="http://dx.doi.org/10.1186/s13058-017-0832-7">http://dx.doi.org/10.1186/s13058-017-0832-7</a>.</p></div></div></section><section data-title="Electronic supplementary material"><div class="c-article-section" id="SecESM1_3055-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="SecESM1_3055">Electronic supplementary material</h2><div class="c-article-section__content" id="SecESM1_3055-content"><div data-test="supplementary-info"><div id="figshareContainer" class="c-article-figshare-container" data-test="figshare-container"></div>
                  
                  
                  
                  
                  
                  
                  
                  
                  
                  
                <div class="c-article-supplementary__item" data-test="supp-item" id="MOESM1"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-track-label="link" data-test="supp-info-link" href="https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_MOESM1_ESM.XLSX" data-supp-info-image="">13058_2012_3055_MOESM1_ESM.XLSX</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Additional file 1: <b>Table S1: Patient characteristics from breast carcinoma microarray tissue sections</b>. The patient characteristics including tumor grade, TNM and lymph node involvement are provided for breast carcinoma microarray slides (BCR961 and T088, Biomax). (XLSX 12 KB)</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM2"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-track-label="link" data-test="supp-info-link" href="https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_MOESM2_ESM.PDF" data-supp-info-image="">13058_2012_3055_MOESM2_ESM.PDF</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Additional file 2: <b>Figure S1: The relationship between p21 expression and clinical outcomes in ER+ and ER- breast cancer patients</b>. <b>A</b> and <b>B</b>, The correlation of p21 expression with overall survival and distant metastasis free survival in ER+ and ER- breast cancer patients was assessed by Kaplan-Meier survival analysis. The patients were divided into high or low groups based on the median of p21 expression. Number of breast cancer patients at risk with higher expression (red) and lower expression (black) of p21 at the indicated time points. (PDF 482 KB)</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM3"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-track-label="link" data-test="supp-info-link" href="https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_MOESM3_ESM.PDF" data-supp-info-image="">13058_2012_3055_MOESM3_ESM.PDF</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Additional file 3: <b>Figure S2: Knocking down p21 does not affect bone osteolytic lesions</b>. Representative radiographs of skeletal lesions in two groups of mice (parental and shRNA p21) were taken by X-ray using Faxitron. <b>A</b>, parental and shRNA p21 SCP2 cells were injected in orthotopic site (mammary gland). <b>B</b> and <b>C</b>, parental and shRNA p21 SCP2 cells were injected in tibia. The lesions are highlighted by arrows. The X-ray scores of bone lesions at Week 8 are shown for the two groups of animals. Data are reported as the mean Â± SEM of eight animals in each group and the X-ray scoring differences were tested by an independent two-sample t-test. No statistically significant difference was observed between the two groups (<i>P</i> = 0.81). <i>P</i> &lt; 0.05 was considered to be statistically significant. (PDF 3 MB)</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM4"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-track-label="link" data-test="supp-info-link" href="https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_MOESM4_ESM.PDF" data-supp-info-image="">13058_2012_3055_MOESM4_ESM.PDF</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Additional file 4: <b>Figure S3: TGFÎ² has no effect on cell growth or cell cycle progression in basal-type triple negative breast cancer cells</b>. <b>A</b>, The indicated cell lines were stimulated with TGFÎ² for 48 hrs and subjected to MTT assay (error bars indicate SD; n = 3 independent experiments). <b>B</b>, SCP2 cells were incubated with or without TGFÎ² for the indicated times and cell cycle distribution was determined by flow cytometry. <b>C</b>, MDA cell lysates were analyzed for phospho-Smad2, phospho-Smad3 and total Smad2/3 protein levels by Western blotting. (PDF 338 KB)</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM5"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-track-label="link" data-test="supp-info-link" href="https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_MOESM5_ESM.PDF" data-supp-info-image="">13058_2012_3055_MOESM5_ESM.PDF</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Additional file 5: <b>Figure S4: Effect of TGFÎ² on cell migration in SUM1315</b>. <b>A</b>, Representative images of phase contrast and wound mask of SUM1315 cell line stimulated with TGFÎ² in scratch/wound healing assay. <b>B</b>, The time course of cell migration for SUM1315 was quantified using the relative wound density metrics (error bars indicate SEM; n = 3 independent experiments). <b>C</b>, Cell viability (MTT) assay of transfected SCP2 cells subjected to scratch/wound healing assay. (PDF 5 MB)</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM6"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-track-label="link" data-test="supp-info-link" href="https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_MOESM6_ESM.PDF" data-supp-info-image="">13058_2012_3055_MOESM6_ESM.PDF</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Additional file 6: <b>Figure S5: Effect of p21 expression on cell proliferation</b>. SUM159 cells were transfected with a Scr siRNA, a p21 siRNA and a flag-tagged p21 construct. Transfected SUM159 cells were then subjected to MTT assay (error bars indicate SD, n = 3). (PDF 286 KB)</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM7"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-track-label="link" data-test="supp-info-link" href="https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_MOESM7_ESM.PDF" data-supp-info-image="">13058_2012_3055_MOESM7_ESM.PDF</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Additional file 7: <b>Figure S6: Effect of p21 depletion on serum and EGF-stimulated cell migration</b>. SCP2 cells were transfected with or without p21 siRNA. Cell invasion was assessed using the Transwell Invasion assay. Total number of cells invaded was counted by Image J (error bars indicate SEM; n = 3 independent experiments). * <i>P</i> &lt; 0.05, n.s., non significant. (PDF 1 MB)</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM8"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-track-label="link" data-test="supp-info-link" href="https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_MOESM8_ESM.PDF" data-supp-info-image="">13058_2012_3055_MOESM8_ESM.PDF</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Additional file 8: <b>Figure S7: Effect of TGFÎ² on cofilin phosphorylation and p21 nuclear localization</b>. <b>A</b>, SCP2 and SUM159 cells were treated with or without 5 ng/ml TGFÎ² for the indicated times. Total cell lysates were analyzed for phospho-cofilin and colifin protein levels by Western blotting. <b>B</b>, Immunocytochemistry was performed using p21 (green) antibody and DAPI (blue). The scale bar is 10 Âµm. (PDF 980 KB)</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM9"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-track-label="link" data-test="supp-info-link" href="https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_MOESM9_ESM.PDF" data-supp-info-image="">13058_2012_3055_MOESM9_ESM.PDF</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Additional file 9: <b>Figure S8: Effect of TGFÎ² on acetylation of total histone proteins</b>. SCP2 cells were treated with TGFÎ² and TSA for the indicated times. Immunoblots of total histone proteins using an acetylated lysine (Ac-Lysine) antibody. (PDF 352 KB)</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM10"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-track-label="link" data-test="supp-info-link" href="https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3322/MediaObjects/13058_2012_3055_MOESM10_ESM.PDF" data-supp-info-image="">13058_2012_3055_MOESM10_ESM.PDF</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Additional file 10: <b>Figure S9: p21 is specifically overexpressed in breast tumor cells</b>. Representative immunohistochemistry images of AE1/AE3 and p21 in lymph node negative (LN-) and positive (LN+) of breast cancer tissue microarray samples. (PDF 19 MB)</p></div></div></div></div></div></section><section data-title="Rights and permissions"><div class="c-article-section" id="rightslink-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="rightslink">Rights and permissions</h2><div class="c-article-section__content" id="rightslink-content"><p class="c-article-rights"><a data-track="click" data-track-action="view rights and permissions" data-track-label="link" href="https://s100.copyright.com/AppDispatchServlet?title=A%20novel%20function%20for%20p21Cip1%20and%20acetyltransferase%20p%2FCAF%20as%20critical%20transcriptional%20regulators%20of%20TGF%CE%B2-mediated%20breast%20cancer%20cell%20migration%20and%20invasion&amp;author=Meiou%20Dai%20et%20al&amp;contentID=10.1186%2Fbcr3322&amp;copyright=Dai%20et%20al.%3B%20licensee%20BioMed%20Central%20Ltd.&amp;publication=1465-542X&amp;publicationDate=2012-09-20&amp;publisherName=SpringerNature&amp;orderBeanReset=true">Reprints and Permissions</a></p></div></div></section><section aria-labelledby="article-info" data-title="About this article"><div class="c-article-section" id="article-info-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="article-info">About this article</h2><div class="c-article-section__content" id="article-info-content"><div class="c-bibliographic-information"><div class="c-bibliographic-information__column"><h3 class="c-article__sub-heading" id="citeas">Cite this article</h3><p class="c-bibliographic-information__citation">Dai, M., Al-Odaini, A.A., Arakelian, A. <i>et al.</i> A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFÎ²-mediated breast cancer cell migration and invasion.
                    <i>Breast Cancer Res</i> <b>14, </b>3055 (2012). https://doi.org/10.1186/bcr3322</p><p class="c-bibliographic-information__download-citation u-hide-print"><a data-test="citation-link" data-track="click" data-track-action="download article citation" data-track-label="link" data-track-external="" href="https://citation-needed.springer.com/v2/references/10.1186/bcr3322?format=refman&amp;flavour=citation">Download citation<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-download"></use></svg></a></p><ul class="c-bibliographic-information__list" data-test="publication-history"><li class="c-bibliographic-information__list-item"><p>Received<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2012-05-29">29 May 2012</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Revised<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2012-07-31">31 July 2012</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Accepted<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2012-08-24">24 August 2012</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Published<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2012-09-20">20 September 2012</time></span></p></li><li class="c-bibliographic-information__list-item c-bibliographic-information__list-item--doi"><p><abbr title="Digital Object Identifier">DOI</abbr><span class="u-hide">: </span><span class="c-bibliographic-information__value">https://doi.org/10.1186/bcr3322</span></p></li></ul><div data-component="share-box"><div class="c-article-share-box u-display-none" hidden=""><h3 class="c-article__sub-heading">Share this article</h3><p class="c-article-share-box__description">Anyone you share the following link with will be able to read this content:</p><button class="js-get-share-url c-article-share-box__button" id="get-share-url" data-track="click" data-track-label="button" data-track-external="" data-track-action="get shareable link">Get shareable link</button><div class="js-no-share-url-container u-display-none" hidden=""><p class="js-c-article-share-box__no-sharelink-info c-article-share-box__no-sharelink-info">Sorry, a shareable link is not currently available for this article.</p></div><div class="js-share-url-container u-display-none" hidden=""><p class="js-share-url c-article-share-box__only-read-input" id="share-url" data-track="click" data-track-label="button" data-track-action="select share url"></p><button class="js-copy-share-url c-article-share-box__button--link-like" id="copy-share-url" data-track="click" data-track-label="button" data-track-action="copy share url" data-track-external="">Copy to clipboard</button></div><p class="js-c-article-share-box__additional-info c-article-share-box__additional-info">
                            Provided by the Springer Nature SharedIt content-sharing initiative
                        </p></div></div><h3 class="c-article__sub-heading">Keywords</h3><ul class="c-article-subject-list"><li class="c-article-subject-list__subject"><span>SUM159 Cell</span></li><li class="c-article-subject-list__subject"><span>Breast Cancer Cell Migration</span></li><li class="c-article-subject-list__subject"><span>Thiazolyl Blue Tetrazolium Bromide</span></li><li class="c-article-subject-list__subject"><span>SCP2 Cell</span></li><li class="c-article-subject-list__subject"><span>Triple Negative Human Breast Cancer</span></li></ul><div data-component="article-info-list"></div></div></div></div></div></section>

                    


                </article>
            </main>

            <div class="c-article-extras u-text-sm u-hide-print" data-track-component="reading companion">
                <aside>
                    
    <div class="c-pdf-download u-clear-both">
        <a href="//breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3322.pdf" class="c-pdf-download__link" data-article-pdf="true"  data-readcube-pdf-url="true" data-test="pdf-link" data-draft-ignore="true" data-track="click" data-track-action="download pdf" data-track-label="link" data-track-external>
            <span>Download PDF</span>
            <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#global-icon-download"/></svg>
        </a>
    </div>

                    

                    
    


                    <div class="c-reading-companion">
                        <div class="c-reading-companion__sticky" data-component="reading-companion-sticky" data-test="reading-companion-sticky">
                            <div class="c-reading-companion__panel c-reading-companion__sections c-reading-companion__panel--active" id="tabpanel-sections">
                                <div class="js-ad">
    
    <aside class="adsbox c-ad c-ad--300x250 u-mt-16" data-component-mpu>
        <div class="c-ad__inner" >
            <p class="c-ad__label">Advertisement</p>
            <div id="div-gpt-ad-MPU1"
                data-ad-type="MPU1"
                data-pa11y-ignore
                data-gpt
                data-gpt-unitpath="/270604982/bmc/breast-cancer-research/articles"
                data-gpt-sizes="300x250"
                data-gpt-targeting="pos=MPU1;doi=10.1186/bcr3322;type=article;kwrd=SUM159 Cell,Breast Cancer Cell Migration,Thiazolyl Blue Tetrazolium Bromide,SCP2 Cell,Triple Negative Human Breast Cancer;pmc=B11001,H33160,H59150;"
            >
                <noscript>
                    <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/270604982/bmc/breast-cancer-research/articles&amp;sz=300x250&amp;pos=MPU1&amp;doi=10.1186/bcr3322&amp;type=article&amp;kwrd=SUM159 Cell,Breast Cancer Cell Migration,Thiazolyl Blue Tetrazolium Bromide,SCP2 Cell,Triple Negative Human Breast Cancer&amp;pmc=B11001,H33160,H59150&amp;">
                        <img data-test="gpt-advert-fallback-img"
                            src="//pubads.g.doubleclick.net/gampad/ad?iu=/270604982/bmc/breast-cancer-research/articles&amp;sz=300x250&amp;pos=MPU1&amp;doi=10.1186/bcr3322&amp;type=article&amp;kwrd=SUM159 Cell,Breast Cancer Cell Migration,Thiazolyl Blue Tetrazolium Bromide,SCP2 Cell,Triple Negative Human Breast Cancer&amp;pmc=B11001,H33160,H59150&amp;"
                            alt="Advertisement"
                            width="300"
                            height="250">
                    </a>
                </noscript>
            </div>
        </div>
    </aside>
</div>
                            </div>
                            <div class="c-reading-companion__panel c-reading-companion__figures c-reading-companion__panel--full-width" id="tabpanel-figures"></div>
                            <div class="c-reading-companion__panel c-reading-companion__references c-reading-companion__panel--full-width" id="tabpanel-references"></div>
                        </div>
                    </div>
                </aside>
            </div>

        </div>


        
            <div class="c-journal-footer">
                <div class="c-journal-footer__inner">
                    <div class="c-journal-footer__summary">
                        <h4 class="c-journal-title c-journal-title--footer">
                            
                            <span class="c-journal-title__text">Breast Cancer Research</span>
                        </h4>
                         <p class="c-journal-footer__issn">ISSN: 1465-542X</p>
                    </div>
                    
                        <div class="c-journal-footer__contact">
                            <h4 class="c-journal-footer__contact-title ">Contact us</h4>
                            <ul class="c-journal-footer__contact-list">
                                
                                    <li class="c-journal-footer__contact-item">Submission enquiries: <a href="mailto:maritess.reyes@springernature.com">maritess.reyes@springernature.com</a></li>
                                
                                
                                    <li class="c-journal-footer__contact-item">General enquiries: <a href="mailto:info@biomedcentral.com">info@biomedcentral.com</a></li>
                                
                            </ul>
                        </div>
                    
                </div>
            </div>
        
        
    <img rel="nofollow" class='tracker' style='display:none' src='/track/article/10.1186/bcr3322' alt=""/>

         
    <footer>
        
            <div class="c-publisher-footer" data-test="publisher-footer">
    <div class="u-container">
        <div class="u-display-flex u-flex-wrap u-justify-content-space-between" data-test="publisher-footer-menu">
            <div class="u-display-flex">
                
                    
                        <ul class="c-list-group c-list-group--sm u-mr-24 u-mb-16">
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="http://blogs.biomedcentral.com/">Read more on our blogs</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="//www.biomedcentral.com/login">Receive BMC newsletters</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="//www.biomedcentral.com/account">Manage article alerts</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="https://authorservices.springernature.com/go/10BMC">Language editing for authors</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="http://authorservices.springernature.com/scientific-editing/">Scientific editing for authors</a>
                                </li>
                            
                        </ul>
                    
                        <ul class="c-list-group c-list-group--sm u-mr-24 u-mb-16">
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="//www.biomedcentral.com/about/policies">Policies</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="//www.biomedcentral.com/accessibility">Accessibility</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="//www.biomedcentral.com/about/press-centre">Press center</a>
                                </li>
                            
                        </ul>
                    
                        <ul class="c-list-group c-list-group--sm u-mr-24 u-mb-16">
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="https://support.biomedcentral.com/support/home">Support and Contact</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="https://biomedcentral.typeform.com/to/VLXboo">Leave feedback</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="//www.biomedcentral.com/about/jobs">Careers</a>
                                </li>
                            
                        </ul>
                    
                
            </div>
            <div class="u-mb-24">
                <h3 id="social-menu" class="u-text-sm u-reset-margin u-text-normal">Follow BMC</h3>
                <ul class="u-display-flex u-list-reset" data-test="footer-social-links">
                    
                        <li class="u-mt-8 u-mr-8">
                            <a href="https://twitter.com/biomedcentral"
                               data-track="click"
                               data-track-category="Social"
                               data-track-action="Clicked BMC Twitter"
                               class="u-gray-link">
                                <span class="u-visually-hidden">BMC Twitter page</span>
                                <svg class="u-icon u-text-lg" width="24" height="24" aria-hidden="true" focusable="false">
                                    <use xlink:href="#icon-twitter-bordered"></use>
                                </svg>
                            </a>
                        </li>
                    
                        <li class="u-mt-8 u-mr-8">
                            <a href="https://www.facebook.com/BioMedCentral"
                               data-track="click"
                               data-track-category="Social"
                               data-track-action="Clicked BMC Facebook"
                               class="u-gray-link">
                                <span class="u-visually-hidden">BMC Facebook page</span>
                                <svg class="u-icon u-text-lg" width="24" height="24" aria-hidden="true" focusable="false">
                                    <use xlink:href="#icon-facebook-bordered"></use>
                                </svg>
                            </a>
                        </li>
                    
                        <li class="u-mt-8 u-mr-8">
                            <a href="http://www.weibo.com/biomedcentral"
                               data-track="click"
                               data-track-category="Social"
                               data-track-action="Clicked BMC Weibo"
                               class="u-gray-link">
                                <span class="u-visually-hidden">BMC Weibo page</span>
                                <svg class="u-icon u-text-lg" width="24" height="24" aria-hidden="true" focusable="false">
                                    <use xlink:href="#icon-weibo-bordered"></use>
                                </svg>
                            </a>
                        </li>
                    
                </ul>
            </div>
        </div>
        <p class="u-reset-margin">
            By using this website, you agree to our
            <a class="u-gray-link" href="//www.biomedcentral.com/terms-and-conditions">Terms and Conditions</a>,
            <a class="u-gray-link" href="https://www.springernature.com/ccpa">California Privacy Statement</a>,
            <a class="u-gray-link" href="//www.biomedcentral.com/privacy-statement">Privacy
                statement</a> and
            <a class="u-gray-link" href="//www.biomedcentral.com/cookies" data-test="cookie-link">Cookies</a> policy.
            
                <a class="optanon-toggle-display u-gray-link" data-cc-action="preferences" href="javascript:void(0);">Manage cookies/Do not sell my data</a> we use in the preference centre.
            
        </p>
    </div>
</div>

        
        <div class="c-corporate-footer">
    <div class="u-container">
        <img src=/static/images/logo-springernature-acb40b85fb.svg class="c-corporate-footer__logo" alt="Springer Nature" itemprop="logo" role="img">
        <p class="c-corporate-footer__legal" data-test="copyright"> &#169; 2022 BioMed Central Ltd unless otherwise stated. Part of
            <a class="c-corporate-footer__link" href="https://www.springernature.com" itemscope itemtype="http://schema.org/Organization" itemid="#parentOrganization">Springer Nature</a>.
        </p>
    </div>
</div>

    </footer>

    </div>



        
    <svg class="u-hide hide">
        <symbol id="global-icon-chevron-right" viewBox="0 0 16 16">
            <path d="M7.782 7L5.3 4.518c-.393-.392-.4-1.022-.02-1.403a1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L7.782 9l1.013-.998z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="global-icon-download" viewBox="0 0 16 16">
            <path d="M2 14c0-.556.449-1 1.002-1h9.996a.999.999 0 110 2H3.002A1.006 1.006 0 012 14zM9 2v6.8l2.482-2.482c.392-.392 1.022-.4 1.403-.02a1.001 1.001 0 010 1.417l-4.177 4.177a1.001 1.001 0 01-1.416 0L3.115 7.715a.991.991 0 01-.016-1.4 1 1 0 011.42.003L7 8.8V2c0-.55.444-.996 1-.996.552 0 1 .445 1 .996z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="global-icon-email" viewBox="0 0 18 18">
            <path d="M1.995 2h14.01A2 2 0 0118 4.006v9.988A2 2 0 0116.005 16H1.995A2 2 0 010 13.994V4.006A2 2 0 011.995 2zM1 13.994A1 1 0 001.995 15h14.01A1 1 0 0017 13.994V4.006A1 1 0 0016.005 3H1.995A1 1 0 001 4.006zM9 11L2 7V5.557l7 4 7-4V7z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="global-icon-institution" viewBox="0 0 18 18">
            <path d="M14 8a1 1 0 011 1v6h1.5a.5.5 0 01.5.5v.5h.5a.5.5 0 01.5.5V18H0v-1.5a.5.5 0 01.5-.5H1v-.5a.5.5 0 01.5-.5H3V9a1 1 0 112 0v6h8V9a1 1 0 011-1zM6 8l2 1v4l-2 1zm6 0v6l-2-1V9zM9.573.401l7.036 4.925A.92.92 0 0116.081 7H1.92a.92.92 0 01-.528-1.674L8.427.401a1 1 0 011.146 0zM9 2.441L5.345 5h7.31z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="global-icon-search" viewBox="0 0 22 22">
            <path fill-rule="evenodd" d="M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z"/>
        </symbol>
        <symbol id="icon-info" viewBox="0 0 18 18">
            <path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="icon-success" viewBox="0 0 18 18">
            <path d="M9 0a9 9 0 110 18A9 9 0 019 0zm3.486 4.982l-4.718 5.506L5.14 8.465a.991.991 0 00-1.423.133 1.06 1.06 0 00.13 1.463l3.407 2.733a1 1 0 001.387-.133l5.385-6.334a1.06 1.06 0 00-.116-1.464.991.991 0 00-1.424.119z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="icon-chevron-down" viewBox="0 0 16 16">
            <path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 1)"/>
        </symbol>
        <symbol id="icon-warning" viewBox="0 0 18 18">
            <path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="icon-plus" viewBox="0 0 16 16">
            <path d="m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="icon-minus" viewBox="0 0 16 16">
            <path d="m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="icon-error" viewBox="0 0 18 18">
            <path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm2.8630343 4.71100931-2.8630343 2.86303426-2.86303426-2.86303426c-.39658757-.39658757-1.03281091-.39438847-1.4265779-.00062147-.39651227.39651226-.39348876 1.03246767.00062147 1.4265779l2.86303426 2.86303426-2.86303426 2.8630343c-.39658757.3965875-.39438847 1.0328109-.00062147 1.4265779.39651226.3965122 1.03246767.3934887 1.4265779-.0006215l2.86303426-2.8630343 2.8630343 2.8630343c.3965875.3965876 1.0328109.3943885 1.4265779.0006215.3965122-.3965123.3934887-1.0324677-.0006215-1.4265779l-2.8630343-2.8630343 2.8630343-2.86303426c.3965876-.39658757.3943885-1.03281091.0006215-1.4265779-.3965123-.39651227-1.0324677-.39348876-1.4265779.00062147z" fill="currentColor" fill-rule="evenodd"/>
        </symbol>
        <symbol id="icon-springer-arrow-left">
            <path d="M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z"/>
        </symbol>
        <symbol id="icon-springer-arrow-right">
            <path d="M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z"/>
        </symbol>
    </svg>

    </body>
</html>

